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The nervous system can be divided into two main systems, i.e., the central nervous 
system (CNS), consisting of the brain and spinal cord, and the peripheral nervous system 
(PNS), consisting of bundles of neurons (nerves), connecting the CNS to other parts of the 
body. The CNS is composed of white and gray matter, the latter being the most external 
layer of the brain, which predominantly contains neuronal cell bodies. Projections from 
these cell bodies, called axons, extend to other areas of the brain, thereby enabling these 
cells to actively participate in the storage and processing of information. White matter 
consists primarily of axons coated with the light-colored myelin, which is produced by 
oligodendrocytes (OLGs). The myelin sheath, which is wrapped around axons, is 
interrupted at regular intervals along these axons, called nodes of Ranvier. Importantly, this 
anatomical construction allows saltatory conduction in which nerve impulses ‘jump’ 
between nodes, rather than they pass in a continuous and monotonous fashion. 
The elaboration of the myelin sheath by OLGs is one of the most complex and 
remarkable features of neural development. Not surprisingly therefore, myelin biogenesis is 
a highly regulated process that requires the coordination of several oligodendrocytic 
events including lipid and protein synthesis, intracellular membrane trafficking and 
morphological changes. Moreover, a carefully regulated balance of myelin synthesis and 
turnover during adult life is crucial for the maintenance of a functional myelin sheath. 
Imbalance in these processes or disruption of this myelin membrane may lead to 
irreparable consequences, resulting in diseases like multiple sclerosis (MS) (de Vries and 
Hoekstra, 2000; Baumann and Pham-Dinh, 2001). In MS, the myelin is destructively removed 
from around the axon in a process known as demyelination, which slows nerve impulses. 
Damage to the myelin can be caused by macrophages that, in the presence of infiltrating 
T cells, are capable of phagocytosis of apparently ‘normal’ sheaths. This abnormal 
immune response may be triggered by genetic, environmental, and/or viral factors. In 
contrast to this generally held opinion, Barnett and Prineas (2004) recently presented data 
that extensive OLG apoptosis is the major pathological feature of myelin forming lesions. 
Consequently, rather than a cause, autoimmunity might well be considered a secondary 
amplifying response to massive OLG apoptosis (Barnett and Prineas, 2004; Matute and 
Pérez-Cerdá, 2005). 
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Nevertheless, for a successful search of an effective therapeutic strategy, which is 
still conspicuously lacking, a detailed understanding of the key events of myelination, and 
hence potential remyelination, including the characteristics of the sorting and trafficking 
pathways of (myelin) membrane proteins in myelinating OLGs, is imperative. In doing so, it 
is relevant to take into account that OLGs can be considered as polarized cells in which 
the overall myelin membrane composition differs dramatically from that of the plasma 
membrane of the OLG cell body, in spite of the continuous nature of these two membrane 
domains. As polarized sorting and trafficking have largely been characterized in Madin-
Darby canine kidney cells (MDCK), the general aspects of the sorting and trafficking of 
membrane proteins will first be described in these cells. Subsequently, by extrapolating 
these findings the focus will be directed to whether similar mechanisms of sorting and 
trafficking of membrane proteins play a role in the biogenesis and maintenance of myelin 
and plasma membrane in OLGs. 
 
Membrane biogenesis in epithelial cells 
Introduction 
Epithelial cells are characterized by an asymmetric distribution of different sets of 
proteins and lipids in their plasma membranes. Specifically, the plasma membrane of these 
cells is separated into two distinct membrane domains, the apical domain, facing the 
organ lumen, and the basolateral domain facing neighboring cells and the underlying 
extracellular matrix (ECM) (Schuck and Simons, 2004). The two domains are separated by 
tight junctions, which form a morphological border and act as an intramembrane diffusion 
barrier. The distinct membrane domains have striking differences in their protein and lipid 
composition which correlates with the specific and distinct biological functions of these 
domains, dictated by environmental differences faced by either surface. The apical 
domain is enriched in glycospingolipids and cholesterol, whereas compositional-wise the 
basolateral domain resembles the plasma membrane of nonpolarized cells. In epithelial 
cells, newly synthesized membrane proteins can reach these surfaces by different cellular 
pathways, a direct pathway from the trans-Golgi network (TGN) to either the apical or 
basolateral surface, and an indirect or transcytotic pathway in which internalized apical 
and basolateral proteins are sorted in endosomes and recycled back to a specific plasma 









Figure 1: Sorting and trafficking routes of membrane proteins in polarized epithelial cells. In polarized epithelial 
cells two plasma membrane domains, the apical and basolateral, separated by tight junctions can be 
distinguished. In these cells targeting of newly synthesized membrane proteins to these membrane domains 
exist by different cellular pathways: in the 'direct' pathway membrane proteins are sorted in the Golgi 
apparatus and directed by vesicular transport to the apical (red arrows, no. 1) and basolateral (blue arrow, no. 
2) membranes. In the 'indirect' pathway, newly synthesized membrane proteins are first transported from the 
TGN to either the apical (orange arrows, no. 3) or basolateral (light blue arrows, no. 4) surface and are then 
endocytosed into endosomes and recycled back to a specific membrane domain. Abbreviations: N – nucleus; 
TGN – trans-Gogi network; TJ – tight junctions; E – endosomes. 
 
For instance, after its biosynthesis, the polymeric immunoglobulin receptor (pIgA-R) is 
transported from the Golgi complex to the basolateral surface after which this protein 
reaches its apical destination following endocytosis from the basolateral surface and 
subsequent transport by transcytosis to the apical surface (Hoppe et al., 1985). Its 
dynamics is illustrated by the notion that Hepatitis A virus (HAV) associated with IgA is 
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(Dotzauer et al., 2005). In the next paragraph sorting and trafficking mechanisms in 
polarized cells will be discussed in more detail. 
 
Basolateral sorting 
The molecular basis of basolateral sorting and targeting is only partially understood. 
Interestingly, in the absence of specific sorting signals, transmembrane proteins 
accumulate in the Golgi apparatus, suggesting that none of the routes to the cell surface 
is an efficient default pathway (Gut et al., 1998; Benting et al., 1999). Basolateral sorting 
and targeting of transmembrane proteins is mediated by specific short amino acid 
sequences located in their cytoplasmic tails and facilitated by cytosolic machineries that 
recognize these signals (Rodriguez-Boulan et al., 2004). These short amino acid sequences 
contain a crucial tyrosine (Y) residue, within a consensus sequence NPXY or YXXФ, where Ф 
is a bulky hydrophobic residue and X is any amino acid. Other basolateral signals include 
Leu-Leu and di-hydrophobic motifs (Odorizzi and Trowbridge, 1997; Bello et al., 2001). 
Given the similarity between basolateral tyrosine sorting determinants and endocytosis 
signals, basolateral cargo and molecules endocytosed from the plasma membrane meet 
in recycling endosomes and move to the basolateral membrane (Matter and Mellman, 
1994; Marks et al., 1997; Traub and Apodaca, 2003; Schuck and Simons, 2004). 
 
Apical sorting 
Apical sorting and targeting of transmembrane proteins is mediated by a number of 
different types of sorting signals, including N-linked or O-linked carbohydrates, specific 
transmembrane domains or glycosylphosphatidylinositol (GPI) anchors, and cytoplasmic 
domain determinants (Ikonen and Simons, 1998; Rodriguez-Boulan and Gonzalez, 1999). 
Whereas the presence of N- or O-glycans in the ectodomain is necessary for mediation of 
apical transport of some transmembrane proteins (Fiedler and Simons, 1996), glycosylation 
does not constitute a universal apical sorting signal, as an inhibition of glycosylation does 
not necessarily lead to missorting while unglycosylated membrane proteins are able to 
reach the apical surface (Lisanti et al., 1989; Alonso et al., 1997; Meerson et al., 2000; 
Bravo-Zehder et al., 2000). Apical delivery of transmembrane proteins is mediated through 
lipid-lipid or lipid-protein interactions (Schuck and Simons, 2004) wherein specific residues in 
the transmembrane domains of such proteins - or in the case of GPI-anchored proteins, the 





cholesterol-enriched membrane microdomains or ‘rafts’ (Simons and Ikonen, 1997; 
Scheiffele et al., 1997; Brown and London, 1998; Keller and Simons, 1998; Pike, 2006). These 
cholesterol-sphingolipid membrane rafts can be isolated based on their insolubility in cold 
detergents like Triton X-100 (TX-100) and 3-[(3-Cholamidopropyl) dimethylammonio]-1-
propanesulfonate (CHAPS). Oligomerization of raft components can initiate raft clustering, 
a mechanism which has also been proposed to be involved in triggering apical delivery 
(Schuck and Simons, 2004). Although the raft mechanism is still considered a typical apical 
sorting mechanism, there is evidence that raft association is not sufficient to ensure apical 
sorting (Ait-Slimane et al., 2003). 
 
Proteins involved in polarized trafficking 
Several proteins have been proposed to function in either the basolateral or apical 
sorting machinery. All identified basolateral sorting signals of integral membrane proteins 
are located in the cytoplasmic domains of the proteins. The tyrosine-dependent and 
dileucine-dependent sorting signals that specify endocytosis or lysosomal transport interact 
with adaptor proteins (APs), AP-1, AP-2, AP-3 and AP-4 (Bonifacino and Dell’Angelica, 
1999; Robinson and Bonifacino, 2001; Hirst et al., 1999). Adaptor proteins are 
heterotetrameric complexes of ‘adaptins’ that link clathrin to membrane proteins playing 
an important role in membrane invagination and protein trafficking (Dell’Angelica et al., 
1997). Adaptor protein-2 complex AP-2 (adaptins γ, β2, µ2, σ2) is involved in endocytosis at 
the plasma membrane, while at the TGN and/or endosomes AP-1 (α, β1, µ1, σ1), AP-3 (δ, 
β3, µ3, σ3) and AP-4 (ε, β4, µ4, σ4) contribute to lysosomal targeting. In general, µ subunits 
interact with tyrosine-based sorting determinants and β subunits with dileucine signals 
(Matter, 2000). 
Cholesterol-binding caveolin-1 is one of the proteins involved in the apical sorting 
machinery. Specifically, large caveolin-1 homooligomers are targeted to the apical 
surface and play a role in apical transport of viral proteins like HA in MDCK cells (Scheiffele, 
et al., 1998). Another protein implicated in apical transport is the myelin and lymphocyte 
proteolipid (MAL), also known as MVP17 (myelin vesicular protein 17; Kim et al., 1995), and 
VIP17 (vesicular integral protein 17; Zacchetti et al., 1995). MAL is a 17 kDa non-
glycosylated four transmembrane protein that is localized to membrane rafts (Kim et al., 
1995; Puertollano et al., 1999), being a component of the transport machinery for the raft 
mediated apical pathway (Zacchetti et al., 1995). Downregulation of MAL expression 
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specifcally inhibited transport to the apical surface (Puertollano et al., 1999; Marin-
Belmonte et al., 2000, 2001). Additionally, depletion of MAL resulted in an impairment of 
overall apical sorting and transport in MDCK cells (Puertollano et al., 1999). Consistently, 
overexpression of MAL increased apical delivery but also disturbed the morphology of the 
MDCK cell layers due to an elaboration of the apical membrane (Cheong et al., 1999).  
Trafficking of membrane proteins is mediated by vesicular transport and their 
integration within the membrane of their final destination, for example the plasma 
membrane, is finalized by a membrane fusion process. During this process, membrane 
vesicles target and fuse with their correct target membranes. Three central players in 
vesicle targeting and fusion can be distinguished (Hay and Scheller, 1997; Jahn and 
Sudhoff, 1999; Ludger and Galli, 1998; Pfeffer, 1996): (1) the Sec proteins, (2) small-
molecular-weight GTP-binding proteins, the rabs, and (3) the SNAREs, a group of 
cytoplasmically oriented integral membrane proteins that are present on vesicles (v-
SNAREs) or target membranes (t-SNAREs) (also reffered to as Q- and R-SNARE; see Weimbs 
et al., 1997; Fasshauer et al., 1998). In the following sections the three protein families 
involved in vesicle targeting and fusion will be briefly discussed. 
 
Exocyst 
The exocyst is an evolutionarily conserved multiprotein complex implicated in 
tethering secretory vesicles at specific sites of the plasma membrane preceding SNARE 
assembly and membrane fusion (Novick and Guo, 2002; Lipschutz and Mostov, 2002; Hsu 
et al., 2004). The exocyst is an octameric complex, consisting of the Sec3p, Sec5p, Sec6p, 
Sec8p, Sec10p, Sec15p, Exo70p and Ex084p components. All are hydrophilic proteins that 
exist in the cytosol and associate with plasma membrane (Terbush and Novick, 1995; 
Terbush et al., 1996; Guo et al., 1999). The exocyst is also important during earlier steps in 
the transport pathway, specifically in post-translational regulation of protein synthesis 
(Lipschutz et al., 2000; 2003). Exocysts mediate vesicle delivery to restricted regions of the 
cell surface discriminating whether and/or where a vesicle docks (Terbush and Novick, 
1995). Mammalian homologs to the exocyst subunits are ubiquitously expressed and also 
form a multimeric complex that is mainly peripherally associated with the plasma 
membrane (Ting et al., 1995; Hsu et al., 1996; Kee et al., 1997). For instance, the 
mammalian counterparts of the yeast Sec6, Sec8 and Sec10 exocyst have been localized 





synthesis of basolateral but not apical proteins, and subsequently favor membrane 




Rab proteins comprise the largest subgroup of small GTPases and belong to the Ras 
superfamily. Rab proteins act as molecular switches regulating intracellular membrane 
traffic by binding to specific organelle membranes (Miaczynska and Zerial., 2002; Pfeffer, 
2003), thereby recruiting effector proteins that control fusion, and perhaps sorting and 
budding of transport vesicles. Rab proteins lack efficient guanine nucleotide exchange 
and hydrolysis activity, and their interactions with effectors are regulated by guanine 
nucleotide exchange factores (GEFs) and GTPase-activating proteins (GAPs) that promote 
the critical assembly of Rab containing protein complexes (Pfeffer, 2001; Bernards, 2003; 
Spang, 2004). Effector complexes formed in response to Rab activation can perform a 
variety of functions. They couple membranes to the cytoskeleton through the recruitment 
of kinesin- and myosin -based motors (Hammer and WU, 2002; Karcher et al., 2002), direct 
the recruitment of tethering factors to initiate transport container docking (Moyer et al., 
2001; Allan et al., 2000), potentially facilitate the function of proteins that alter membrane 
lipid composition (Gruenberg, 2003), and may organize the activity of SNARE components 
that mediate membrane fusion (Pfeffer, 2001; Gerst, 2003; Spang, 2004). All together, Rab 
proteins regulate distinct transport steps along the biosynthetic/secretory and endocytotic 




SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein) (Nuoffer and 
Balch, 1994; Rothman and Wieland, 1996; Jahn and Sudhof, 1999; Larocca and Rodriguez-
Gabin, 2002) proteins are integral membrane proteins that form stable complexes which 
are present on both vesicle (v-SNARE) and the target mambranes (t-SNARE) (Chen and 
Scheller, 2001). The vesicle and target membranes are pulled together upon assembly of 
the v-t- SNARE complex, together with a variety of accessory proteins, thus bringing 
apposed bilayers in close approach, eventually leading to the fusion of vesicle and target 
membrane (Chen and Scheller, 2001). SNARE proteins are found in all tissues and cell types 
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and there are more than 9 VAMP isoforms, 19 syntaxin isoforms, and 3 SNAP25 isoforms 
across the animal and even the plant kingdoms (Jahn and Sudhoff, 1999). Syntaxins are 
the prototype family of SNARE proteins, constituting an important subunit of the t-SNAREs. 
Syntaxins usually consist of three main regions: a very short extracellularly/luminally directed 
COOH terminus, a central SNARE transmembrane domain which is characteristic of and 
conserved in all syntaxins, and a long cytoplasmic NH2-terminal region encompassing two 
coil-coil domains (Foster et al., 2000). Most importantly, the apical and basolateral plasma 
membrane domains of polarized epithelial cells may contain specific syntaxins, e.g. 
syntaxin 3 is located exclusively at the apical membrane, as well intracellularly in 
endosomes and lysomes (Gaisano et al., 1996; Low et al., 1996; Fujita et al., 1998) wheras 
syntaxin 4 is located entirely at the basolateral membrane surface. By expression of 
chimeric variants of syntaxin 3 and 4 in MDCK cells, it was demonstrated that these 
syntaxins play a role in determining the specificity of membrane targeting by regulating 
protein delivery to only certain target membranes (ter Beest et al., 2005). In syntaxin 3 
overexpressing cells or cells treated with anti-syntaxin 3 antibodies only the apical delivery 
was inhibited (Lafont et al., 1999; Low et al., 1998). 
Vesicle targeting and fusion at the basolateral membrane was inhibited by addition 
of anti-NSF antibodies, NEM, mutant NSF, rab-GDI, or tetanus and botulinum F neurotoxins, 
whereas the transport from the TGN to the apical domain was not changed (Ikonen et al., 
1995; Apodaca et al., 1996), suggesting the involvement of a distinct protein machinery in 
finalizing transport to either surface. Specifically, membrane traffic to the apical plasma 
membrane is regulated by Syntaxin 3 and T1-VAMP, which are associated with rafts (Lafont 
et al., 1999), whereas syntaxin 4 has been implicated in TGN to basolateral traffic, requiring 
NSF, rab proteins and VAMP-2 (Low et al., 1998; Lafont et al., 1999). How Rab GTPases, 
SNARE proteins, and their associated effectors and regulators confer membrane identity 
and coordinate the dynamics of cargo flux through sequential compartments to define 
the highly distinct subcellular organizations found in different mammalian cell and organ 
systems, remains largely unknown. 
 
Sorting and transport of myelin components: concepts of membrane traffic 
Composition and formation of myelin 
To discriminate between the various mechanisms involved in the sorting and 





composition of the myelin sheet. During myelin biogenesis, OLGs mature in a process in 
which distinct developmental stages can be identified. The cells differentiate from a 
bipolar progenitor cell (O2A stage) to a cell with branched primary processes (GalC 
stage), when the earliest myelin specific protein 2’, 3’ –cyclic nucleotide 3’-
phosphodiesterase (CNP, Pfeiffer et al., 1993) is expressed. Final maturation into myelin-
forming OLGs and the assembly of the sheath as such is characterized by the sequential 
expression of the proteins that ultimately make up the myelin, including myelin-associated 
glycoprotein (MAG), myelin basic protein (MBP), proteolipid protein (PLP), and myelin-




Figure 2: Schematic representation of the membrane interactions of the different myelin proteins in CNS myelin. 
CNP is associated with the cytoplasmic plasma membrane by isoprenylation. PLP is a transmembrane protein 
with a large extracellular domain. MBP, rich in positively charged lysine and arginine, interacts with the 
cytoplasmic faces at the phospholipid bilayer. MAG contains both a membrane-spanning domain and an 
extracellular region that contains five immunoglobulin domains. MOG, contains only one transmembrane 
domain and one immunoglobulin segment. Abbreviations: CNP - 2’,3’-cyclic nucleotide 3’-phosphodiesterase; 
PLP - proteolipid protein; MBP – myelin basic protein; MAG – myelin-associated glycoprotein; MOG – myelin 
oligodendrocyte glycoprotein. 
 
Apart from a distinct biochemical composition when compared to the plasma 
membrane of the glial cell soma, the myelin membrane is segregated into distinct 
subdomains with an asymmetric protein distribution. Indeed, myelin can be considered to 
be subdivided in a compact region, responsible for its physical insulation properties (Arroyo 
and Scherer, 2000) and a non-compact region. The compact myelin is formed by the 
apposition of the external faces of the membrane of the myelinating cell, forming the 
double intraperiodic line; the apposition of the internal faces followed by the extrusion of 
the cytoplasm, gives rise to formation of the major dense line. A tight junctional array is 
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located between compact and non-compact myelin, which likely serves as a diffusion 
barrier between these myelin subdomains (Gow et al., 1999; Morita et al., 1999; Bronstein et 
al., 2000). The compact region, enriched in the glycosphingolipids galactocerebroside 
(GalCer) and sulfatide, represents the bulk of the sheath. In this region the major myelin 
proteins PLP/DM20 and MBP are located as well as MAL (see above), as a minor non-
specific myelin protein (Lees and Brostoff, 1984; Griffiths et al., 1998; Norton and Cammer, 
1984; Frank, 2000). The non-compact myelin contains the minor myelin-specific proteins 
CNP, MAG and MOG.  
 
Myelin specific proteins 
The proteolipid protein PLP is the major integral membrane protein of CNS myelin. 
PLP spans the membrane four times and is highly hydrophobic with 50 % hydrophobic 
amino acids (fig. 2). Alternative splicing of the plp gene generates two proteins, PLP and 
DM-20, which lacks amino acids 116-150 of the PLP sequence (Macklin et al., 1987; Nave et 
al., 1987). As a structural protein, PLP plays a major role in assembly and stabilization of the 
myelin sheath in that the protein brings about the correct apposition of the extracellular 
leaflets of the membrane, thereby stabilizing the multilayered myelin membrane structure 
after compaction (Gudz et al., 1996; Klugmann et al., 1997, Rosenbluth et al., 2006). 
Indeed, in PLP-null CNS axons often lack myelin entirely or are surrounded by abnormally 
thin myelin sheaths. Moreover, mutations in the plp gene, such as jimpy and jimpymsd results 
in premature arrest of oligodendrocyte differentiation and early death, while 
overexpression of the normal plp gene in transgenic mice (Kagawa et al., 1994; Readhead 
et al., 1994) leads to severe dysmyelination (Griffiths et al., 1995; Dimou et al., 1999). In 
humans, a variety of mutations, including missense mutations, deletions, and duplications, 
of the PLP gene are known to cause the dysmyelinating disorders like Pelizaeus-
Merzbacher disease (PMD) and spastic paraplegia (Garbern et al., 1999). In fact, gene 
duplications of the human PLP locus are responsible for the majority of cases of PMD, 
leading to enhanced expression of the PLP protein and patients die in their early teens 
(Hodes and Dlouhy, 1996; Griffiths et al., 1998; Garbern et al., 1999; Yool et al., 2000). 
Although it is thus evident that PLP plays a vital role in myelin assembly and maintenance, 
on a functional and molecular level, its precise role remains undefined. 
MBP is a highly basic protein, located at the cytoplasmic surfaces of compact 





protein, which binds primarily via electrostatic interactions with charged lipid headgroups 
(Smith, 1992; Ter Beest and Hoekstra, 1993). In aqueous solution MBP is relatively unfolded, 
while in the presence of lipids, it seems to have a tendency to fold (Stuart, 1996; Polverini et 
al., 1999). MBP is derived by splicing from a common mRNA (Campagnoni, 1988) and 
various alternatively spliced isoforms of 14, 17, 18.5, 21.5 kDa (in rodents) are known. These 
isoforms are targeted, dependent on the presence or absence of the exon 2 encoded 
peptides, to distinct subcellular locations (Staugaitis et al., 1990; Allinquant et al., 1991). The 
major isoforms of MBP in compact myelin, i.e., the 14 kD and 18.5 kD isoforms (exon 2-
minus), display a strong affinity for cellular membranes. In contrast, the less abundant 17 kD 
and 21.5 kD isoforms (exon 2-plus) (Carson et al., 1983) localize to the nucleus and are 
diffusely distributed throughout the cytoplasm of transfected cells (Pedraza et al., 1997). As 
for the mRNA, exon 2-minus mRNAs are preferentially transported into the cell’s processes, 
while exon 2-plus mRNAs are confined to the cell body (de Vries et al., 1997). MBP plays a 
major role in myelin compaction as revealed by studies of the shiverer mutant mouse, 
where a large deletion of the MBP gene results in severe perturbation of myelin 
compaction (Privat et al., 1979). In fact, MBP is thought to be required for facilitating the 
approach of apposed inner leaflets of the plasma membrane, structurally characterized 
by the intraperiod line. 
In the non-compact region, the minor myelin specific proteins are located. CNP, 
present in two isoforms (46 and 48 kDa), is one of the earliest myelin-related proteins to be 
expressed in differentiating OLGs. It is located periaxonally and in the outer loops, 
associated with the inner leaflet of the myelin membrane and the actin/cytoskeleton (De 
Angelis and Braun, 1996) (fig. 2). A proposed role for CNP in process formation, i.e., initial 
sites where myelin membrane extensions originate, comes from the observations that 
overexpression of CNP causes aberrant OLG membrane formation and perturbs 
myelination (Gravel et al., 1996). It has also been reported that CNP-deficient mice extend 
smaller and less branched processes (Lee et al., 2005). In addition, a role for CNP in the 
formation of the paranodes has been suggested (Rasband et al., 2005). 
MAG, a cell adhesion molecule belonging to the immunoglobulin superfamily, is a 
transmembrane glycoprotein with a molecular weight of 100 kDa (Quarles et al., 1972; 
1973), of which approximately 30 % is carbohydrate (Frail and Braun, 1984) (fig. 2). As a 
result of alternative splicing of the primary MAG transcript, MAG exists as two isoforms, 
designated small-MAG (S-MAG, 67 kDa) and large-MAG (L-MAG, 72 kDa) (Lai et al., 1987; 
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Tropak et al., 1988). The polypeptide chains of the two isoforms differ only by the carboxy 
terminus of their respective cytoplasmic domains, which most probably determine the 
isoform-specific functions (Fujita et al., 1998). L-MAG, containing a larger cytoplasmic 
intracellular domain, is expressed early in development and has been implicated in 
signalling, whereas S-MAG, representing the major isoform in mature myelin is upregulated 
later during development. The cytoplasmic domain of L-MAG contains two putative 
tyrosine internalisation signals, which may account for selective endocytosis of L-MAG (Bo 
et al., 1995). Since MAG is mainly localized in the periaxonal region of the paranodal loops 
while in MAG/deficient mice the CNS develops with a prominent defect in the formation of 
the periaxonal cytoplasmic collar, these observations suggest a role of MAG in directing 
OLG processes towards myelinated and nonmyelinated axons thereby being intimately 
involved in axo/glial interaction (Li et al., 1994).  
MOG is another CNS specific minor myelin constituent, which is highly conserved 
and present only in mammalian species (Birling et al., 1993). MOG is a glycosylated protein 
with a molecular mass of 26-28 kDA that can form dimers of 52-54 kDa (Amiguet et al., 
1992; Birling et al., 1993), and which is mainly localized in the abaxonal loop thereby facing 
the extracellular environment. Besides MOG ‘s role in defining the structural integrity of the 
myelin sheath, it has also been suggested that it might interact with proteins of the immune 
system. MOG, located at the cell surface, is the only CNS component that can induce an 
antibody-mediated response and a T-cell mediated immune reaction in an animal model 
for MS, experimental autoimmune encephalomyelitis (EAE) (Linington et al., 1988). 
 
Lipids 
Lipids comprise 70–80 % of the dry weight of the myelin, containing a major fraction 
of cholesterol and the glycosphingolipids (GSL) galactosylceramide (GalCer) and its 
sulfated derivative, sulfatide. The outer leaflet of the myelin membrane is enriched in GSL 
and cholesterol, whereas the inner leaflet is enriched in phospholipids (Stoffel and Bosio, 
1997). GalCer is synthesized in the endoplasmatic reticulum (ER) upon attachment of a 
galactose to ceramide by UDP-galactose ceramide galactosyltransferase (CGT). Part of 
the GalCer is converted to sulfatide by the transfer of a sulfate molecule to the third 
carbon of the GalC sugar ring by galactosyl ceramide 3’-sulfotransferase (CST) in the 
lumen of the Golgi apparatus. The remaining part is present in the periphery of the myelin 





apparatus and used as loci for compartmentalization and transport of GalCer and 
cholesterol. Thus, an ER-plasma membrane transport pathway for GalCer inside OLGs exists 
that bypasses the Golgi apparatus just like that known for transport of cholesterol. Sigma-1 
receptors colocalize with cholesterol and neutral lipids and form detergent-insoluble lipid 
microdomains on the ER subcompartments. Upregulation of sigma-1 receptors affects the 
levels of plasma membrane lipid rafts by changing the lipid components therein, 
suggesting that sigma-1 receptor in OLGs might be involved in myelination by direct 
interference with cholesterol biosynthesis. Galactosphingolipids are possibly involved in 
affecting the orientation and/or lateral movement of signaling proteins in the outer leaflet 
of the plasma membrane. Possibly, for effective signaling, molecules like growth factor 
receptors and cell adhesion molecules require oligomerization, which could be driven by 
the clustering capacity of glycosphingolipids (Iwabuchi et al., 1998). These observations 
underscore the vital role that glycosphingolipids play during development and 
differentiation, and that they are involved in crucial processes that trigger these events. In 
the next section the sorting and trafficking of the myelin proteins, and their dependence 
on the presence of glycosphingolipids, will be discussed. 
 
Sorting and trafficking in oligodendrocytes 
To maintain the myelin specific composition and its spatial organzation, OLGs not 
only have to synthesize large amounts of proteins and lipids, the cells also must specifically 
target these compounds to locations where cell processes emerge and eventually wrap 
around axons. Thus, specific lipid and protein sorting mechanisms are required during 
myelinogenesis and myelin maintenance. 
 
PLP trafficking 
PLP and its alternatively spliced isoform DM20, are synthesized in the endoplasmic 
reticulum and subsequently transported via vesicles to the Golgi, followed by transport to 
the compacted internodal region of the myelin sheath. As indicated above, the myelin 
sheath is enriched in glycosphingolipids and cholesterol, thereby resembing the apical 
plasma membrane of polarized cells. De Vries et al. (1998) demonstrated that the 
biogenesis of the myelin sheet in vitro involved basolateral-like sorting features rather than 
parmameters typically directing apical transport. Thus, the apical domain marker influenza 
hemagglutinin (HA) was transported to the cell body plasma membrane, localizing to 
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detergent resistant microdomains, whereas the basolateral membrane marker vesicular 
stomatitis virus glycoprotein (VSV G) accumulated in the myelin sheet, being fully 




Figure 3: Sorting and trafficking pathways of membrane (associated) proteins in cultured oligodendrocytes. In 
OLGs the biochemical composition of the plasma membrane of OLG cell body is different from the membrane 
of the myelin sheet. Targeting of newly synthesized proteins to these distinct surfaces exist by different cellular 
pathways: in the 'direct' pathway membrane proteins are sorted in the Golgi apparatus and served by an 
apical-like transport route to OLG cell body plasma membrane (red arrow, no. 1) and a basolateral-like 
transport route to the myelin sheet (blue arrows, no. 2). In the 'indirect' pathway, proteins are first transported 
from the TGN to either cell body plasma membrane surface and are then endocytosed into endosomes and 
recycled back to the myelin sheet (orange arrows, no. 3). Abbreviations: N – nucleus; TGN – trans Golgi 
network; E – endosomes 
 
In OLGs it is still unknown how PLP/DM20 is transported to its final destination, i.e., the 
compact domain of the myelin sheath. Thus, evidence as to a role of glycosphingolipids 


















(1994) demonstrated that in primary OLGs the sorting and trafficking of PLP/DM20 to the 
processes and the myelin sheet is not affected by inhibition of sulfation, indicating that 
PLP/DM20 was not raft-associated (van der Haar et al. 1998). In the latter study (van der 
Haar et al., 1998) it was shown that the delivery of overexpressed PLP to the plasma 
membrane in GalC- and sulfatide-deficient Chines hamster ovary (CHO) cells was not 
affected and was very similar to that observed in cells, expressing these glycosphingolipids. 
Moreover, also in vivo, mice which were unable to synthesize GalC and sulfatide could still 
transport PLP to myelin (Coetzee et al., 1996). In contrast, other data demonstrated that 
PLP/DM20 is sorted by a raft-dependent mechanism, indicating that the association of PLP 
with cholesterol and galactosylceramide-enriched membrane domains during 
biosynthetic transport in primary cultures of OLGs, is critical. In isolated brain slice the 
translocation of PLP into myelin was 50 % reduced by inhibition of GSL synthesis through the 
effect of L-cycloserine, whereas the incorporation of MBP and overall protein synthesis was 
unaffected (Pasquini et al., 1989). Furthermore, in OLG infected with influenza virus, PLP 
colocalized with HA, which is transported via a raft-mediated mechanism to the apical 
domain in polarized epithelial cells (Simons et al., 2000). In other studies (Brown et al., 1993) 
claims has been made suggesting PLP co-transport with sulfatide, although it should be 
noted that this GSL species largely resides in the plasma membrane of the OLG cell body 
rather than in the myelin membrane, which is strongly enriched in GalCer (Baron et al., 
manuscript in preparation).  
Endocytic sorting and transcytosis may be an alternative pathway of trafficking of 
PLP/DM20 to the myelin sheath. Trajkovic et al. (2006) demonstrated that myelin 
membrane sorting and trafficking is regulated by neurons. They showed that in the 
absence of neurons, PLP is internalized and stored in late endosomes/lysosomes (LEs/Ls) by 
a cholesterol-dependent and clathrin-independent endocytosic pathway. Upon 
maturation, the rate of endocytosis reduced, and a cAMP-dependent neuronal signal 
triggered the transport of PLP from LEs/Ls to the plasma membrane. These findings 
revealed a fundamental and novel role of LEs/Ls in OLGs. Krämer et al. (2001) 
demonstrated in vitro by immunofluorescence labelling that in differentiating OLGs 
PLP/DM20 colocalized with the late endosome marker LAMP-1, also indicating that 
PLP/DM20 was sorted to the endocytic pathway. In summary, it is still unclear how PLP is 
transported to its final destination, but an indirect route, involving an intermediate 
endocytic step, where PLP is (partly) associated with rafts, is optional. 
 





MBP is synthesized close to the site of myelin assembly where compaction takes 
place (Colman et al., 1983; Trapp et al., 1987; Barbarese et al., 1995; Ainger et al., 1997). 
Therefore this protein is not detectable in rough ER, lysosomes or any other cytoplasmic 
organelles. The mRNA of MBP has been observed to be bound to free polysomes near the 
myelin membrane (Colman et al., 1982). After exiting the nucleus, MBP mRNA assembles 
into ribonucleoprotein complexes termed granules, preventing adhesion via electrostatic 
interaction to inappropriate intracellular components, which move along microtubules for 
reaching their final destination, the myelin compartment (Ainger et al., 1993, 1997; Carson 
et al., 1997). In cultured OLGs exon 2-minus MBP mRNAs are transported into the processes, 
whereas exon 2-plus transcripts are not, indicating that in OLGs the exon 2 sequence is 
crucial in determining the destination of an MBP mRNA. Due to the secundary structure in 
exon 2, an OLG (co)factor responsible for MBP mRNA trafficking cannot bind to exon 2-plus 
mRNA. This OLG (co)cofactor could be involved in the linkage of exon 2-minus mBP mRNA 
transport particles to the cytoskeleton. This proces is dependent on the selective 
recognition of A2RE, a cis-acting element in MBP mRNA, heterogenous nuclear 




MAG is synthesized in the cell body and subsequently transported via a vesicular 
trafficking route to the myelin membrane (Krämer et al., 2001). Expression of the two 
isoforms of MAG in MDCK cells demonstrated that L-MAG was primarily targeted to the 
basolateral membrane, whereas S-MAG was first sorted to the apical plasma membrane 
and then targeted to the basolateral plasma membrane (Minuk and Braun, 1996). L-MAG 
contains the consensus motif YXXФ, YAEI in its carboxyl terminal region, important for 
transport from the trans-Golgi to endocytic compartments (Bonifacino and Dell-Angelica, 
1999). Endocytic compartments containing MAG are observed in OLG processes including 
areas close to the axon where active formation of myelin occurs (Trapp et al., 1989; Bo et 
al., 1995). Taylor et al. (2002) showed that MAG is soluble both in TX-100 and CHAPS, 
whereas PLP is associated with CHAPS-insoluble microdomains. This differential distribution 





by the segregation of the two proteins into different vesicle population, thus rationalizing 
the specific delivery to distinct target membranes. Hence, the different domains discerned 
in myelin may well be served by transport vesicles operating in distinct pathways. Indeed, 
electron microscopic immunocytochemical studies indicated that PLP and MAG are 
present on separate vesicular structures in the cell, presumably originating from a sorting 
event in the TGN. Accordingly, this segregation into different vesicular structures could be 
the mechanism by which MAG and PLP are targeted to different membrane domains. 
 
CNP 
CNP is a prenylated protein which is synthesized on free ribosomes in the 
oligodendrocyte perinuclear cytoplasm (Trapp et al., 1988; Gillespie et al., 1990). During 
development, the expression of CNP is highly upregulated in premyelinating OLGs and is 
maintained throughout life, suggesting an important role in the myelination process as well 
as for the lifelong maintenance of the myelin sheath (Scherer et al., 1994). Entry into the 
myelin/ plasma membrane fraction is similar to that of MBP (Gillespie et al., 1990). CNP is 
bound to the actin-based cytoskeleton and associated with rafts (Kim and Pfeiffer, 1999). 
The protein induces microtubule and F-actin reorganization, necessary for process 
outgrowth and aborization (Lee et al., 2005). 
In summary, in OLGs multiple sorting and trafficking mechanism occur. There 
appears to be no common pathway, which is used for the sorting and trafficking of all 
myelin (specific) proteins. Rather, prevailing evidence suggest specificity in the pathways, 
which therefore raises questions as to their communication and regulation of each of these 
transport steps, given the relevance of each of the myelin components to a proper 
biogenesis and maintenance of the sheath. In the next section some extracellular factors 
are described which are involved in biogenesis of myelin. 
 
Involvement of extracellular matrix 
Myelination ensues after recognition of the axon by the progenitor cells, followed by 
the ensheathment of the axon by oligodendrocyte processes and synthesis of the 
compacted myelin. This cell-cell interaction is highly specific, causing only large-diameter 
axons rather than dendrites to be myelinated (Lubetzki et al., 1993). The axonal surface 
plays a pivotal instructive role in determining where and when myelination occurs. In this 
respect the extracellular matrix (ECM), a complex structural entity that is found around 
 
 General Introduction and Scope of Thesis  
 
 27 
cells of almost any cell type in multicellular organisms, is of major importance for the 
development of the CNS (Buttery et al., 1999; Pires-Neto et al., 1999; Probstmeier et al., 
2000; De Winter et al., 2002; Garcion et al., 2004). Changes in the extracellular environment 
may regulate morphological changes by alterating vesicular transport of myelin sheet 
directed proteins. In the next sections the role of the ECM molecules laminin-2 and 




Laminin-2 (Ln2) is a glycoprotein expressed on axons. It interacts with 
oligodendrocyte laminin-binding integrins and dystroglycan (Colognato et al., 2007), 
thereby stimulating OLGs to elaborate the extensive myelin membrane which wraps the 
axon, thereby forming the myelin sheath (Buttery and ffrench-Constant, 1999). Integrins are 
a large family of heterodimeric glycoproteins capable of bidirectional signaling, i.e. from 
inside to the extracellular environment and also in the reverse direction (Calderwood et al., 
2000; Liang et al., 2004). Ln2 induces a redistribution of integrins in the membrane, thereby 
promoting OLG survival (Frost et al., 1999; Corley et al., 2001; Colognato et al., 2002) and 
myelin formation (Buttery and ffrench-Constant, 1999; Relvas et al., 2001). By observing that 
Ln2 induces clustering of the laminin binding integrin α6β1 with the PDGFαR-containing lipid 
raft domains, Baron et al. (2003) demonstrated that the interaction between lipid rafts and 
ECM molecules may play an important role in the development of the myelin sheath. 
 
Fibronectin 
Fibronectin (Fn) exists in two main forms: (1) as an insoluble glycoprotein dimer, 
formerly called cold-insoluble globulin, that serves as a linker in the ECM and (2) as a 
soluble disulphide linked dimer composed of 250 kDa subunits found in the plasma. Its 
proposed role in cell adhesion, migration and invasion comes from the observation that it 
may serve as a general cell adhesion molecule by anchoring cells to collagen or 
proteoglycan substrates. Fn, absent in adult brain at normal conditions, enters the tissue 
upon blood-brain-barrier disruption at pathological conditions (Inoue et al., 1997), which 
occurs during MS. Fn has been proposed to interfere with formation of membrane 
microdomains (Baron et al., 2003; Maier et al., 2005), thereby interfering with proper myelin 





In fact, the data strongly indicate that Fn impedes biosynthetic protein trafficking to the 
myelin sheet, relying on a mechanism that is most likely related to β1 integrin mediated 
activation of PKC. Mysristoylated alanine-rich C-kinase substrate (MARCKS), a major PKC 
substrate, will be translocated into the cytosol, which may lead to an inhibition of dynamic 
actin cytoskeleton remodeling, highly relevant for myelin sheet-directed protein transport. 
Permanent displacement of MARCKS, may result in a “frozen”actin cytoskeleton that 
interferes with vesicle trafficking towards the myelin sheet (Šiškowá et al., 2006).  
 
Expression and function of protein trafficking in oligodendrocytes 
As indicate above, multiple pathways are involved in the assembly of mature 
myelin membranes. To establish polarity and specific transport to either plasma 
membrane of the cell body or myelin membranes, OLGs likely use similar trafficking and 
fusion proteins, as has been described for polarized epithelial cell (see above), which will 
be discussed in the next sections. 
 
Exocyst complex proteins 
It has been recently demonstrated that OLGs express several key components 
necessary for tethering transport vesicles to areas of rapid membrane growth, including 
the exocyst components Sec8 and Sec6 (Anitei et al., 2006). The exocyst complex appears 
to be central in myelin biogenesis, as it has been recently demonstrated that Sec8 
expression is important for the recruitment of transport vesicles to the plasma membrane 
(Anitei et al., 2006). Next to a role in tethering vesicles, Sec8 plays a role during early steps 
in the secretory pathway, as it coordinates early events in protein synthesis of MBP and 
MAG (Anitei et al., 2006). Sec6, another component of the exocyst complex, 
coimmunoprecipitates with Sec8, as are the multidomain scaffolding proteins CASK and 
Mint1. Thus exocyst complex proteins seem to be important regulators of OLG 
differentiation and myelin membrane formation. 
 
Rab-GTPases 
Thus far, twenty-three different Rab proteins have been detected in OLGs (Burcelin 
et al., 1997; Bouverat et al., 2000). Among these are two OLG-specific Rab proteins, 
Rab22b and Rab40c (Rodriguez-Gabin et al., 2001; 2004), which expression are 
upregulated during OLG differentiation.  Three other Rab proteins, Rab 3a, -5a, and -8a, 
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are also upregulated during OLG maturation (Madison et al., 1999; Bouverat et al., 2000). 
In addition, the endosomal Rab proteins 4, 5, 11, and 18 are prominently expressed in 
OLGs (Bouverat et al., 2000), suggesting that endocytic membrane recycling might be an 
important process in myelin biogenesis (Krämer et al., 2001). The expression of a large 
number of Rab proteins indicates the complexity of membrane trafficking in OLGs. Yet, 
thus far no Rab proteins have been identified as being involved in the targeting of myelin 
proteins. 
 
SNARE complex proteins 
Several laboratories have identified SNARE proteins in OLGs. In cultured OLGs, 
transcripts of the v-SNARE VAMP-2, its t-SNARE partners syntaxin 4 and syntaxin 2 have 
been detected (Madison et al., 1999), as well as protein expression of another cognate 
SNARE pair, VAMP-7/syntaxin 3 (Krämer et al., 2000). In addition, two other t-SNAREs, SNAP-
25 and SNAP-23 (Hepp et al., 1999; Madison et al., 1999; Krämer et al., 2001) that are also 
required for the formation of functional SNARE complexes, are localised in myelin. Thus, 
the components for functional SNARE complexes are present in OLGs, however, 
knowledge about the extent of SNARE involvement in myelin biogenesis is very scanty. 
Interestingly, in polarized epithelial cells, syntaxin 3 and syntaxin 4 are involved in apical 
and basolateral membrane trafficking, respectively (Galli et al., 1998; Low et al., 1998; 




Both myelinating cells, i.e., OLGs (CNS) and Schwann cells (PNS), express the MAL 
protein (Schaeren-Wiemers et al., 1999). In immature, non-myelinating Schwann cells, the 
MAL proteolipid, having a function in differentiation, is present prior to myelin formation 
(Frank et al., 1999), whereas in OLGs MAL is upregulated during active myelination (Kim et 
al., 1995; Schaeren-Wiemers et al., 1995). The MAL proteolipid, is predominantly localized in 
the compact myelin and is tightly associated with the glycosphingolipids, 
galactosylceramide and sulfatide. Functional studies, carried out in vitro, suggest that MAL 
is required for apical protein sorting in epithelia (Cheong et al., 1999; Martin-Belmonte et 
al., 1999; Puertollano et al., 1999). Together with the observation that in transgenic mice 





formation in kidney and stomach were altered, these data suggest that MAL is involved in 
the assembly and targeting of apical transport vesicles, while it also plays a role in the 
stabilization and maintenance of glycosphingolipid-rich membrane domains in myelinating 
cells. By MAL gene disruption, Schaeren-Wiemers et al. (2004) demonstrated a critical role 
for MAL in the maintenance of central nervous system paranodes. Major alterations of the 
structural level seen in MAL-deficient mice include aberrant inclusions of cytoplasm within 
compact CNS myelin. Furthermore, paranodal loops at the node of Ranvier are detached 
from the axon and face away from it. Because MAL is expressed in the brain exclusively by 
OLGs, it is likely that lack of MAL is causing altered axon-glia interactions, and 
malfunctioning of NF155 would be an excellent candidate in causing impaired axon-glia 
interactions. This cell adhesion molecule is located at the glial side of the paranodal 
junction (Tait et al., 2000), is associated with the Caspr-contactin complex (Charles et al., 
2002; Collan et al., 2003), and is remarkledly reduced in the absence of paranodal septa 
(Bhat et al., 2001; Boyle et al., 2001; Poliak et al., 2001). Indeed, NF155 is almost absent in 
paranodal loops and is recruited in rafts, thus supporting the notion of being a potential 
candidate for MAL-mediated sorting and/ or trafficking. 
 
Scope of the thesis 
During myelin formation OLGs may utilize basic mechanisms of epithelial membrane 
trafficking, as described and summarized in the introductory chapter (Chapter 1). 
However, whether specific transport pathways, unique to myelin biogenesis are involved 
and how such pathways might be regulated in biogenesis and maintenance of the myelin 
sheath, is largely unexplored. Such insight is of major relevance for devising strategies for 
exogenous manipulation to stimulate and/or promote de novo biogenesis of the myelin 
sheath and its (re)assembly at pathological demyelinating conditions, as in the case of 
multiple sclerosis (MS). In addition, given the special nature of OLGs, consisting of a cell 
body, bounded by a plasma membrane, and myelin ‘protruding’ from that cell body, yet 
maintaining a highly specific and quite distinct membrane composition when compared 
to the plasma membrane, this kind of work will also contribute to solving fundamental 
questions of great interest to current cell biology. Accordingly, the main purpose of the 
work described in this thesis was to acquire insight into the sorting and trafficking of major 
myelin components such as PLP and MBP, and to reveal regulatory mechanisms, 
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instrumental in promoting myelin sheath biogenesis. It is felt that this insight is a prerequisite 
for a prosperous advancement of therapeutic approaches in a disease as complex as MS.  
The trafficking and sorting of myelin constituents was primarily studied in vitro, using 
isolated OLG precursor cells from newborn rats. This approach also allowed us to study 
myelin biogenesis as a function of cellular development. In chapter 2, molecular 
parameters that govern the targeting and incorporation of myelin proteins and model 
proteins into myelin membranes are investigated to further clarify the polarized nature of 
oligodendrocytes. The purpose of these studies was to reveal the nature of sorting signals in 
myelin-directed trafficking and whether this pathway was regulated by protein kinase 
activity. Chapter 3 describes the distribution and functional role of syntaxins 3 and 4 in 
OLGs, since both proteins usually display a specific, polarized distribution in epithelial cells. 
We investigated how these syntaxins regulate the trafficking of myelin specific proteins, 
including PLP and MBP mRNA. Apart from intracellular factors, the role of the ECM was also 
examined, as described in experiments presented in chapter 4. OLGs were grown on 
different ECM substrates and their effect on the transport of the PLP and myelin assembly 
was determined. In chapter 5 the role of MAL in the regulation of sorting and transport of 
PLP was investigated, using a GFP-MAL construct that was (over)expressed in proliferating 
oligodendrocyte progenitor cells. The intracellular distribution of MAL was determined and 
its effect on myelin protein transport was studied as a function of OLG development. 
Finally, in chapter 6 major observations reported in this thesis are summarized and 
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A detailed understanding of trafficking pathways in mature oligodendrocytes 
(OLGs) is essential for addressing issues aimed at controlling (re)myelination by modulating 
myelin-directed transport. Previously, we have shown that the viral marker proteins, HA and 
VSV G, reaching in polarized epithelial cells the apical and basolateral surface, 
respectively, are primarily transported to plasma membrane and myelin sheet, 
respectively, in OLGs. Here, we demonstrate that in OLGs similar basolateral sorting signals 
as in epithelial cells may target proteins to the myelin sheet, emphasizing the basolateral- 
and apical-like nature of myelin sheet and plasma membrane, respectively. Thus, 
substitution of essential amino acids reverses the direction of targeting of these proteins, 
whereas elimination of apical targeting of HA coincides with its dissipation from detergent-
resistant microdomains. Furthermore, protein kinase C (PKC) activation negatively 
regulated transport of the OLG resident transmembrane protein PLP to the myelin sheet, 
like that of VSV G as shown previously, but did not affect the localization of the 
membrane-associated myelin specific proteins MBP and CNP. These data imply that 
several, distinctly regulated pathways operate in myelin sheet directed transport, which at 
least partly rely on a cognate basolateral sorting signal. 
 




During development, oligodendrocytes (OLGs), the myelinating cells of the central 
nervous system (CNS), express large quantities of myelin proteins and lipids that are 
transported from the cell body to the processes, which form myelin sheaths that enwrap 
axons to facilitate nerve impulse signal conduction. In vitro, OLGs grown in mono-culture 
follow the same developmental pattern as in vivo, i.e., all the myelin components are 
expressed in a coordinated fashion and transported to the different subdomains in the 
myelin sheet (Pfeiffer et al., 1993; Gielen et al., 2006), corresponding to non-compacted 
myelin-like membranes. Given the high glycosphingolipid content of the myelin sheet as 
compared to the plasma membrane of OLGs, it is tempting to correlate the membrane 
organisation of the myelin sheet to that of the apical domain of polarized epithelial cells 
(Weimbs et al., 1997; Lafont et al., 1999; de Vries and Hoekstra, 2000; Gielen et al., 2006). 
Intriguingly, we observed that the biogenesis of the myelin sheet in vitro involves 
basolateral-like features, rather than features typical of apical membrane directed 
transport, seen in polarized epithelial cells (de Vries et al., 1998). Thus in OLGs the apical 
domain marker influenza hemagglutinin (HA) is typically transported to the cell body 
plasma membrane, and localizes to detergent resistant microdomains, whereas the 
basolateral membrane marker vesicular stomatitis virus glycoprotein (VSV G) accumulates 
in the myelin sheet, and is solubilized upon detergent treatment of the cells. By 
extrapolation, this would imply that in OLGs a cognate basolateral rather than an apical 
pathway is used to transport proteins to the myelin sheet. 
The operational definitions concerning polarity and polarized trafficking have been 
largely defined based upon work in Madin-Darby canine kidney (MDCK) cells. In these 
cells polarity is generated by sorting of apical- and basolateral-directed proteins in the 
trans-Golgi network (TGN) and/or endosomes (Ikonen and Simons, 1998; Matter, 2000; 
Gravotta et al., 2007). Basolateral sorting signals are mainly restricted to the cytosolic tails 
of proteins, which frequently contain crucial tyrosine- or di-leucine-based amino acid 
motifs. It has been shown that the presence of a tyrosine at position 501 in the C-terminal 
part of VSV G is an important intramolecular signal for basolateral sorting (Brewer and 
Roth, 1991; Hunziker et al., 1991; Muth et al., 2003). Furthermore, by converting cysteine 543 
to tyrosine in the cytoplasmic domain of HA, the protein is no longer sorted apically but 
acquires both a basolateral sorting signal and an internalization signal (Brewer and Roth, 





sorting mechanisms often rely on lipid-lipid or lipid-protein interactions and partitioning in 
membrane microdomains (Ikonen and Simons, 1998; Matter, 2000; Delacour and Jacob, 
2006). 
Apart from ‘intrinsic’ signals, protein kinase activity has been recognized as an 
important regulator of polarized trafficking in MDCK (Pimplikar and Simons, 1994; Cardone 
et al., 1994) and polarized HepG2 liver cells (Zegers and Hoekstra, 1997; Tyteca et al., 
2005). Such knowledge is lacking in mature OLGs, but in OLG progenitors PKC activation 
impedes the sheet-directed ‘basolateral-like’ pathway (VSV G), and activates ‘apical-like’ 
(HA) trafficking to the membrane of the cell body (Baron et al., 1999).  
We therefore further examined the polarized nature of mature OLGs, in particular 
the relevance of basolateral-like trafficking to the sheet. Here, we show that the 
basolateral tyrosine ‘signal’ in the C-terminal part of viral model proteins is sufficient (HA) 
and essential (VSV G) for myelin sheet targeting, while transport of specific myelin proteins 
to the sheet is differentially affected upon PKC activation. Our results corroborate that 
myelin-directed trafficking is served by a cognate basolateral transport pathway, and 
regulated by distinct signalling pathways.  
 
Materials and Methods 
Materials 
Dulbecco’s Modified Eagle’s Medium (DMEM, with 4500 mg/l Glucose and L-
glutamine), L-glutamine, penicillin/streptomycin and Geneticin (G418) were purchased 
from Gibco Invitrogen Corporation (Paisley, UK). Fetal calf serum (FCS) was obtained from 
Bodinco (Alkmaar, The Netherlands). The transfectant FuGene 6 and protease inhibitor 
cocktail tablets (Complete Mini) were obtained from Roche Diagnostic Corp (Mannheim, 
Germany). Growth factors FGF-2 and PDGF-AA were supplied by PeproTech Inc. (London, 
UK). Paraformaldehyde was supplied by Merck (Darmstadt, Germany). Nonidet P40 (NP40) 
was purchased from Fluka BioChemica (Buchs, Switzerland). Phorbol-12-myristate-13 
acetate (PMA) and bisindolylmaleimide I (BIM) were from Calbiochem-Novabiochem 
Corporation (La Jolla, Ca). Sulfo-NHS-LC-Biotin was obtained from Pierce (Rockford, IL). 
Streptavidin was obtained from Upstate Lake Placid (New York, NY). All other chemicals 
were purchased from Sigma Chemical Co. (St. Louis. MO). 
 




The monoclonal antibody against PLP (Greenfield et al., 2006) and the polyclonal 
antibody against HA were generously provided by Prof. Dr. V. Kuchroo (Center of 
Neurological Diseases, Harvard Medical School, Boston, MA) and Prof. Dr. I. Braakman 
(Research Group of Cellular Protein Chemistry, Utrecht, the Netherlands), respectively. The 
R-mAb hybridoma (Ranscht et al., 1982) was a kind gift of Dr. Guus Wolswijk (NIBR, 
Amsterdam, The Netherlands). The monoclonal antibodies anti-VSV G (IgG1) and anti-
CNPase (IgG1) were obtained from Sigma (St. Louis, MO). Anti-MBP was purchased from 
Serotec (Oxford, UK). Fluorescein isothiocyanate (FITC) and tetramethylrhodamine 
isothiocyanate (TRITC) conjugated antibodies were supplied by Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA). Secondary horseradish peroxidase (HRP)-conjugated 
antibodies were obtained from Amersham Biosciences (Little Chalfort, UK). 
 
Constructs 
General procedures for cloning and DNA manipulations were performed as 
described by Sambrook et al. (1989). The cDNA’s encoding HA, HAY+, VSV G and VSV GY- 
were a kind gift of Dr. M.G. Roth (Department of Molecular Medicine, Cleveland, OH). For 
cloning the viral genes in the retroviral vector pLXIN (Clontech Biosciences, Mountain View, 
CA), an XhoI restriction site in close distance of the ATG start codon of the HA, HAY+, VSV 
G, VSV GY- genes and an XhoI restriction site after the stop codon were introduced by the 
polymerase chain reaction. The following primers were used:  
5’ GGTACACGCTTCTCGAGAAGCTTATGTAC 3’ (forward HA, HAY+),  
5’ GCACCCGGGATCCTCGAGAACTAGTGGATC 3’ (reverse HA, HAY+),  
5’ CGATCTTTTTCCTCGAGACTATGAAGTG 3’ (forward VSV G, VSV GY-) 
5’ CAGGGATGCACTCGAGATCCTCTAG 3’ (reverse VSV G, VSV GY-) 
The PCR products were digested with restriction enzyme Xho1 (Gibco Invitrogen 
Cooperation, Paisly, UK) and ligated with the 1.8 kb retroviral vector pLXIN. Recombinant 
plasmids were grown in Escherichia coli DH5α cells, and plasmids with the cDNA insert in 
the correct orientation with respect to transcription were identified by restriction analysis. 






Production of retroviral particles 
The production of retroviral particles and the subsequent infection of OLG 
progenitors were performed according to Relvas et al. (2001). Briefly, for production of 
recombination-deficient retroviruses, the constructs were transfected into the GP+E86-
packaging cell line (Genetix Pharmaceuticals Inc., Cambridge, MA), using the FuGene 6 
transfection reagent. Two days after transfection, cells were collected, diluted 5-fold and 
cultured under selection in packaging cells medium (DMEM medium containing 10% FCS) 
supplemented with 1 mg/ml G418 (corrected for inactivity) until resistant clones appeared 
(70% confluent). The cells were subsequently washed with PBS, and packaging cells 
medium without G418 was added. The conditioned medium was collected after 24 hrs, 
filtered (Schleicher and Schuell, Dassel, Germany, 0.45 μm pore size), and either used 
immediately or stored frozen at -80 °C. 
 
Cell culture 
Primary OLG cultures were prepared from brains of 1-2 day old Wistar rats as 
described previously (Baron et al., 1998), with slight modifications. Briefly, after 
decapitating the rats, the forebrains were removed and the cells were dissociated, first 
mechanically and then with papaine (30 U/ml) in the presence of L-cysteine (0.24 mg/ml) 
and DNase (10 μg/ml) for 1 hr at 37°C. A single cell suspension was prepared by repeated 
pipetting in a trypsin inhibitor solution (1 mg/ml). After centrifugation, the cells were 
resuspended in DMEM medium, containing 10% FCS, and seeded into 75 cm2 flasks (Nalge 
Nunc International, Roskilde, Denmark), at approximately 1.5 brain per flask. The flasks had 
been precoated with poly-L-Lysine (PLL, 5 μg/ml). The OLG progenitor cells appear as 
round-shaped, phase dark cells on top of monolayers of flat type-1 astrocytes. After 11-12 
days in culture, the OLG progenitor cells were isolated by mechanical shaking at 240 rpm 
over a time interval of 18-20 hrs, as described by McCarthy and de Vellis (1980), which was 
followed by differential adhesion to remove astrocytes and microglia. The OLG progenitor 
cells were plated in proliferation SATO medium (Buttery et al., 1999; Maier et al., 2005), 
supplemented with the growth factors FGF-2 (10 ng/ml) and PDGF-AA (10 ng/ml). For 
biochemical assays, cells were plated at a density of 1 X 106 cells per 100 mm PLL-coated 
(5 µg/ml) dish and for immunocytochemical studies the OLG progenitors were seeded at a 
density of 2 X 104 cells per well on PLL-coated permanox chambers slides (Nunc). After two 
days in proliferating medium, differentiation was induced by growth factor withdrawal and 
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further culturing in SATO medium supplemented with 0.5% FCS. After 10 days on 
differentiation medium cells were left either untreated (control) or exposed to 100 nM PMA, 
with or without the PKC inhibitor BIM (0.5 μM) for 24 hrs after which they were analyzed as 
indicated. 
 
Retroviral infection  
OLG progenitor cells cultured for 48 hrs in proliferation medium (SATO containing 
PDGF-AA and FGF-2) were retrovirally infected with the HA, HAY+, VSV G and VSV GY- 
constructs, prepared as described above, for 16-18 hrs in media that contained 8 µg/ml 
polybrene, 10 ng/ml FGF-2 and 10 ng/ml PDGF-AA. The cells were cultured for another 24 
hrs in proliferation medium and then cultured under selection in proliferation medium, 
supplemented with 400 μg/ml G418 (corrected for inactivity) for 5 days. After selection the 
cells were cultured on differentiation medium (SATO supplemented with 0.5% FCS) for 9 
days to obtain fully mature OLGs bearing myelin-like membranes (myelin sheets). 
 
Viral infection of cells 
VSV strain San Juan A was a kind gift from Dr. Peter Rottier (University of Utrecht). 
Cells were infected with virus as described previously (Braakman et al., 1991; de Vries et al., 
1998). In brief, cells were rinsed twice with culture medium, pH 6.8, before adding the virus. 
Cells were infected for 1 hr at 37°C with the virus in culture medium, pH 6.8, without CO2. 
Then the medium was removed, fresh culture medium (pH 7.6) was added and cells were 
incubated for 5.5 hrs at 37°C under an atmosphere of 5% CO2. Viral concentrations were 
chosen such that almost all cells were infected. When PMA was used with virus-infected 
cells it was added 24 hrs before infection at a concentration of 100 nM and removed just 
prior to addition of the virus.  
 
Immunocytochemistry 
Paraformaldehyde (PFA)-fixed cells (4% PFA in phosphate-buffered saline (PBS) for 
20 min at room temperature (RT)) were rinsed with PBS and blocked and permeabilized for 
30 min with 10% FCS and 0.1% TX-100 (in PBS), respectively. For staining with R-mAb, which 
detects the surface-localized galactolipids GalCer and sulfatide, the permeabilization step 
was omitted. The cells were subsequently incubated for 1-2 hrs with diluted primary 





supplemented with 2.5% FCS and 0.1% TX-100 (incubation buffer). The cells were washed 
with PBS and incubated for 30 min at RT with appropriate FITC- or TRITC-conjugated 
secondary antibody diluted in incubation buffer. To prevent image fading, the cells were 
covered with 2.5% 1,4-diazobicyclo[2.2.2]octane (DABCO, Janssen Chimica, Beerse, 
Belgium) in 90% glycerol/ 10% PBS, after washing with PBS. The cells were analyzed with an 
Olympus AX70 fluorescence microscope, equiped with analySIS software. Data were 
processed using Paint Shop Pro and/or Adobe Photoshop software. 
 
Preparation of detergent extracts  
The cells were washed with PBS, and harvested by scraping the cells with a rubber 
policeman in ice-cold TNE lysis buffer (20 mM Tris HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% 
TX-100 and a cocktail of protease inhibitors). Cells were lysed for at least 30 min on ice, and 
the protein content was measured by a Bio-Rad DC protein assay (Bio-Rad, Hercules, CA) 
using BSA as standard. From equal protein amounts, soluble and insoluble fractions were 
separated by centrifugation at 13.000 rpm for 15 min at 4 °C. Pellets (insoluble) and 
supernatants (soluble) were mixed with SDS reducing sample buffer, heated for 2 min at 
95ºC or 30 min at 37°C, and subjected to SDS-PAGE and Western blotting. 
 
Surface protein biotinylation 
After washing twice with ice-cold PBS, the cells were incubated for 2 hrs with Sulfo-
NHS-LC-Biotin (0.1 mg/ml in PBS) at 4°C. Excess biotin was removed by washing the cells 
three times 5 min with cell wash buffer (65 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1 
mM MgCl2) and once with PBS. The cells were harvested in PBS by scraping with a rubber 
policeman, and pelleted at 7.000 rpm for 5 min at 4°C). Cell pellets were lysed in TNE lysis 
buffer on ice for 30 min and the protein content was measured by a Bio-Rad DC protein 
assay (Bio-Rad, Hercules, CA) using BSA as standard. Equal amounts of protein were 
incubated with streptavidin-agarose (SA-agarose) in a head over head tumbler overnight 
at 4 °C. SA-agarose (biotinylated protein, i.e. surface localised) was washed 4 times with 
ice-cold cell wash buffer supplemented with 1% NP40 and 0.35 M NaCl, once with PBS, 
and heated for 2 min at 95 °C in 2x SDS reducing sample buffer. The non-bound fraction 
(non-biotinylated proteins, i.e. the fraction localized intracellularly) was concentrated by 
trichloric acid (TCA) precipitation. In brief, the fractions were adjusted to a final volume of 
1 ml with TNE and treated with sodiumdeoxycholate (25 mg/ml) for 5 min at 4 °C, followed 
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by precipitation with 6.5% TCA for 15 min at 4 ºC. Precipitates were centrifugedat 10000 
rpm for 20 min at 4°C. The pellets were dried and resuspended in 2x SDS reducing sample 
buffer, and after the pH was adjusted to 6.8 by exposure to ammonia, the samples were 
heated for 2 min at 95 ºC. Both the biotinylated and non-biotinylated fraction were 
subjected to SDS-PAGE and Western blotting.  
 
SDS-PAGE and Western Blotting 
Samples were loaded onto 10 or 12.5% SDS-polyacrylamide gels and transferred to 
either nitrocellulose (Bio-Rad) or PVDF membranes (Millipore) by semi-dry blotting. The 
membranes were blocked with 5% nonfat dry milk in Tris buffered saline (TBS) to inhibit 
nonspecific binding. The membranes were washed and incubated for 30 min at RT with 
appropriate primary antibodies (VSV G 1:1000, HA 1:1000, and PLP 1:50) in TBS with 0.5% 
nonfat dry milk and 0.1% Tween (TBS-TM). After washing with TBS-T, the membranes were 
incubated for 1 hr at RT in appropriate horseradish peroxidase-conjugated antibodies at a 
1:2000 dilution in TBS-TM. The signals were visualized by ECL (Amersham, Pharmacia 
Biotech) and quantified by Paint Shop Pro and Scion Image Software. Statistical analysis 
was performed using the appropriate Student’s t-test. Values are expressed as means ± 
standard error (SE). In all cases a p-value < 0.05 was considered significant. 
 
Results 
The localization of VSV G and HA in oligodendrocytes is determined by their targeting 
sequences  
To define molecular requirements for apical-like and basolateral-like sorting and 
targeting in OLGs to plasma membrane and myelin sheet, respectively, trafficking was 
determined of wild-type (wt) and mutant forms of the viral marker proteins HA and VSV G. 
Since complete viruses with a specific mutation in their (glyco-) proteins are difficult to 
obtain, while primary OLGs are difficult to transfect, we made use of a retroviral expression 
system to express wt and mutant forms of the viral proteins. Notably, after selection, with 
the retroviral expression system essentially all cells of the population express the protein. For 
the glycoprotein VSV G, the tyrosine (Y) residue at position 501 in the cytoplasmic domain, 
relevant to its basolateral sorting in epithelial cells (Hunziker et al., 1991; Muth and Caplan, 
2003), was replaced by a serine (S) (VSV GY-, Thomas and Roth, 1993). Furthermore, in the 





substituted for a tyrosine (HAY+, Brewer and Roth, 1991) (fig. 1A), as a result of which it’s 









Figure 1: (A) Primary structures of the sorting domains in VSV G and HA. The amino acid sequences of the 
relevant parts of VSV G and influenza HA are shown. In the VSV G transport mutant VSV GY- the tyrosine (Y) 
residue at position 501, necessary for basolateral sorting, has been replaced by a serine. In the HA mutant 
HAY+, cysteine residue 543 has been replaced by a tyrosine (Y) to comply with basolateral-type trafficking 
requirements. (B-E). Localization of wild-type and mutant forms of the viral marker proteins HA and VSV G. OLG 
progenitors were retrovirally infected with wt VSV G (B), VSV GY- (C), wt HA (D) and HAY+ (E), differentiated for 9 
days and the distribution of the proteins was determined by (immuno)fluorescence microscopy, as described 
in Materials and Methods. Representative cells out of three independent experiments are shown. Scale bar is 
20 µm. Note that wt VSV G and mutant HAY+ are localized in the myelin-like membranes, i.e. the myelin sheet 
(arrows), whereas wt HA and mutant VSV GY- are localised to the cell body and primary processes. 
 
The localization of the wt and mutant viral proteins in mature primary OLGs was 
subsequently analyzed by immunofluorescence. As shown in figure 1, apart from being 
expressed in the cell body and primary processes of mature OLGs, wt VSV G is also 
prominently present in the sheets (arrow, fig. 1B). In contrast, VSV GY- was largely localized 
to the cell body and primary processes, implying that the mutant protein apparently lost its 
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ability of acquiring access to the myelin sheet (fig. 1C). Thus, the mislocalization of VSV GY- 
demonstrates that the unique tyrosine in position 501 in VSV G is critically important for 
functioning as a basolateral-like sorting signal, instrumental in mediating transport to the 
myelin sheet in OLGs (de Vries et al., 1998).  
To further support the basolateral-like nature of the myelin sheet, we next 
investigated the effect of substituting a tyrosine residue for cysteine at position 543 in the 
the apical marker HA. In polarized epithelial cells, it has been demonstrated that this 
substitution causes internalization of the protein and switches sorting from the apical to the 
basolateral membrane surface (Brewer and Roth, 1991; Lazarovits and Roth, 1988). In 
figure 1D and 1E it is shown that whereas wt HA is particularly present in vesicle structures 
(as reflected by its punctate appearance) in the cell body and primary processes (cf. fig. 
1D vs.1B), the mutant protein HAY+, next to a localization in the cell body, was also clearly 
discernable in the processes and myelin sheet (cf. fig. 1E vs. fig.1B). Importantly, the total 
expression levels of wt and mutant viral proteins were very similar (data not shown). These 
data thus indicated that substitution of amino acid residues, known to be critical to proper 
apical and basolateral sorting of proteins in polarized epithelial cells, also causes an 
analogous missorting in OLGs. The results thus reflect a similarity in sorting signals operating 
in both cell types and moreover, support the apical-like and basolateral-like features of 
cell body plasma membrane and myelin sheet, respectively. 
Given that both viral proteins are typical membrane-localized proteins, we next 
considered the possibility that the mutations may have caused a change in their lateral 
distribution in the plane of the bilayer, their subsequent partitioning into different 
membrane microdomains possibly contributing to their sorting into different transport 
vesicles. 
 
Replacement of cysteine at position 543 by a tyrosine causes HA to become TX-100 
soluble in mature oligodendrocytes 
In polarized epithelial cells HA associates with detergent resistant microdomains 
(‘rafts’, Scheiffele et al., 1997; de Vries et al., 1998). Importantly, distinct amino acid 
residues in the HA transmembrane domain are important for this association, as sequence 
substitutions in this domain ablate its association with rafts (Lin et al., 1997). Previously, we 
demonstrated (de Vries et al., 1998) that in OLGs, wt HA is recovered in a TX-100 insoluble 





VSV G is recovered in a TX-100-soluble fraction. To determine whether differences in sorting 
of the wt versus mutant proteins, as reported above, could (in part) have relied on 
alterations in detergent solubility, presumably reflecting a change in their lateral 
membrane distribution, TX-100 extractions were carried out at 4 ºC of cells, expressing wt or 




Figure 2: (A) Immunoblots of TX-100-soluble and -insoluble fractions of wild-type and mutant forms of VSV G and 
HA in primary mature OLGs. After TX-100 extraction at 4oC and centrifugation, insoluble (pellets) and soluble 
(supernatants) fractions were analyzed by Western blot for the distribution of the wild-type and mutant forms of 
HA and VSV G. Soluble and insoluble fractions are indicated by ‘S’ and ‘I’, respectively. Representative blots 
are shown of three independent experiments. Note that wt HA is mainly TX-100 insoluble, whereas mutant HAY+ 
is TX-100 soluble and that VSV GY- remained detergent soluble. (B and C) OLG progenitors were retrovirally 
infected with (B) HA or HAY+ and (C) VSV G or VSV GY- and surface biotinylated as described in Materials and 
Methods. The biotinylated (outside, o) and non-biotinylated (inside, i) protein fractions were analyzed by 
Western blot and quantified (bars underneath the blots), the white bar reflecting the inside fraction and the 
dark bar representing the biotinylated (surface exposed outside) protein fraction. Representative blots are 
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As shown in figure 2A, both VSV G and VSV GY- almost exclusively partitioned in the 
detergent soluble (S) fractions, indicating that the replacement of tyrosine at position 501 
by a serine had not altered this distribution. Interestingly, whereas wt HA localizes to a 
major extent in the TX-100 insoluble fraction (I), HAY+ primarily localized in the supernatant, 
indicating that a mutation at position 543 in HA eliminated its association with TX-100 
insoluble microdomains (fig. 2A), thereby likely enabling transport to the myelin sheet. 
 
HAY+ and VSV GY- are not localized in the plasma membrane of mature oligodendrocytes 
The results described above revealed that VSV GY- was mislocalized, prominently 
accumulating in the cell body, whereas introduction of a tyrosine in HA caused the protein 
to be transported (in part) to the myelin sheet. To determine whether the mutant proteins 
still resided at the membrane surface of either plasma membrane (cell body) or myelin-like 
membranes or that missorting also affected their (intra)cellular localization, OLGs were 
surface biotinylated following expression of wt and mutant forms of HA and VSV G. In 
figure 2B it is shown that the surface labeling of HAY+ (o, black bar; right panel) is increased 
in comparison to the surface labeling of HA (o, black bar, left panel). Thus, nearly 75 % of 
the HAY+ was accessible for biotinylation at conditions where only 35 % of HA was exposed 
at the cells surface. These data are consistent with the fluorescence localization data in 
figure 1, supporting the notion that upon missorting of HAY+, the myelin sheet provides a 
larger surface area for membrane surface exposure than the cell body plasma 
membrane, which is essentially the target site of wt HA. By contrast, and consistent with an 
apparent strong diminishment of VSV GY- transport to the sheet (cf. fig. 1), in OLGs 
expressing the mutant protein only 20 % of the total protein fraction is expressed on its 
surface, while approx. 60 % of wt VSV G is surface-localized (fig. 2C). Hence, the cellular 
distribution of the proteins is likely not influenced by an altered surface expression, but 
rather by differences in protein distribution over the total surface area. 
Having thus identified a remarkable similarity in (at least some) sorting signals 
operating in membrane transport of VSV G and HA in both polarized epithelial cells and 
OLGs, implying basolateral-like sorting features operating in transport to the myelin sheet, 
we next investigated some regulatory aspects of this pathway by examining the role of 
protein kinase C (PKC), previously shown to carefully regulate polarized membrane 





Trafficking to the myelin sheet is inhibited upon activation of PKC 
In OLG progenitors, PKC activation by phorbol ester (PMA) causes a redistribution of 
actin filaments with a concomitant perturbation of VSV G transport from the TGN to the 
plasma membrane (Baron et al., 1999). As shown in figure 3B (compared to 3A), in mature 
OLGs, PMA-induced activation of PKC caused a significant decrease in VSV G transport to 
the myelin sheet. The activation of PKC resulted in a punctate appearance of the VSV G 
protein within the processes (see arrows). Thus, these data demonstrate, and in essence 
are consistent with previous data obtained in OLG progenitors (Baron et al., 1999), that 
PKC activation negatively regulates myelin sheet-directed transport, as characterized by 
transport of the basolateral marker VSV G. To investigate whether modulation of VSV G 
transport into the sheet reflected that of myelin-specific proteins as well, the effect of PKC 
activation on some resident myelin protein transport was monitored similarly. As shown in 
figure 3C in untreated cells proteolipid protein (PLP), next to a pool in the cell body, also 
prominently localizes to the myelin sheet, whereas treatment with PMA resulted in an 
effective inhibition of transport into the sheet (fig. 3D). Thus, like in the case of VSV G, a 
major part of PLP was largely retained in the cell body, its distribution within the processes 
showing a similar punctate distribution as observed for the viral protein VSV G (see arrows). 
Quantitative support for the pronounced impediment of PLP and the subsequent 
diminishment in the protein’s surface localizaton was obtained by determining the relative 
overall membrane surface expression by means of surface biotinylation, after activation of 
PKC. These data are presented in figure 4 and demonstrate that upon activation of PKC, 
an enhanced fraction of PLP, from approx. 85 % at control conditions increasing to 99 % 
upon activation, is no longer localized at the cell surface. A likely explanantion for this 
observation is that transport vesicles, observed to accumulate in the processes (fig. 3D, 
arrows) are no longer able to dock, thereby precluding PLP insertion into the myelin 
membrane. The PKC inhibitor BIM counteracted the effect of surface transport, 
underscoring the specific involvement of PKC in modulating PLP transport to myelin-like 
membranes (fig. 4). Hence, these findings demonstrate that transport of a typical myelin 
protein like PLP, being an essential part of myelin biogenesis, is negatively regulated by 
PKC activation, as observed for VSV G marker protein. Another important myelin protein, 
myelin basic protein (MBP), is exceptional in that it is not transported to the myelin sheet as 
a protein.  
 





Figure 3: Effect of PMA-stimulated activation of PKC on transport of VSV G and resident myelin proteins in 
primary oligodendrocytes. In A, C, E, and G the localization of VSV G (A), PLP (C), MBP (E), and R-mAb (anti-
GalCer/sulfatide, G) is shown in primary mature OLGs (ctrl) by immunofluorescence, using appropriate 
antibodies (see Materials and Methods). In B, D, F, and H the effect of prior treatment (24 hrs) of the cells with 
100 nM PMA on protein distribution (same order as above) is shown. To express VSV G, primary mature OLGs 
were infected with VSV (A, B) as described in Materials and Methods. Representative cells out of three 
independent experiments are shown. Scale bar is 20 µm. Note that PMA-induced activation of PKC caused a 
punctate appearance of VSV G (B) within the cells (arrows). Upon PKC activation, PLP sheet labelling (D) is 





Rather, its messenger is transported into the sheet in a microtuble-dependent manner, 
where the protein is subsequently synthesized locally (Barbarese et al., 1995; Boccaccio 
and Colman, 1995). Therefore, it is likely that its trafficking may be regulated differently 
from that of PLP. Indeed, as shown in figure 3E and F, the appearance of MBP, as opposed 
to that of PLP, is not affected by PKC activation. Interestingly, however, neither transport or 
localization of CNP was significantly affected upon PKC activation (not shown), CNP 
representing a myelin-specific protein that like MBP associates with myelin membranes, 
while its transport occurs by a non-vesicular transport mechanism.  
 
Figure 4: PKC activation inhibits the surface appearance of PLP. Primary OLG progenitors were differentiated 
for 10 days, and were untreated, exposed to PMA or exposed to PMA and BIM, followed by surface 
biotinylation to determine the surface-associated pool of the protein, as described in the Materials and 
Methods. In the upper panel the Western blot of the biotinylated fraction (outside, o) and the non-biotinylated 
fraction (inside, i) are shown. Note that on some of the blots a lower band is appearing, presumably DM20, 
which is an alterative spliced form of the plp-gene. The PLP-bands were quantified and a graphical 
representation of these data is shown underneath the blots, black bars representing the surface fraction and 
the white bar the fraction within the cells, i.e., not accessible to biotinylation. Representative blots are shown. 
Data represent means of three independent experiments. *** p<0.001. 
 
In OLG progenitors, PKC activation inhibits morphological differentiation (Baron et 
al., 1999; Šišková et al., 2006), whereas long-term exposure at later differentiation stages 
suggests that PKC activation induces process outgrowth and myelination by mature OLGs, 
i.e., a more complex network (reviewed by Stariha and Kim, 2001). As shown in figure 3 
(MBP and R-mAb), the morphological consequences of a relatively short-term PMA 
treatment (24 hrs) are minimal if apparent at all, when compared to untreated cells. 
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Indeed, also in cells stained with the R-mAb (anti-GalCer/sulfatide) the integrity of the 
sheet is seemingly maintained following PMA exposure (fig. 3G and 3H). Furthermore, the 
microtubule system is not significantly affected (data not shown), whereas differences in 
actin cytoskeleton restructuring are less compelling than in OLG progenitors (Baron et al., 
1999, Šišková et al., 2006). We therefore exclude that effects on PLP transport are related to 
an indirect effect of PKC activation via an overall change in morphology.  
 
Discussion 
In the present study, we have further investigated the polarized nature of the cell 
body plasma membrane versus myelin sheet in oligodendrocytes. By employing viral 
marker proteins, i.e., hemagglutin HA and VSV G, which specifically target to apical and 
basolateral membrane domains in epithelial cells, respectively, we demonstrate that the 
same sorting signals as in epithelial cells are operating in OLGs in directing membrane 
domain-specific targeting of these proteins. Thus, transport to the myelin sheet is driven by 
a basolateral-like signal and vesicular trafficking is negatively regulated by PKC. Removing 
a tyrosine at position 501 in the cytoplasmic tail of the basolateral marker VSV G seriously 
impeded transport of the protein to the sheet, resulting in its apparent intracellular 
accumulation in the cell body. In case of HA, the Cys/Tyr mutation at position 543 caused 
a lateral redistribution of the protein, as suggested by a shift from a TX-100 insoluble to a TX-
100 soluble membrane fraction, and its concomitant appearance in the myelin sheet 
instead of the cell body plasma membrane, the latter being seen for wt HA. Possibly, this 
difference in lateral membrane distribution underlies a difference in sorting based upon 
recruitment into distinct membrane transport vesicles, (co-)determining the eventual 
destination of the protein. In this context it is of interest to note that although the sheet is 
enriched in microdomain-stabilizing glycosphingolipids, displaying detergent resistance, 
the majority of the mutated HA (HAY+) is detergent soluble, as opposed to the largely 
insoluble properties seen for the wt HA, which localizes in particular at the cell body 
plasma membrane. Importantly, the shift in membrane surface expression from body to 
sheet (HAY+) or sheet to body (VSV GY-) is quantitatively supported by biotinylation 
experiments, indicating that ‘missorting’ is not likely related to an impediment in vesicular 
transport to and/or inhibition of vesicle docking at the target membrane, as the 
appearance of the relative protein fractions at plasma membrane and sheet are 





it should be noted that the net protein fraction actually expressed at the cell surface at a 
given time (and detectable by biotinylation; fig. 2) will depend on the effectiveness of 
target membrane-directed transport (following its biosynthesis) and the dynamics of the 
acceptor membrane (endocytosis and recycling), implying that an exclusive presence of 
HA or VSV G at the membrane surface is not realistic (c.f. fig. 1). Interestingly, impediment 
of transport and docking may underlie the mechanism by which PKC activation regulates 
sheet-directed trafficking (fig. 3). More intriguingly however, while transport of the 
basolateral marker VSV G and the resident protein PLP is impeded upon PKC activation, in 
part at the level of vesicle docking (cf. fig. 3B and D), these studies also revealed that 
sheet-directed transport pathways in parallel exist that operate independent of PKC, as 
observed for transport of CNP and MBP (mRNA), both of which were relatively unaffected 
upon PKC activation (fig. 3E and F). This distinction can be presumably attributed to the 
fact that whereas transport of the latter occurs via a non-vesicular mechanism (Gielen et 
al., 2006, and references therein), transport of both VSV G and PLP, both representing 
integral membrane proteins, is vesicle mediated. 
In previous work it was demonstrated that PKC activation by the phorbol ester PMA 
in OLG progenitors causes a perturbation of membrane-directed transport of VSV G (Baron 
et al., 1999), an effect that was related to phosphorylation of MARCKS, a membrane-
bound protein that is closely involved in maintaining the structural integrity of the actin 
cytoskeleton. Moreover, the physiological significance of this finding was recently 
demonstrated by showing that fibronectin inhibits myelin sheet directed trafficking via a 
similar PKC-dependent mechanism (Šišková et al., 2006). The observed PKC-dependent 
mechanism of regulating sheet directed trafficking makes it thus likely that this basolateral-
like transport pathway in OLGs depends on cytoskeletal elements. Indeed, cytoskeletal 
filaments are known to facilitate vesicular transport (Zegers and Hoekstra, 1998; Jacob et 
al., 2003), and rearrangement of the actin cytoskeleton is thought to play an important 
role in the establishment and maintenance of cell polarity (Drubin and Nelson; 1996; Zegers 
and Hoekstra, 1997).  
The present data further emphasize the unique polarity properties of OLGs.  Clearly, 
in OLGs, sorting of VSV G to the sheet occurred via a tyrosine-dependent mechanism, also 
operating in basolateral sorting in MDCK cells, thus further highlighting the basolateral-like 
features of the sheet. Inclusion of a tyrosine signal in HA (HAY+) similarly rerouted the protein 
to the sheet, in stead of the plasma membrane, with a concomitant loss of its localization 
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in a detergent resistant microdomain. In terms of its primary sequence, the created HA 
C543Y basolateral sorting signal resembles that identified in the VSV G (Thomas and Roth, 
1994). It is then tempting to suggest that as a result the HA mutant might interact 
selectively with the same recognition molecules (AP molecules; cf. Gravotta et al., 2007) 
for sorting, as those involved in targeting of native VSV G, thereby causing the apical-like 
protein HA to be targeted to the (basolateral-like) myelin sheet.  
Of physiological relevance is the issue whether this tyrosine signal is also operating in 
sorting and transport of myelin specific proteins. The myelin-associated glycoprotein (MAG) 
is expressed as two isoforms, designated as the large isoform (L-MAG) and the small isoform 
(S-MAG) (Frail and Braun, 1985; Minuk and Braun, 1996; Erb et al., 2006). L-MAG, containing 
an invariable basolateral sorting signal, is sorted to the basolateral membrane in MDCK 
cells, i.e., in a mechanistic sense reminiscent of the myelin sheet,  whereas S-MAG rather 
depends on extrinsic factors, localizing to both the apical and basolateral membrane in 
MDCK cells (Minuk and Braun, 1996). Interestingly, L-MAG contains a crucial tyrosine 
residue (Tyrosine-620) in its D8 domain (the C-terminal domain specific to L-MAG). 
Moreover, both isoforms of MAG contain a sequence resembling a clathrin-coated pit 
internalization signal, including a tyrosine, which is crucial for basolateral sorting (Matter 
and Mellman, 1994). Of further interest, a dual tyrosine-leucine motif in myelin protein P0 has 
been identified, which mediates basolateral targeting in MDCK cells (Kidd et al., 2006). 
Finally, PLP contains a dileucine motif which localizes at the N-terminal region, immediately 
next to the palmitoylation sites, which were reported to be imperative for proper transport 
of PLP to the myelin sheet (Pham-Dinh et al., 1991; Schneider et al., 2005). Clearly, these 
examples warrant further investigations in the role of ‘typical’ basolateral and apical 
sorting signals in myelin protein transport and myelin assembly.   
In summary, in the present work sorting signals have been identified for targeting 
membrane trafficking into the myelin sheet. In conjunction with specific signalling, vesicular 
trafficking into this pathway is regulated by PKC. However, trafficking of several myelin-
specific resident proteins, which do not rely on vesicle-mediated transport including MBP 
(mRNA) and CNP, appears independent of PKC-dependent regulation. Accordingly a 
carefully coordinated expression and transport of individual proteins in myelin biogenesis 
and remyelination is required, desirable in case of disease-induced demyelination. A 
detailed understanding of these pathways may provide tools for exogenous modulation of 
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The myelin membrane is a sheet-like extension of the plasma membrane of 
oligodendrocytes (OLGs) that consists of myelin-specific lipids and proteins, and its 
biogenesis and maintenance presumably requires specialized sorting and targeting 
devices. Given the polarized nature of plasma membrane versus myelin sheet, we have 
investigated whether vesicular transport events in these cells exploit a polarized distribution 
of syntaxins 3 and 4, as part of the mechanism to establish this membrane polarity. We 
demonstrate that syntaxins 3 and 4, as part of the SNARE machinery regulating 
intravesicular transport and membrane docking at target membranes, are distinctly 
distributed in OLGs and their expression is developmentally regulated. Whereas syntaxin 3 is 
present throughout development, syntaxin 4 becomes significantly expressed when OLGs 
differentiate and its expression further increases concomitant with myelin sheet biogenesis 
and OLG maturation. Consistently, syntaxin 3, which partitions equally in detergent-soluble 
and insoluble microdomains, largely localizes to the cell body and plasma membrane, 
whereas syntaxin 4, which predominantly localizes in detergent-soluble domains, is strongly 
enriched in secondary and tertiary processes and in the myelin sheet. Interestingly, 
overexpression of syntaxin 3 caused an accumulation of the myelin specific protein 
proteolipid PLP in the cell body, which was accompanied by a shift in PLP membrane 
localization, i.e., from a detergent soluble to a detergent-insoluble localization. 
Remarkably, overexpression of syntaxin 4 was without any effect on PLP transport, but 
completely inhibited MBP mRNA transport, thereby preventing MBP expression in the sheet, 
but not its biogenesis. The intracellular distribution of both syntaxins is consistent with the 
presumed apical- and basolateral-like properties of plasma membrane and sheet, 
respectively. Moreover, the data suggest that PLP transport to the sheet may proceed via 
a transcytotic mechanism, which involves syntaxin 3 for sheet-directed trafficking, but does 
not seem to depend on a syntaxin 4 dependent docking event in the sheet itself. 
 




During myelination, oligodendrocytes (OLGs) express large quantities of myelin 
proteins and lipids that are subsequently transported from the cell body to the distal end of 
the processes, which are wrapped around axons to form the myelin sheath. Like the apical 
and basolateral plasma membrane domains in polarized epithelial cells, the myelin and 
plasma membrane can similarly be considered as a reflection of the polarized nature of 
OLGs. Indeed, in previous work we observed that distinct viral proteins, i.e. the 
hemagglutinin (HA) of influenza and the G-protein of vesicular stomatitis virus (VSV G), 
which are sorted and transported to the apical and basolateral domains, respectively, in 
epithelial cells, also display a localized expression preference in OLGs (de Vries et al., 
1998). However, rather than being expressed in the myelin sheet, its high glycolipid content 
bearing reminiscence to the glycosphingolipid (GSL)-enriched apical membranes of 
polarized epithelial cells (Weimbs et al., 1997, Lafont et al., 1999), HA, partitioning in 
detergent resistant microdomains, particularly localized to the cell body plasma 
membrane, whereas the detergent-soluble VSV G shows a preferential localization in the 
myelin sheet (de Vries et al., 1998). These data were taken to suggest that in OLGs myelin 
sheet biogenesis relies on a basolateral, rather than an apical-like transport and sorting 
mechanism. However, more recently it was shown that when expressed in polarized 
Madin-Darby canine kidney (MDCK) cells, PLP is transported to the apical rather than the 
basolateral membrane (Kroepfl and Gardinier, 2001). Thus, evidently, further work is 
needed to clarify the mechanism of transport of myelin-specific proteins, which was the 
purpose of the present work. 
The final step in vesicular transport of membrane proteins involves the docking and 
fusion of a vesicle with its target membrane, which is mediated by a protein family referred 
to as SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein) (Jahn and 
Sudhof, 1999; Larocca et al., 2002). The SNARE proteins are integral membrane proteins 
that form stable complexes and are present on both the vesicles (v-SNARE) and the target 
membranes (t-SNARE), syntaxins constituting an important subunit of the latter. Importantly, 
the apical and basolateral plasma membrane domains of polarized epithelial cells 
contain distinct t-SNAREs (Weimbs et al., 1997), i.e. syntaxins 3 and 4, which are 
preferentially localized at the apical and basolateral plasma membrane, respectively 
(Fujita et al., 1998; Low et al., 1998). Previously, mRNA studies by Madison et al. (1999) 





localization and distribution of these syntaxins in OLGs has not been reported, a feature 
that could shed more light on the polarized nature of the OLG plasma and myelin 
membrane. In this work we demonstrate that syntaxin 3 and syntaxin 4 are functionally 
expressed in OLGs in a developmentally regulated and polarized manner, syntaxin 3 being 
largely restricted to the cell body and plasma membrane, while syntaxin 4 is enriched in 
the myelin sheet. The intimate involvement of syntaxin 3 in regulating PLP transport to the 
sheet is taken to suggest that a transcytotic transport mechanism might be operational in 
OLGs, relevant to the biogenesis of myelin membranes. 
 
Materials and Methods 
Materials 
Dulbecco’s Modified Eagle’s Medium (DMEM, with 4500 mg/l Glucose and L-
glutamine), L-glutamine, penicillin/steptomycin and G418 were purchased from Gibco 
Invitrogen Corporation (Paisley, UK). Fetal calf serum (FCS) was obtained from Bodinco 
(Alkmaar, The Netherlands). The transfectant FuGene 6 and protease inhibitor cocktail 
tablets (Complete Mini) were obtained from Roche Diagnostic Corp (Mannheim, 
Germany). Growth factors FGF-2 and PDGF-AA were supplied by PeproTech Inc. (London, 
UK). Paraformaldehyde was supplied by Merck (Darmstadt, Germany). All other chemicals 
were purchased from Sigma Chemical Co. (St. Louis. MO). 
 
Antibodies 
 The polyclonal antibodies against syntaxins 3 and 4 were a generous gift of Dr. 
Thomas Weimbs (Department of Molecular Medicine, Cleveland, OH). The monoclonal 
antibodies against PLP (Greenfield et al., 2006) and TGN-38 (IgG1, Luzeo et al., 1990) were 
generously provided by Dr. V. Kuchroo (Center of Neurological Diseases, Harvard Medical 
School, Boston, MA) and Dr.George Banting (Bristol, UK), respectively. The polyclonal anti-
caveolin-1 was obtained from BD Transductions Laboratories (Lexington, KY). The 
monoclonal antibody anti-MBP was purchased from Serotec (Oxford, UK). Fluorescein 
isothiocyanate (FITC), tetramethylrhodamine isothiocyanate (TRITC) and Cy-3 conjugated 
antibodies were supplied by Jackson ImmunoResearch Laboratories, Inc. (West Grove, 
PA). Secondary horseradish peroxidase (HRP)-conjugated antibodies were provided by 
Amersham Biosciences (Buckinghamshire, UK). 
 
 




General procedures for cloning and DNA manipulations were performed as 
described by Sambrook et al. (1989). The cDNAs encoding syntaxin 3 and syntaxin 4 (Low 
et al., 1996) were a kind gift of Dr. Thomas Weimbs (Department of Molecular Medicine, 
Cleveland, OH). For cloning the syntaxin genes in the retroviral vector pLXIN (Clontech 
Biosciences, Mountain View, CA), an XhoI restriction site at the ATG start codon of the 
syntaxin 3 and syntaxin 4 gene and an XhoI restriction site after the stop codon of both 
genes were introduced by the polymerase chain reaction (PCR). The following primers 
were used:  Forward syntaxin 3:   5’CATGTATTCGAAGAGCTCTTCGCACATGG 3’  
Reverse syntaxin 3:   5’CTAGGTGATCAAGAGCTCCTAGGGCCCACG 3’  
Forward syntaxin 4:  5’CGAATAGCTATGAGCTCCATGGTCTAG 3’ 
Reverse syntaxin 4:  5’GATCTCCTAGAGCTCACGTAGGGAC 3’ 
The PCR products were digested with Xho1 (Gibco Invitrogen Cooporation, Paisly, UK) and 
ligated with the 1.8 kb retroviral vector pLXIN. Recombinant plasmids were grown in 
Escherichia coli DH5α cells, and plasmids with the cDNA insert in the correct orientation 
with respect to transcription were identified by restriction analysis. The orientation and the 
integrity of the obtained pLXIN constructs were confirmed by DNA sequencing. 
 
Production of retroviral particles 
The production of retroviral particles and the subsequent infection of OLG 
progenitor cells were performed according to Relvas et al. (2001). Briefly, for production of 
recombination-deficient retroviruses, the constructs were transfected into the GP+E86-
packaging cell line (Genetix Pharmaceuticals, Inc. Cambridge, MA), using the FuGENE 6 
transfection reagent. Two days after transfection, cells were collected, diluted 5-fold and 
cultured under selection in packaging cells medium supplemented with 1 mg/ml G418 
until resistant clones appeared (70 % confluent). The cells were subsequently washed with 
PBS, and packaging cells medium without G418 was added. The conditioned medium was 
collected after 24 hrs, filtered (Schleicher and Schuell, Dassel, Germany, 0.45 μm pore size), 
and either used immediately or stored frozen at -80 °C. 
 
Cell culture 
Primary cultures of OLGs were prepared from brains of 1-2 day old Wistar rats as 





decapitating the rats, the forebrains were removed and the cells were dissociated, first 
mechanically and then with papaine (30 U/ml) in the presence of L-cysteine (0.24 mg/ml) 
and DNase (10 μg/ml) for 1 hr at 37 °C. A single cell suspension was prepared by repeated 
pipetting in a trypsin inhibitor (1 mg/ml) solution. After centrifugation the cells were 
resuspended in DMEM supplemented with 10 % FCS and seeded into 75 cm2 flasks (Nalge 
Nunc International, Roskilde, Denmark), which were precoated with poly-L-Lysine (PLL, 5 
μg/ml), at approximately 1.5 brain per flask. The OLG progenitor cells appear as round-
shaped, phase dark cells on top of monolayers of flat type-1 astrocytes. After 11-12 days in 
culture, the OLG progenitor cells were isolated by mechanical shaking at 240 rpm and 18-
20 hrs as described by McCarthy and de Vellis (1980). Contaminating astrocytes and 
microglia were subsequently removed by differential adhesion for 20 min at 37 ºC. 
For biochemical analysis, the OLG progenitor cells were plated in proliferation 
medium (SATO medium (Buttery et al., 1999; Maier et al., 2005) supplemented with the 
growth factors FGF-2 (10 ng/ml) and PDGF-AA (10 ng/ml)) on PLL-coated dishes (Nunc) at 
a density of 1 X 106 cells per 100 mm dishes. Differentiation was initiated by switching to 
SATO medium supplemented with 0.5 % FCS. For immunocytochemical studies the OLG 
progenitor cells were seeded at a density of 2 X 104 cells per well on PLL-coated 8 well 
permanox chambers (Nunc) and cultured as described above. 
 
Infection of oligodendrocyte progenitor cells  
For overexpression of syntaxins, the OLG progenitor cells were plated in proliferation 
medium on PLL-coated 100 mm dishes or 8 well chamber slides as described above and 
cultured for 48 hrs in proliferation medium. Infections were carried out by exposing the cells 
to retroviral particles, 8 µg/ml polybrene, 10 ng/ml FGF-2 and 10 ng/ml PDGF-AA for 16-18 
hrs. The cells were cultured for 24 hrs in proliferation medium and then cultured under 
selection in proliferation medium supplemented with 400 μg/ml G418 (corrected for 
inactivity) during 5 days. After selection the cells were cultured on differentiation medium 
(SATO supplemented with 0.5 % FCS) for 3 to 9 days. 
 
Immunofluorescence and confocal microscopy 
Paraformaldehyde-fixed cells (4 % paraformaldehyde in PBS for 20 min at room 
temperature (RT)) were subsequently rinsed with PBS, blocked and permeabilized with 10 % 
FCS and 0.1 % Triton X-100 (TX-100) in PBS, respectively, for 30 min at RT. The cells were 
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incubated for 1-2 hrs with appropriately diluted primary antibodies in PBS supplemented 
with 2.5 % FCS and 0.1 % TX-100 (incubation buffer). The cells were washed with PBS and 
incubated for 30 min at RT with the appropriate secondary antibody conjugated with FITC, 
TRITC or Cy3 diluted in incubation buffer. After washing with PBS, the cells were covered 
with 2.5 % 1,4-diazobicyclo[2.2.2]octane (DABCO) in 90 % glycerol/ 10 % PBS, to prevent 
image fading. The samples were analyzed with an immunofluorescence microscope 
(Olympus AX70), equiped with analySIS software. Confocal microscopy analyses were 
performed using a TCS Leica SP2 Confocal Laser Scanner Microscope (Leica Heidelberg, 
Germany) in combination with Leica Confocal Software. Data were processed using Paint 
Shop Pro and/or Adobe Photoshop software. 
 
Preparation of detergent extracts  
The cells were washed with PBS, and harvested by scraping the cells with a rubber 
policeman in 350 μl TNE lysis buffer (20 mM Tris HCl pH 7.4, 150 mM NaCl, 1 mM EDTA 
supplemented with 1 % TX-100 and a cocktail of protease inhibitors). Lysis occurred on ice 
for 30 min and the protein content was determined by a Bio-Rad DC Protein Assay (Bio-Rad 
Laboratories, Hercules, CA), using BSA as a standard. Soluble and insoluble material were 
separated by centrifugation for 15 min at 10000 rpm at 4 °C. Pellets and supernatants were 
mixed with SDS reducing sample buffer, heated for 2 min at 95 ºC or 30 min at 37 °C and 
subjected to SDS-PAGE and Western Blotting. 
 
OptiPrep density centrifugation 
For density gradient centrifugation a discontinuous OptiPrep gradient (2.25 mL 10 %, 
2.25 mL 30 %, and 750 µl 40 %) was prepared. For preparing 40 % OptiPrep 250 µl of total 
cell lysates (equal protein) were added to 500 µl of 60 % OptiPrep. This mixture was then 
overlaid with 30 % OptiPrep and 10 % OptiPrep. Gradients were centrifuged overnight at 
40000 rpm (SW55 Beckman, 4 °C) and 7 750 μl gradient fractions were collected from the 
top (fraction 1) to the bottom (fraction 7). For Western blot analysis, equal volumes were 
TCA precipitated, resuspended in SDS reducing sample buffer and analyzed by SDS-PAGE 







To concentrate proteins, the fractions were adjusted to a final volume of 1 ml with 
TNE and treated with DOC (25 mg/ml) for 5 min at 4 °C followed by precipitation with 6.5 % 
trichloric acid (TCA) for 15 min at 4 °C. Precipitates were centrifuged for 20 min at 10000 
rpm and 4 °C. The pellets were dryed and resuspended in 2x SDS reducing sample buffer. 
After the pH was adjusted to 6.8 by exposure to ammonia, the samples were heated for 
2 min at 95 ºC or 30 min at 37 °C and subjected to SDS-PAGE and Western Blotting. 
 
SDS-PAGE and Western Blotting 
Samples were loaded onto 10 or 12.5 % SDS-polyacrylamide gels and transferred to 
nitrocellulose membranes (Bio-Rad) by semi-dry blotting. The membranes were blocked 
with 5 % nonfat dry milk in Tris buffered saline (TBS) to inhibit nonspecific binding. The 
membranes were washed with TBS-T (TBS supplemented with 0.1 % Tween-20) and 
incubated with appropriate primary antibodies in TBS-T with 0.5 % nonfat dry milk for at 
least 2 hrs at RT. After 3 times washing with TBS-T, the membranes were incubated for 1 hr 
at RT with the appropriate HRP-conjugated antibody (1:2000 in TBS-T). The signals were 
visualized by ECL (Amersham, Pharmacia Biotech), processed with Paint shop Pro and 
quantified by using Scion Image Software. 
 
In situ hybridization 
 The in situ hybridization protocol was based on the procedure described by de Vries 
et al. (1997). Briefly, paraformaldehyde-fixed cells were subsequently rinsed, with PBS and 
SSC (Saline Sodium Citrate), dried and hybridized with sense and antisense digoxigenin-
labeled probes overnight at 60 °C in a solution containing formamide, NaCl, Tris, EDTA, 
tRNA, Denhardt’s solution and dextran sulfate and a final probe concentration of 1-5 ng/μl. 
After hybridization, the cells were treated with ribonuclease A at 37 °C and washed in SSC 
at 65 °C. Hybridization signals of digoxigenin-labeled RNA-RNA complex were visualized 
after incubation with alkaline phosphatase-conjugated sheep anti-digoxigenin using 
nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate (BCIP) as a substrate. 
Endogenous non-intestinal phophatase activity was inhibted by the addition of levamisole 
to the staining solution, developed overnight and terminated by rinsing the cells in a buffer 
solution consisting of Tris-HCl and EDTA, pH 8.0. The dark purple precipitate, indicating the 
presence of hybridized mRNA, was detected with brightfield microscopy. 
 




Total RNA from infected cells was isolated using an RNeasy Mini kit (Qiagen, Hilden, 
Germany). The yield and purity were quantified spectrophotometrically by measuring A260 
and A280 optical densities. 0.5 μg of total RNA was reversed transcribed in the presence of 
oligo(dT)12-18 and dNTPs (Gibco Invitrogen Cooporation, Paisly, UK) with superscript II 
reverse transcriptase (Roche Diagnostic Corporation, Mannheim, Germany) according to 
the manufacturer’s instructions. The resulting cDNA was amplified using primers specific to 
the myelin proteolipid protein PLP, MBP and as a control β-actin: 
5’GGCCGAGGGCTTCTACACCAC 3’ (forward PLP) 
5’CAGGAGCCCACTGTGGAGAA 3’ (reverse PLP)) 
5’ACTGCGGATAGACAGG 3’ (forward MBP) 
5’GATGGTGACCTTCGGC 3’ (reverse MBP) 
5’ACCACACAGCTGAGAGGGAAATC 3’ (forward β-actin) 
5’GGTCTTTACGGATGTCAACG 3’(reverse β-actin) 
All PCR products were analyzed by agarose gel electrophoresis. Resultant bands were 
stained with ethidium bromide and visualised by using a Polaroid Direct Screen Camera. 




Syntaxin 4 but not syntaxin 3 is strongly upregulated during OLG development 
Upon development, OLGs undergo a carefully defined process of maturation, 
during which different developmental stages can be discerned. Thus the cells differentiate 
from a bipolar progenitor cell (O2A stage) to a cell with branched primary processes 
(GalC stage) and eventually to one with elaborate laminar sheets (MBP stage), the mature 
stage of OLGs in culture (fig. 1A, Pfeiffer et al., 1993; Baron et al., 2005). This development is 
accompanied by the biogenesis and maintenance of different surface membrane 
domains in that next to the cell body plasma membrane, constituting the main boundary 
domain during early development (O2A), an elaborate myelin membrane sheet domain is 
formed upon full differentiation (MBP stage). Not unlikely, syntaxins 3 and 4, known to be 
localized at distinct membrane surfaces in polarized cells, are playing a prominent role in 
the sorting and trafficking events involved in the assembly and maintenance of these 





syntaxins as a function of OLGs development. Total lysates obtained at different 
developmental stages of OLGs were prepared and analyzed by Western blotting. As 





Figure 1: Regulated expression of syntaxin 3 and syntaxin 4 in developing oligodendrocytes. (A) Schematic 
overview of OLG development and differentiation as reflected by changes in morphology from progenitor 
cells, O2A, via O4 and GalC stages to mature and fully differentiated cells, defined as the MBP stage 
(adapted from Baron et al., 2005). (B) Relative expression levels of syntaxin 3 and syntaxin 4 in OLGs during 
development. Protein extracts were prepared, and equal amounts of protein were loaded on a SDS-PAGE gel. 
The gels were visualized by Western blotting, using antibodies directed against rat syntaxin 3 or 4. Syntaxin 3 
(black bars) and syntaxin 4 (gray bars) expression were quantified and expressed relative to that at the O2A 
stage (= 100). Data were obtained from at least three independent experiments. Statistical significance 
between O2A stage and the other developmental stages is shown (***P < 0.001). 
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Interestingly and in contrast, the expression of syntaxin 4 was substantially 
upregulated during development and relative to its expression in OLG progenitor cells 
(O2A) increased more than four fold under conditons of avid myelin sheet biogenensis 
(MBP stage). From these data it is tempting to suggest that syntaxin 4 might thus 
particularly be involved in myelin sheet-directed transport, whereas syntaxin 3 would 
largely act in vesicular transport directed toward the cell body plasma membrane. To 
investigate this possibility, their localization was determined by immunofluorescence 
microscopy. 
 
Syntaxin 3 is localized in the plasma membrane and primary processes, whereas syntaxin 
4 is localized towards the myelin sheet. 
To analyze the localization of syntaxins 3 and 4 during OLG development, the 
localization of the syntaxins in the different developmental stages was visualized by 
immunofluorescence. In the O2A stage, syntaxin 3 largely localizes to the perinuclear 
region, whereas in the O4 and GalC stage syntaxin 3, besides a more punctuate 
distribution, presumably reflecting its presence in vesicular structures throughout the 
cytoplasm of the cell body, can also be discerned at the plasma membrane of the 
primary processes (data not shown; cf. fig. 2A). Importantly, in fully differentiated cells (MBP 
stage), no significant colocalization of the myelin sheet marker MBP with syntaxin 3 could 
be observed, implying that syntaxin 3 is excluded from the myelin sheet. Indeed, as during 
early development, syntaxin 3 labeling was largely associated with the cell body plasma 
membrane and primary processes (fig. 2 A-C).  
In cells at the O2A and O4 stages, syntaxin 4, like syntaxin 3, was located in 
intracellular vesicles. However, the syntaxin 4 containg vesicles, in contrast to those 
containing syntaxin 3, were not scattered throughout the cytoplasm and partially 
colocalized with TGN-38 (data not shown). At later stages of development syntaxin 4 was 
directed towards the plasma membrane of the processes.  
Most interestingly and in marked contrast to the localization of syntaxin 3, syntaxin 4 
prominently colocalized with MBP in the myelin sheet, as shown in figures 2D-F. These data 
thus suggest a preferential, polarized distribution of syntaxins 3 and 4 in OLGs, syntaxin 3 in 
contrast to syntaxin 4 being largely present in the cell body plasma membrane and 








Figure 2: Endogenous syntaxin 4 but not syntaxin 3 localize to the sheet and colocalizes with MBP in mature 
oligodendrocytes. OLGs in the MBP stages were fixed, permeabilized and costained for either syntaxin 3 (A) or 
syntaxin 4 (D), and MBP (B and E). Merged images are shown in C (syntaxin 3/MBP) and F (syntaxin 4/MBP). Bar 








 Syntaxin 3 and 4 in myelin biogenesis 
 
 65 
Membrane microdomains, also known as ‘lipid rafts’, have received much attention 
as organizing platforms and potential regulators of membrane trafficking pathways. 
Syntaxin 3, but not syntaxin 4, has been reported to be particularly enriched in such 
microdomains (Lafont et al., 1999; Pombo et al., 2003). Whether both syntaxins, apart from 
a preferential asymmetric distribution, also displayed a distinct preference for a raft 




Figure 3: Syntaxin 3, but nor syntaxin 4 preferentially accumulates into detergent-resistent microdomains during 
oligodendrocyte development. TX-100-soluble and –insoluble fractions, obtained from OLGs at different stages 
of development (see fig. 1A) were immunoblotted and syntaxin 3 (A) and 4 (B) were visualized by ECL. The 
soluble (black bars) and insoluble fractions (grey bars) were quantified and expressed as percentage of the 
total fraction (=100 %). Note that the detergent-resistant fraction of syntaxin 3 increases when the cells 
become more mature while the partitioning of syntaxin 4 remains unaltered during development. Data were 
obtained from at least three independent experiments. Statistical significance between O2A and the other 
developmental stages is shown (**P<0.01). (C) Microdomain localization of endogenous syntaxin 3 and 
syntaxin 4 in the MBP stage. OLGs (MBP stage) were extracted with 1 % TX-100 at 4 °C, and analyzed by 
OptiPrep density gradient centrifugation (40 %, 30 % and 10 %). Proteins were visualized by Western Blotting, 
using antibodies directed against syntaxin 3, syntaxin 4 and the raft marker caveolin. The figure represents a 
typical result of three independent experiments. 
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Relative to syntaxin 4, syntaxin 3 is enriched in Triton X-100 microdomains 
To analyze the lateral membrane microdomain distribution of syntaxins 3 and 4 in 
OLG, cells were extracted with cold Triton X-100 (TX-100) and centrifuged to separate the 
detergent soluble and insoluble fractions. As shown in figure 3A, during maturation the 
detergent-insoluble fraction of syntaxin 3 (grey bars) increased from approximately 25 % in 
the O2A stage to approx. 50 % in the MBP stage, indicating that syntaxin 3 becomes 
increasingly detergent-resistent during OLG maturation. A fraction of approx. 25 % of 
syntaxin 4 localized to a TX-100 insoluble pool at all stages of OLG development (fig. 3B). 
Virtually identical results were obtained when the proteins were analyzed by density 
gradient centrifugation (fig. 3C). Thus these data indicate that in mature OLGs, syntaxin 3 is 
roughly equally distributed between raft and non-raft structures while syntaxin 4 
preferentially localizes to non-raft domains, using TX-100 solubulity as operational criterion 
for defining raft structures. Given differences in their intracellular distribution and 
partitioning into detergent-resistant membrane microdomains, we therefore next 
examined how these distinct distribution profiles related to functional aspects of syntaxin 3 
and syntaxin 4 in membrane transport, involved in the assembly of the myelin sheet. 
 
Overexpressed syntaxin 4 specifically inhibits the expression and localization of MBP  
We first investigated the role of syntaxin 4 on the trafficking of myelin-sheet specific 
proteins, following its overexpressing in the cells. At the early stages of OLG development 
(fig. 4A), the localization of overexpressed syntaxin 4 resembled that of endogenous 
syntaxin 4, and was also found at the plasma membrane of the cell body. Later in 
development (GalC and mature MBP stages), overexpressed syntaxin 4 (fig. 4C and D) 
was more prominently present in the processes and in the myelin sheets of the OLGs, very 
similar as observed for the disitrubution of endogenous syntaxin 4 (cf. fig. 2D). 
In all cases, the morphology of the cells and/or appearance of the sheets were 
indistinguishable from those of mock transfected cells. The different developmental stages 
of OLGs are characterized by the sequential appearance of several myelin specific 
markers. 2', 3' -cyclic nucleotide 3’-phosphodiesterase (CNP) is the earliest myelin specific 
protein that is expressed in the OLG lineage and can be used as a marker for the onset of 
differentiation. MBP and PLP serve as markers for OLG maturation. At a roughly 5-fold 
overexpression of syntaxin 4, no differences were observed between the overexpressed 
 
 Syntaxin 3 and 4 in myelin biogenesis 
 
 67 
and mock infected cells in terms of the number of cells in each population, expressing the 




Figure 4: Localization of syntaxin 4 in syntaxin 4 overexpressing oligodendrocytes as a function of cell 
development. OLG progenitor cells, retrovirally overexpressing syntaxin 4, were prepared as described in 
Materials and Methods. The localization of syntaxin 4 was subsequently determined in OLGs, grown to various 
developmental stages O2A (A), O4 (B), GalC (C) and MBP (D). To this end, the cells were fixed, permeabilized 
and stained with an anti-rat syntaxin 4 antibody. Bar = 20 µm. Representative pictures of three independent 
experiments are shown. Note that upon OLG maturation (MBP stage) syntaxin 4 is localized to the myelin sheet. 
 
Also, at the MBP stage, the number of PLP positive cells, as well as the protein’s 
intracellular distribution were indistinguishable for mock infected and syntaxin 4 
overexpressing cells (fig. 5A versus B), suggesting that overexpression of syntaxin 4 did not 
visibly interfere with the differentitation pattern of the cells. Remarkably, however, in 
contrast to its appearance in mock infected cells (fig. 5C), MBP expression was virtually 
absent in syntaxin 4 overexpressing cells (fig. 5D), when examined by immunofluorescence 
microscopy. To obtain further support for these observations total cell lysates were 
prepared from syntaxin 4 overexpressing and mock infected cells, which were 
subsequently analyzed by SDS-PAGE and Western blotting. Whereas the expression of the 
myelin specific proteins CNP (data not shown), MAG (data not shown) and PLP (fig. 5E) at 
D                    MBP 
A                     O2A B                     O4 





various stages of development were virtually unaffected by syntaxin 4 overexpression, the 
latter caused a dramatic decrease of MBP expression (fig. 5E), consistent with the 
fluorescence imaging. Interestingly, in contrast to most other myelin-specific proteins, MBP 
insertion into the myelin sheet is unique in that it involves sheet-directed transport of its 
mRNA followed by local transcription (Ainger et al., 1993; de Vries et al., 1997). 
Accordingly, these data would suggest that overexpressed syntaxin 4 may interfere with 




Figure 5: Sheet localization and expression of MBP, but not PLP, is modulated in syntaxin 4 overexpressing cells. 
Localization of the myelin specific proteins PLP (A, B) and MBP (C, D) in syntaxin 4 overexpressing and mock 
infected (pLXIN) OLGs in the MBP stage as determined by immunofluorescence. Bar = 20 µm. Representative 
pictures of three independent experiments are shown. In E, immunoblots of total lysates (equal protein 
fractions) obtained from syntaxin 4 overexpressing OLGs and mock infected cells in the MBP stage. Proteins 
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Syntaxin 4 is involved in MBP mRNA transport  
Having established that in cells overexpressing syntaxin 4 both the expression level 
and localization of MBP were altered, in situ hybridization experiments were performed to 
analyze whether MBP mRNA transport from the cell body to the processes and sheet was 
blocked. For in situ hybridization, the mRNA probe coding for the 14 kDa isoform of MBP 
was used. This probe hybridizes to all isoforms of MBP as well as to the MBP exon 0’ 






Figure 6: Syntaxin 4 mediates MBP mRNA transport towards the myelin sheet. In situ hybridization of MBP mRNA 
with digoxigenin-labeled 14 kDa MBP sense (A) and antisense (B, C) RNA probes was carried out in mock 
infected cells and syntaxin 4 overexpressing cells as described in Materials and Methods. Bar = 20 µm. 
Representative pictures of three independent experiments are shown. In D, mRNA was isolated from mock 
infected (grey bars) and syntaxin 4 overexpressing (black bars) OLGs in the MBP stage, and RT-PCR was 
performed using primers specific for PLP, MBP and β-actin. Expression of each gene was calculated relative to 
the expression of housekeeping gene, β-actin. Note that MBP mRNA is equally expressed in mock infected and 
syntaxin 4 overexpressing cells. 
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As shown in figure 6B, in mock infected cells the probe hybridized to the cell body and to 
both the primary and the secundary processes. However, in OLGs overexpressing syntaxin 
4 the probe only hybridized to the cell body, implying that MBP mRNA localizes only to the 
cell body and the primary processes. No mRNA of MBP was present in the sheet (fig. 6C), 
suggesting that the MBP mRNA could not be transported to its final target, the myelin 
sheet.  
To further determine whether these results could also (partly) result from an 
interference of overexpressed syntaxin 4 with MBP mRNA expression, total RNAs were 
isolated and the concentration was determined via RT-PCR. In cells overexpressing syntaxin 
4, the amount of MBP mRNA was very similar to the amount of MBP mRNA seen in mock 
infected cells (fig. 6D). Taken together, these data are thus in accordance with the notion 
that overexpression of syntaxin 4 causes an MBP mRNA transport-related inhibition of MBP 
expression in myelin sheets without affecting protein transport to the sheet as such, as 
reflected by unaltered transport of another major sheet protein, PLP (fig. 5), as well as that 
of CNP and MAG (data not shown). 
 
Overexpression of syntaxin 3 inhibits transport of the myelin specific proteolipid PLP 
To similarly analyze the role of syntaxin 3 in the expression and trafficking of myelin 
proteins, the same experimental protocol was followed as that described above for 
cultured OLGs, overexpressing syntaxin 4. First, it was investigated whether there was a 
difference in morphology and differentiation pattern after syntaxin 3 overexpression. It 
appeared that cells overexpressing syntaxin 3 resembled the mock infected cells at all 
stages (data not shown; cf. Fig. 5). Also the expression level of syntaxin 3 and that of the 
myelin specific proteins CNP, MAG, PLP and MBP was determined at the various stages of 
development. In cells, displaying an approx. 10-fold overexpression of syntaxin 3 
compared to wildtype, the expession levels of CNP, MAG and MBP were not significantly 
different when compared to those in mock infected cells. Neither was there a difference in 
intracellular distribution of either of these proteins, compared to control cells. Intriguingly, 
although no effect was observed in the expression level of PLP as analyzed by Western 
Blotting (cf. fig. 7D), immunofluorescence microscopy (fig. 7A versus B) revealed that in 
OLGs overexpressing syntaxin 3 transport of PLP to the sheet was apparently blocked, since 
PLP accumulated in intracellular vesicles in the cell body and could hardly be detected in 
the myelin sheet (MBP stage). It is also important to emphasize that as observed for 
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syntaxin 4, overexpressed syntaxin 3 showed a very similar distribution as endogenous 
syntaxin 3, accumulating in particular in the cell body at the MBP stage (cf. fig. 2). In 
search of a clue for the underlying mechanism that causes a block in PLP transport, we 
next examined whether differences arose in the nature of the accumulating PLP fraction 
within the cell body when overexpressing syntaxin 3, compared to mock infected cells. To 
this end the syntaxin 3 overexpressing OLG progenitor cells were differentiated until the 
MBP stage, extracted with TX-100, layered on an OptiPrep density gradient and analyzed 




Figure 7: Overexpression of syntaxin 3 inhibits sheet-directed transport of PLP. The localization of the myelin 
specific protein PLP was determined by immunofluorescence in mock infected (vector only, A) and syntaxin 3 
overexpressing (B) OLGs in the MBP stage. Note the presence of sheets in syntaxin 3 overexpressing cells, as 
visualized by MBP immunofluorescence (C). Bar = 20 µm. Representive pictures of three independent 
experiments are shown. Potential differences in lateral membrane localization of PLP was analyzed in syntaxin 
3 overexpressing and mock infected OLGs by detergent extraction and gradient analysis as shown in D. OLGs 
in the MBP stage were extracted with 1 % TX-100 at 4 °C, and analyzed by OptiPrep density gradient 
centrifugation (40%, 30% and 10%) as described in Materials and Methods. PLP was visualized by Western 
blotting. The blots are representitive of at least three independent experiments. Note that PLP is TX-100-resistant 
in syntaxin 3 overexpressing OLGs, whereas in mock infected OLGs PLP is largely TX-100-soluble (fraction 7). 
 












As shown in figure 7D, whereas in control cells PLP essentially localizes to detergent soluble 
fractions (mock), in syntaxin 3 overexpressed cells PLP’s localization has shifted to the 
floating TX-100 insoluble fraction (fig. 7D, syntaxin 3). 
Hence, these data would suggest that PLP, following its biosynthesis, might 
transiently integrate into TX-100-resistant microdomains preceeding a subsequent 
transport/localization step involved in its ultimate deposition at the myelin sheet, which 
does not depend on such a TX-100-resistant localization. Apparently, (overexpressed) 
syntaxin 3 interferes with this transport step at the level of the cell body. 
 
Discussion 
 There is ample evidence that SNARE proteins, including the t-SNARE subunit syntaxin, 
are intimately involved in docking and fusion of vesicles, mediating numerous intracellular 
transport processes of membrane proteins (Lafont et al., 1998; Breuza et al., 2000; Ter Beest 
et al., 2005). The present work demonstrates a distinct role of syntaxin 3 and syntaxin 4 in 
transport events in OLGs, connected with the biogenesis of the myelin sheet. Thus, our 
data suggest that syntaxin 3, which is particularly enriched in the cell body where it 
distributes about equally between raft- and non-raft lipid fractions, is particularly involved 
in regulating transport of the major myelin protein PLP to the myelin membrane sheet. In 
contrast, syntaxin 4, which is largely soluble when extracted with TX-100 and to a major 
extent localizes to the myelin sheet, predominantly perturbs MBP mRNA transport from the 
cell body to the sheet, without significantly interfering with other myelin specific proteins, 
such as PLP, CNP and MAG. Our data also clearly indicate a polarized distribution of both 
syntaxins, in line with previous observations on the polarized nature of OLGs. Most 
intriguingly, based on the inhibitory effect of overexpressed syntaxin 3 on sheet-directed 
PLP transport, our results support the notion that ‘transcytosis’ between the plasma 
membrane of the OLG cell body and the myelin sheet may be an operating mechanism in 
myelin sheet assembly in OLGs. 
In previous work (De Vries et al., 1997) we noted the polarized nature of the myelin 
membrane versus the cell body plasma membrane in mature OLGs. In those studies we 
observed that the influenza protein hemaglutinine (HA), which is sorted to the apical 
membrane domain in polarized epithelial cells where it resides in a TX-100 insoluble 
membrane fraction, localizes to the plasma membrane of the OLG cell body, whereas the 
TX-100 soluble basolateral marker in epithelial cells, VSV G, traffics to the myelin sheet. In 
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this manner, a cognate basolateral domain, i.e., the myelin sheet, and a cognate apical 
domain, i.e., the cell body plasma membrane domain, were thus identified in mature 
OLGs (MBP stage). In the present work, the polarized features of the OLGs are now further 
corroborated by the observation that syntaxin 3 localizes in particular to the cell body, 
including the plasma membrane, whereas syntaxin 4 is most prominently present in the 
sheet. This polarized distribution of these syntaxins in OLGs is entirely consistent with well-
established properties in various epithelial cells that syntaxin 3 is involved in apical 
trafficking i.e., towards the cell body plasma membrane in OLGs, whereas syntaxin 4 
localizes to the basolateral surface (Low et al., 1996; 1998; Lafont et al., 1999; Pombo et al., 
2003), i.e., the myelin sheet in mature OLGs. Moreover, next to paralleling a polarized 
distribution, we similarly observed analogous differences in the lateral localization of both 
syntaxins. Thus, in mature OLGs, syntaxin 3, but not syntaxin 4 displayed a distinct 
preference for a raft-like localization, as previously reported for the localization of syntaxin 
3 in epithelial MDCK cells (Low et al., 1996; Lafont et al., 1999) and in membranes of mast 
cell granules (Pombo et al., 2003). Most interestingly, by expressing chimeric variants of 
syntaxins 3 and 4 and determining the functional sorting of relevant marker proteins in 
polarized MDCK cells, recent evidence indicated that these syntaxins may play a role in 
determining the specificity of membrane targeting by regulating protein delivery to only 
certain target membranes (ter Beest et al., 2005). In this context, the observation of an 
inhibition of PLP transport to the sheet in syntaxin 3, but not syntaxin 4 overexpressing cells is 
of major interest. In MDCK cells it has been demonstrated that overexpression of syntaxin 3, 
but not of syntaxin 4, causes an inhibition of apical-directed membrane transport (Low et 
al., 1998). Although the mechanism underlying this inhibitory effect remains to be 
determined, excess syntaxin 3 apparently precludes docking and/or merging of cargo 
vesicles to the apical membrane, which, however, is not accompanied by subsequent 
missorting to the basolateral surface. Of further interest is the observation that when PLP is 
expressed in MDCK cells, the protein sorts exclusively to the apical membrane (Kroepfl and 
Gardinier, 2001). This finding is in agreement with our contention of a cognate apical 
character of the OLG cell body plasma membrane which, in line with the specificity of 
syntaxin-dependent vesicle targeting (ter Beest et al., 2005), would thus depend on 
syntaxin 3, present in plasma membrane and cell body. The observations thus also imply 
that a syntaxin 3 dependent mechanism is a prerequisite for subsequent transport of PLP to 





TX-100 resistant membrane fraction (fig. 7), would be consistent with an indirect transport 
pathway of PLP to the sheet. Thus, our data (fig. 7) suggest that following biosynthesis, PLP 
is first transported to the plasma membrane of the cell body, which occurs in a raft-like 
fraction and depends on syntaxin 3, after which the protein will be (re-)internalized as part 
of a membrane carrier that solubilizes in TX-100, and that is directed to the myelin 
membrane. This process can be seen as a transcytotic step, as occurs in polarized 
epithelial cells and, in case of PLP transport, is apparently independent of syntaxin 4. This is 
in line with the notion that transcytotic transport from basolateral to apical membrane in 
epithelial cells does not necessarily depend on syntaxin 3 (Low et al., 1999). 
In analogy to an inhibitory effect of overxpressed syntaxin 3 on a transport step, 
overexpressed syntaxin 4 inhibited transport of MBP mRNA towards the sheet, but not that 
of the other proteins examined, i.e., MAG, CNP and PLP. As a result, the expression level of 
MBP became almost negligible and the protein was no longer detectable in the myelin 
sheet. Importantly, compared to mock infected cells the level of mRNA MBP did not 
change in syntaxin 4 overexpressing cells. In situ hybridization revealed that in mock 
infected OLGs, MBP mRNA was transported deeply into the secondary processes, where it 
is translated into MBP protein, i.e., near the site where myelin is formed. The present data 
show that in cells overexpressing syntaxin 4 the MBP mRNA only reached the primary 
processes and remained mostly perinuclear, suggesting that syntaxin 4 may play a role in 
the translocation of MBP mRNA from the cell body to the myelin sheet. This observation is 
remarkable in that MBP mRNA is thought to be part of a so-called granule, which is not 
bounded by a membrane, and which is transported along microtubules to its site of 
destination (Barbarese et al., 1995; Carson et al., 1998; Song et al., 2003). At present, it is 
unclear whether syntaxin 4 directly interferes with the docking of this granule at the sheet 
or that it inhibits sheet-directed vesicular transport of co-factors, necessary for mRNA 
delivery. However, in yeast mRNA transport has been linked to vesicular transport, which 
was reported to be regulated by SNAREs (Aronov et al., 2004). Evidently, in light of the 
regulatory role of syntaxin 4 in MBP mRNA transport, further work to clarify its mechanism in 
this context, is warranted. 
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During the process of myelination of axons by oligodendrocytes (OLGs) in the 
central nervous system, myelin-specific proteins and lipids are sorted and transported from 
their site of synthesis, the OLG cell body, to their site of destination, the myelin sheath. 
Insight into the mechanism of these events is crucial for the development of therapeutic 
approaches in devastating demyelinating diseases, like multiple sclerosis. Here, we 
demonstrate in cultured OLGs, grown on different substrates of extracellular matrix 
proteins, that transcytotic transport of the major myelin resident protein, PLP, from cell body 
plasma membrane to myelin sheet is a key step in the mechanism of proper myelin 
assembly. By carrying out pulse chase experiments, in conjunction with biotinylation to 
determine and characterize its surface pool, our data reveal that following biosynthesis, 
PLP is transported to the cell surface of the cell body in microdomains that were 
operationally defined as Triton X-100 resistant. The latter was confirmed by in situ detergent 
extraction. The involvement of sulfatide in this process was suggested by the observation of 
plasma membrane-directed PLP transport in the oligodrendoglia derived cell line OLN-93, 
overexpressing ceramide sulfatide transferase but not in cells overexpressing ceramide 
galactosyl transferase. Interestingly, PLP only transiently associated with the Triton X-100 
resistant microdomains at the plasma membrane, its lateral dissipation being followed by 
subsequent re-internalization and transport towards the sheet. We propose a model in 
which PLP traffics to the myelin sheet via syntaxin 3 mediated docking at the cell body 
plasma membrane, involving a transcytotic transport mechanism, consistent with the 
polarized nature of oligodendrocytes. 
 




Oligodendrocytes (OLGs), the glial cells in the central nervous system (CNS), 
synthesize a multilamellar membrane structure called the myelin sheath, which wraps 
around the axons thereby facilitating rapid saltatory conduction. Myelin, which is essential 
for proper functioning of the nervous system, is a specialized membrane structure, being 
enriched in glycosphingolipids and cholesterol and containing myelin-specific proteins 
(Lees and Brostoff, 1984; Norton and Cammer, 1984; Simons et al., 2000; de Vries and 
Hoekstra, 2001). Since myelin proteins, except MBP, are synthesized in the OLG cell body, 
followed by subsequent transport to the myelin sheet, it is evident that sorting and transport 
of proteins and lipids to the myelin membrane must be carefully regulated. In previous 
work we have shown (Klunder et al., submitted; chapter 3) that the t-SNAREs syntaxin 3 and 
4, as part of the docking and fusion machinery of transport vesicles for membrane proteins 
(Low et al., 1996; Madison et al., 1999), are intimately involved in intracellular transport and 
sheet delivery of the major myelin protein PLP and MBP mRNA, respectively, the latter 
being locally expressed in the sheet upon arrival. In OLGs, which can be considered as 
polarized cells (de Vries et al., 1998; Krämer et al., 2000; Kroepfl and Gardinier, 2001), 
syntaxin 3 was found to localize largely at the plasma membrane of the OLG cell body 
and the primary processes, whereas syntaxin 4 was enriched at the myelin sheet (Klunder 
et al., submitted; chapter 3). Particularly intriguing, this work indicated that transport of PLP 
which is synthesized at the rough endoplasmic reticulum (RER), processed through the 
Golgi apparatus (Colman et al., 1982; Nussbaum et al., 1983; Schwob et al., 1985), 
depends on syntaxin 3. In fact, the data suggested that PLP transport to the sheet could 
rely on a transcytotic mechanism. Intriguingly, the previous data also suggested that in this 
transport process, PLP transiently associated with microdomains that displayed Triton X-100 
(TX-100) resistance. Hence, this transient association of PLP with TX-100 resistant domains 
may (at least partly), in conjunction with a gradually expanding panel of non-ionic 
detergents, used to identify such microdomains (Simons et al., 2000), explain the 
controversy as to the extent to which PLP transport is coupled to glycosphingolipid 
transport, the lipid being considered as a typical component of TX-100 resistant 
micordomains (Pasquini et al., 1989; Brown et al., 1993; van der Haar et al., 1998; Bansal et 
al., 1999). 
Thus far, knowledge as to how myelin biogenesis is regulated and maintained has 





of several neurological diseases. In particular, failure of remyelination seems to be an 
underlying cause of the detrimental consequences of such diseases. Accordingly, at least 
for therapeutic purposes, fundamental insight into molecular events related to the onset 
and maintenance of myelin sheet biogenesis are crucial. The present work was 
undertaken to further corroborate previous observations on the potential involvement of a 
transcytotic transport mechanism in myelin assembly.  
 
Materials and Methods 
Materials 
Dulbecco’s Modified Eagle’s Medium (DMEM, with 4500 mg/l Glucose and L-
glutamine), L-glutamine, penicillin/streptomycin and G418 were purchased from Gibco 
Invitrogen Corporation (Paisley, UK). Fetal calf serum (FCS) was obtained from Bodinco 
(Alkmaar, The Netherlands). Growth factors FGF-2 and PDGF-AA were supplied by 
PeproTech Inc. (London, UK). Protease inhibitor cocktail tablets (Complete Mini) were 
obtained from Roche Diagnostic Corp (Mannheim, Germany). Nonidet P40 (NP40) was 
purchased from Fluka BioChemica (Buchs, Zwitserland). Sulfo-NHS-LC-Biotin was obtained 
from Pierce (Rockford, IL). Streptavidin was obtained from Upstate Lake Placid (New York, 
NY). Paraformaldehyde was supplied by Merck (Darmstadt, Germany). All other chemicals 
were purchased from Sigma Chemical Co. (St. Louis. MO).  
 
Antibodies 
 The polyclonal antibody against rat syntaxin -3 was a generous gift of Dr. Thomas 
Weimbs (Department of Molecular Medicine, Cleveland). The monoclonal antibodies 
against PLP (Greenfield et al., 2006) and TGN-38 (IgG1, Luzio et al., 1990) were generously 
provided by Dr. V. Kuchroo (Center of Neurological Diseases, Harvard Medical School, 
Boston, MA) and Dr. George Banting (Bristol, UK), respectively. The monoclonal antibody 
anti-GFP was purchased from Roche Diagnostic Corp (Mannheim, Germany). The O4 
hybridoma was a kind gift of Guus Wolswijk (NIBR, Amsterdam, the Netherlands). 
Fluorescein isothiocyanate (FITC), tetramethylrhodamine isothiocyanate (TRITC) and Cy-3 
conjugated secondary antibodies were supplied by Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA). Secundary horseradish peroxidase (HRP)-conjugated 
antibodies were provided by Amersham Biosciences (Buckinghamshire, UK). 
 




 General procedures for cloning and DNA manipulations were performed as 
described by Sambrook et al. (1989). The cDNAs encoding galactosyl ceramide 3’- 
sulfotransferase (cst) and ceramide galactosyltransferase (cgt) were kind gifts of Drs. 
Matthias Eckhardt and Brian Popko (Chapel Hill, NC), respectively. For cloning, the cst and 
cgt genes were inserted into the retroviral vector pLXIN (Clontech Biosciences, Mountain 
View, CA). Recombinant plasmids were grown in TOP10 cells, and plasmids with the cDNA 
insert in the correct orientation with respect to transcription were identified by restriction 
analysis. The orientation and the integrity of the obtained pLXIN constructs were confirmed 
by DNA sequencing. 
 
Production of retroviral particles 
The production of retroviral particles and the subsequent infection of OLN-93 cells 
were performed according to Relvas et al. (2001). Briefly, for production of recombination-
deficient retroviruses, the constructs were transfected into the GP+E86-packaging cell line 
(Genetix Pharmaceuticals, Inc. Cambridge, MA), using lipofectamine 2000 (Invitrogen, 
Breda, The Netherlands). Two days after transfection, cells were collected, diluted 5-fold 
and cultured under selection in packaging cells medium supplemented with 1 mg/ml 
G418 (corrected for inactivity) until resistant clones appeared (70 % confluent). The cells 
were subsequently washed with PBS, and packaging cells medium without G418 was 
added. The conditioned medium was collected after 24 hrs, filtered (Schleicher and 
Schuell, Dassel, Germany, 0.45 μm pore size), and either used immediately or stored frozen 
at -80 °C. 
 
Cell culture 
 Primary cultures of OLGs were prepared from brains of 1-2 day old Wistar rats as 
described previously (Baron et al., 1998), with slight modifications. Briefly, after 
decapitating the rats, the forebrains were removed and the cells were dissociated, first 
mechanically and then with papaine (30 U/ml) in the presence of L-cysteine (0.24 mg/ml) 
and DNase (10 μg/ml) for 1 hour at 37 °C. A single cell suspension was prepared by 
repeated pipetting in a trypsin inhibitor solution (1 mg/ml). After centrifugation the cells 
were resuspended in DMEM  supplemented with 10 % FCS and seeded into 75 cm2 flasks 





(PLL, 5 μg/ml), at approximately 1.5 brain per flask. The OLG progenitor cells appear as 
round-shaped, phase dark cells on top of a monolayer of flat type-1 astrocytes. After 11-12 
days in culture, the OLG progenitor cells were isolated by mechanical shaking at 240 rpm 
and 18-20 hrs as described by McCarthy and de Vellis (1980). Contaminating astrocytes 
and microglia were subsequently removed by differential adhesion for 20 min at 37°C.  
For biochemical analysis, the OLG progenitor cells were plated in proliferation 
medium (SATO medium (Buttery et al., 1999) supplemented with the growth factors FGF-2 
(10 ng/ml) and PDGF-AA (10 ng/ml)) on PLL or laminin-2 (Ln2, 10 μg/ml) coated dishes 
(Nalge Nunc, Naperville, IL) at a density of 1 Χ 106 cells per 100 mm dishes. To differentiate 
the cells, the cells were cultured on SATO medium supplemented with 0.5 % FCS for 3 days 
(GC-stage), 7 days (MBP-stage) or 10 days (MBP+-stage). For immunocytochemical studies 
the OLG progenitor cells were seeded at a density of 2 Χ 104 cells per well on PLL- or Ln2-
coated 8 well permanox chambers (Nunc) and treated as described above. 
 
Infection of OLN-93 cells  
The oligodendroglia derived cell line OLN-93, a kind gift of Dr. Christiane Richter-
Landsberg (University of Oldenburg, Germany; Richter-Landsberg and Heinrich, 1996), 
were cultured in DMEM supplemented with 10% heat-inactivated FCS, L-glutamine, and 
the antibiotics penicillin and streptomycin. Cells were trypsinized when they reached near-
confluency. GalCer and sulfatide expressing OLN-93 cells (OLN-G and OLN-GS, 
respectively) were obtained via retroviral infections with the plasmids pLXIN-cgt and pLXIN-
cgt/pLXIN-cst respectively. A mock-OLN-93 cell-line was obtained by retroviral infection 
with vector only, pLXIN. Retroviral infections of OLN-93 cells were carried as described 
previously (Maier et al., 2006). Briefly, OLN-93 cells at 50% confluency were exposed to 
retroviral particles (see above) and 8 µg/ml polybrene for 16-18 hrs. The cells were cultured 
for another 24 hrs, trypsinized and cultured in the presence of 2 mg/ml G418 (corrected for 
inactivity) for 14 days. Colonies were isolated and selected for the appearance of GalCer 
and/or sulfatide on the cell surface. Since cgt and cst mRNAs in OLN-93 are hardly 
detectable, for the sulfatide-expressing OLN-93 cells (OLN-GS), a retroviral infection with 
pLXIN-cgt followed by a second infection with pLXIN was necessary. 
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Expression of PLP-GFP 
OLN-mock, OLN-G and OLN-GS (see above) cells were transfected with pEGFP-N1-
PLP using lipofectamin 2000 as a transfection reagent. In short, cells cultured on an 8 well 
permanox chamber slides at a density of 10000 cells per well for 4 hrs, were incubated with 
lipofectamine 2000 and pEGFP-N1-PLP (pEGFP-N1-PLP was a kind gift of Niels Hellings, 
Biomedisch Onderzoeksinstituut and Transnationale Universiteit Limburg, Diepenbeek, 
Belgium) for 16-20 hrs. The cell were analysed by immunofluorescence with anti-GFP 
antibodies 48 hrs after transfection.  
 
Antibody perturbation experiment 
The hybridoma cells producing O4 monoclonal antibodies were grown in heat-
inactivated FCS/DMEM, upon antibody production cells were grown without medium 
change for 2 weeks in the absence FCS. Antibodies were concentrated from the 
hybridoma culture supernatants by ammonium sulfate precipitation and dialysis to the 
appropriate buffer. OLG were cultured till the onset of myelin sheet formation, i.e. 3 days in 
differentiation medium (GC-stage). The cells were then further cultured in either control or 
antibody-containing (O4, 10 µg/ml) media for another 4 days (MBP-stage). 
 
Immunocytochemistry and in situ extraction 
 Antibody staining of cell surface components was performed on live cells at 4°C. 
After blocking non-specific binding with 4% BSA in PBS, cells were incubated with O4 (anti-
sulfatide antibody) for 30 min, washed three times and incubated for 25 min with FITC-
conjugated goat-anti-mouse IgM. The cells were fixed with 4 % paraformaldehyde (pfa) in 
PBS for 20 min at room temperature (RT). For double or single staining of intracellular 
antigens, cells were fixed with 4% pfa, and permeabilized and blocked with 0.1 % TX-100 
and 4% BSA in PBS for 30 min at RT. The cells were incubated for 1-2 hours with anti-PLP 
antibodies or anti-GFP antibodies at RT. The cells were washed with PBS and incubated 
with appropriate TRITC-conjugated secondary antibodies and DAPI for 25 min at RT. After 
washing with PBS, the cells were covered with 2.5 % 1,4-diazobicyclo[2.2.2]octane 
(DABCO) in 90 % glycerol/ 10 % PBS, to prevent image fading. For in situ extraction, cells 
were exposed to cold 0.5 % TX-100 in PBS for 2 min at 4 °C, followed by pfa fixation at 4 °C. 





equiped with analySIS software. Pictures were processed with Paint Shop Pro and/or 
Adobe Photoshop. 
 
OptiPrep density gradient centrifugation  
The cells were washed with PBS, harvested by scraping with a rubber policeman in 
350 μl TNE-lysis buffer (20 mM Tris HCl pH 7.4, 150 mM NaCl, 1 mM EDTA supplemented with 
1 % TX-100 and a cocktail of protease inhibitors), and pressed 18 times through a 21-gauge 
needle. Lysis was done on ice for 30 min and the protein content was determined by a Bio-
Rad DC Protein Assay (Bio-Rad Laboratories, Herculas, CA), using BSA as a standard. For 
density gradient centrifugation a discontinous OptiPrep gradient (2.25 ml 10 %, 2.25 ml 
30 %, and 750 μl 40 %) was prepared. For preparing 40 % OptiPrep 250 µl of total cell lysates 
(equal protein) were added to 500 µl of 60 % OptiPrep. This mixture was then overlaid with 
30 % and 10 % OptiPrep, respectively. Gradients were centrifuged overnight at 40000 rpm 
(SW55 Beckman, 4 °C) and 750 μl gradient fractions were collected from the top (fraction 
1) to the bottom (fraction 7). For Western blot analysis, equal fraction volumes were TCA 
precipitated, resuspended in SDS reducing sample buffer and analyzed by SDS-PAGE and 
Western blotting.  
 
TCA precipitation 
To concentrate proteins, the fractions were adjusted to a final volume of 1 ml with 
TNE and treated with DOC (25 mg/ml) for 5 min at 4 °C, followed by precipitation with 6.5 
% trichloric acid (TCA) for 15 min at 4 °C. Precipitates were centrifuged for 20 min at 10000 
rpm at 4°C. The pellets were dryed and resuspended in 2 Χ SDS reducing sample buffer. 
After the pH was adjusted to 6.8 by exposure to ammonia, the samples were heated for 2 
min at 95 ºC or 30 min at 37 °C and subjected to SDS-PAGE and Western blotting. 
 
Surface biotinylation 
 Cells were differentiated for 3 or 10 days, washed twice with ice-cold PBS, and 
incubated for 1 hr with Sulfo-NHS-L-C-Biotin (0.1 mg/ml in PBS) at 4 °C. The cells were 
washed three times for 5 min with cell wash buffer (CWB, 65 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1 mM CaCl2, 1 mM MgCl2) to remove excess biotin and twice with PBS. The cells 
were harvested by scraping with a rubber policeman in 350 μl TNE-lysis buffer and pressed 
18 times through a 21-gauge needle. Lysis occured on ice for 30 min and the protein 
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content was determined by a Bio-Rad DC protein assay (Bio-Rad, Herculas, CA), using BSA 
as a standard. Equal amounts of protein were subjected to OptiPrep density gradient 
centrifugation. Biotinylated proteins from equal volumes of the fractions were 
immunoprecipitated with streptavidin (SA)-agarose for 16-18 hrs at 4 °C. After 
centrifugation the SA-agarose beads (biotinylated proteins) were washed four times with 
CWB supplemented with 1% NP-40 and 0.35 M NaCl and once with PBS. Non-biotinylated 
proteins (supernatants) were concentrated by TCA precipitation. Samples from SA-
agarose and supernatant fractions were mixed with SDS sample buffer, heated for 2 min at 
95 ºC or 30 min at 37 °C and  were subjected to SDS-PAGE and Western blotting.  
 
SDS-PAGE, Western Blotting and dotblots 
Samples were loaded onto 10 % SDS-polyacrylamide gels and transferred to 
Immobilon-P membrane (Millipore, Bedford, MA) by semi-dry blotting. The membranes 
were blocked with 5 % nonfat dry milk in PBS to inhibit nonspecific binding, washed with 
buffer (0.1% Tween-20 in PBS), and incubated overnight at 4°C with primary antibody in 0.5 
% nonfat dry milk in buffer, followed by a 2 hrs incubation with the appropriate horseradish 
peroxidase (HRP)-conjugated antibodies (1:2000 in 0.5 % nonfat dry milk in buffer). For 
GM1-dotblots, 5 μl of each fraction was spotted onto a nitrocellulose membrane (BioRad). 
The membranes were blocked with 5 % nonfat dry milk in Tris buffered saline (TBS) for 1 hr at 
RT, washed with 0.1% Tween-20 in TBS, and incubated with CTB-HRP (1:1000, Calbiochem-
Novabiochem Corporation, La Jolla, CA) for 1 hr at RT. The signals were visualized by ECL 
(Amersham, Pharmacia Biotech) and films were processed with Adobe Photoshop and 
quantified with Scion Image Software. 
 
Pulse-chase experiment 
OLGs were cultured on 10 cm PLL-coated dishes for 3 days. The cells were pre-
incubated in DMEM minus methionine (Invitrogen, Breda, the Netherlands) for 1 hour. Cells 
were labelled for 10 min in this medium with the addition of 200 μCi/dish Tran35S-label 
(Amersham, BioSciences, Buckinghamshire, UK). The cells were then chased by replacing 
the labeling medium supplemented with 10 mM methionine (Merck, Darmstaft, Germany). 
The chase periods were 0, 15, 30 and 60 min. Cells were scraped in PBS, extracted with TNE-
lysis buffer at 4°C, and separated by centrifugation into TX-100-soluble supernatants (S) 





(Amersham, BioSciences, Buckinghamshire, UK) overnight at 4 °C from the TX-100-soluble 
and –insoluble fractions. Protein G-sepharose beads were washed four times with TNE-lysis 
buffer supplemented with 0.2 % SDS and once with PBS. Washed Protein G-sepharose 
beads were resuspended in SDS sample buffer, incubated 30 min at 37° C, and counted 
for 2 min in a microplate scintillation and luminescence counter (Packard Instrument 
Company, Meriden, CT). 
 
Results and Discussion  
Intracellular distribution and dynamic partitioning of PLP in detergent resistant membranes 
depends on cell development 
The multi-spanning membrane protein PLP is the major myelin protein and reaches 
this specialized membrane domain in OLGs by vesicular transport (Simons et al., 2000). Its 
biosynthesis becomes distinctly apparent in newly formed OLGs, and rapidly increases 
when the cells further develop into mature myelinating cells.  To accurately define its 
membrane trafficking pathway, following biosynthesis, we first determined the intracellular 
localization of PLP at various stages of OLG development in cells, grown on the inert PLL.  
Examination by immunofluorescence microscopy revealed (fig. 1) that in newly formed 
OLGs (3 days, GC stage), when processes develop, PLP is abundantly localized in vesicular 
structures in the perinuclear region of the cell (fig. 1A2), often showing a punctuate 
appearance when associated with primary processes. Furthermore, in a small subset of the 
cells, a prominent labeling of the plasma membrane was observed (fig. 1A1 and 1A3), 
suggesting a transient association of PLP with the plasma membrane of the cell body. In 
mature, well differentiated OLGs (7-10 days), the protein is present in the cell body, but 
particularly the processes and membrane sheets showed extensive PLP labeling with a 
diffuse appearance, suggesting its proper membrane integration (fig. 1B and C). 
The primarily intracellular localization of PLP in newly formed OLGs was further 
confirmed by a biotinylation experiment, allowing a distinction to be made between 
surface localized (i.e., biotinylated) PLP versus intracellular (i.e., non-biotinylated) PLP by 
means of streptavidine precipitation (see Materials and Methods). To simultaneously obtain 
insight into the lateral membrane distribution of PLP, the biotinylated cells were extracted 
with TX-100 and the lysates were applied to an OptiPrep density gradient to determine 
whether PLP partitioned in detergent-resistant microdomains, as subsequently revealed by 
Western blotting analysis. 
 






Figure 1: Localization of PLP at various stages of oligodendrocyte development. Newly formed (A1, A2, A3), 
mature (B) and myelinating (C) OLGs were cultured on PLL and differentiated for 3 days, 7 days and 10 days, 
respectively. Cells were fixed, permeabilized and the localization of PLP was analyzed via immunostaining as 
described in Materials and Methods. For clear presentation a segment of A1 is enlarged in A3. The arrow shows 
plasma membrane localization of PLP, whereas the arrowhead points to PLP-containing structures in the 
perinuclear region, showing a punctuate appearance when associated with primary processes. Scale bar = 
20 µM. Representative pictures of at least 5 independent experiments are shown. 
 
As shown in figure 2, biotinylated PLP was not detected in newly formed OLGs cultured on 
PLL, implying that at steady state conditions the residence time of PLP surface localization, 
if occurring at all, is negligible. In addition, the entire PLP fraction, thus largely localized 
intracellularly, was solubilized by TX-100. In contrast, in mature cells, biotinylated PLP was 
present on the surface (approx. 40 %), and this surface pool partitioned roughly equally 
between a detergent-resistant and detergent soluble fraction. Of the intracellular fraction, 
less than 15 % was resistant to solubilization by TX-100. 
The foregoing data suggested a dynamic behavior of PLP as reflected by distinct 
cell development dependent differences in its intracellular distribution as well as its ability 
to partition into different lateral membrane pools, characterized by TX-100 soluble and 
insoluble fractions. However, the apparent absence of such a partitioning in newly formed 
A1                         O2A 
B                          MBP C                          MBP+ A2                         O2A 





OLGs, i.e., relatively early in development, would be consistent with previous observations 
on the developmental expression of such domains in neurons (Ledesma et al., 1999), 




Figure 2: Association of PLP with TX-100-resistant membrane microdomains during oligodendrocyte 
differentiation on PLL. Newly formed OLGs (GC-stage) and myelinating OLGs (MBP+-stage) were cultured on 
PLL and differentiated for 3 and 10 days, respectively. Cell surface proteins were biotinylated at 4°C, lysed, and 
subjected to OptiPrep density gradient centrifugation (40 %, 30 % and 10 %). Of each fraction (equal volumes), 
the pools of biotinylated, i.e. surface localized (extra) and non-biotinylated, i.e., intracellularly localized (intra) 
protein, were determined as described in Materials and Methods. PLP distribution was analyzed by SDS-PAGE, 
followed by Western blotting with anti-PLP antibodies. As a control for microdomain distribution along the 
gradient GM1 dotblots were performed (Materials and Methods). 
 
These data thus raise several questions, including when and where PLP integrates 
into such detergent resistant microdomains (DRM), particularly since previous observations 
indicated that in both isolated myelin and cultured (mature) OLGs, the majority of PLP is 
solubilized upon extraction with 1 % TX-100 (Pereyra et al., 1998; Krämer et al., 1997; van der 
Haar et al., 1998; Kim and Pfeiffer, 1999; Simons et al., 2000). Likely, because of the 
relatively small absolute size of the pool residing in DRM, the significance of such a fraction 
may well have been underestimated. However, given PLP’s seemingly dynamic behavior, 
the present observations may also imply that localization in these domains is only transient, 
which could have largely precluded detection at steady state conditions. This issue was 
therefore addressed next. 
 
Following biosynthesis, PLP transiently associates with Triton X-100-resistant microdomains  
To investigate the potentially transient association of PLP with a given microdomain, 
operationally distinguished here as a TX-100 soluble and insoluble domain(s), we carried 
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out pulse chase experiments. Newly formed and mature OLGs were cultured on PLL and 
metabolically labeled with Tran35S for 10 min at 37 °C. Subsequently, excess non-
radioactive methionine was added, and the cells were chased for 0, 15, 30 and 60 min, 
followed by extraction with 1 % TX-100 and analysis of PLP in pellet (insoluble) and 
supernatant (soluble) by counting of radioactive label. As shown in figure 3 for newly 
formed OLGs (GC-stage), during the first 15 min, essentially all PLP was present within a 
detergent resistant fraction, while over the next 45 min, PLP gradually partitioned in a TX-
100 solubilized fraction.  
 
 
Figure 3: Intercalation of PLP in TX-100 resistant microdomains, analyzed by pulse-chase analysis. Newly formed 
OLGs cultured on PLL were pulse-labeled with Tran35S for 10 min, which was followed by incubation in chase 
medium for the indicated time intervals. Subsequently, the cells were extracted with 1% TX100 at 4 °C as 
described in Materials and Methods. Soluble (S; supernatant) and insoluble (I; pellet) fractions were obtained 
by centrifugation, after extracting equal protein amounts of total cell lysates. PLP was immunoprecipitated and 
the amount in the soluble and insoluble fraction was analyzed by radioactive counting. Black bars represent 
soluble protein and grey bars represent insoluble protein. Data were obtained from three independent 
experiments. Statistical significance between O2A stage and the other developmental stages is shown (**P < 
0.01, ***P < 0.001). Note that following biosynthesis PLP primarily associates with TX-100 resistant membrane 
microdomains, but subsequently acquires TX-100 solubility, as becomes apparent after 30-60 min. 
 
Very similar data were obtained when analogous experiments were carried in 
mature OLGs, grown on PLL. Intriguingly, Simons et al. (2000) reported that in cultured 
mature OLG PLP acquires significant CHAPS detergents resistance only after 30-60 min. 
Thus, the kinetics of PLP’s acquirement of Triton-solubility versus CHAPS insolubility are very 
similar and it is therefore tempting to suggest that these kinetics reflect the transient 
partitioning of PLP into different membrane domains at different stages of its processing 
after de novo biosynthesis. Specifically, these results thus indicated that de novo 
synthesized PLP localizes to membrane microdomains that are characterized by TX-100 

























major fraction of the total PLP fraction, which appears to be largely localized 
intracellularly, has become TX-100 soluble (fig. 2), whereas the insoluble fraction is relatively 
enriched at the cell surface. Accordingly, the observations led us to consider the following 
scenario. After synthesis at the ER, PLP likely integrates into a membrane domain, typified 
by TX-100 resistance, which presumably occurs at the Golgi, analogously as observed for 
other membrane spanning proteins (Kundu et al., 1996; Millan et al., 1997; Aït Slimane et al., 
2003). The kinetics of TX-100 solubilization of PLP, seen in figure 3, would be consistent with 
the time likely required (30-60 min) for PLP-containing transport vesicles to reach the cell 
surface (cf. Aït Slimane et al., 2003). After reaching the cell surface, PLP redistributes, as 
reflected by an increasing fraction that acquires TX-100 solubility in mature OLGs (fig. 2). In 
newly formed OLGs, the transition is even more dramatic in that initially, like in mature cells, 
all newly synthesized PLP is detergent resistant, while at steady state essentially all PLP is 
detergent soluble, and localized almost exclusively intracellularly. Yet the kinetics of 
solubilization (fig. 3) was very similar as those observed in mature cells. Thus, in conjunction 
with the data in mature cells (MBP+-stage) this could imply that after reaching the surface, 
as part of detergent resistant domain of a transport vesicle, PLP, after dissipating to a 
detergent-soluble region, is internalized again in vesicles (fig. 1) that no longer contain 
domain components that convey TX-100 detergent resistance to PLP. Presumably, the 
major glycosphingolipids present in OLGs, GalCer and sulfatide, both being expressed in 
newly formed and mature OLGs, likely co-determine this property, in conjunction with 
cholesterol (Lees and Brostoff, 1984; Norton and Cammer, 1984; de Vries and Hoekstra, 
2000; Simons et al., 2000), which was subsequently examined. In addition, a transient 
localization of PLP at the cell body plasma membrane followed by its subsequent 
internalization would, as a matter of mechanistic principle, be consistent with recent 
observations reported by Trajkovic et al. (2006). These authors suggested that myelin 
compounds might be stored into endocytic compartments prior to signal-mediated 
delivery towards the myelin sheet.  
 
PLP transiently localizes in sulfatide domains at the plasma membrane of the 
oligodendrocyte cell body  
In preliminary work, we have observed by TX-100 extraction in situ that GalCer 
positive microdomains are largely confined to the myelin sheets, whereas sulfatide 
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containing microdomains are restricted to the cell body and primary processes (Baron et 
al., manuscript in preparation).  
 
Figure 4: Colocalization of PLP with GalCer and sulfatide in oligodendrocytess. Newly formed (A-L, 3 days of 
differentiation) and mature OLGs (M-O, 10 days of differentiation) were cultured on PLL (A-C, J-O) or Ln2 (D-I). 
Colocalization of PLP (B, E, H, K, N) with sulfatide, visualized by staining with O4 (A, D, G, J) or GalCer, stained 
with O1 (M), was carried out as described in Materials and Methods. Live surface labeling with the O4 antibody 
was performed in A and D, whereas in J and M, PLP colocalization was carried out with O4 (J) or O1 (M) in fixed 
and permeabilized cells. In G-H, in situ detergent extraction prior to fixation was performed (see Materials and 
Methods). Merged pictures (C, F, I, L, O) were obtained using Adobe Photoshop software. Representative 
pictures of at least three independent experiments are shown. Scale bar = 20 µm. Note that PLP colocalized 
with sulfatide (O4) at the plasma membrane in TX-100 resistant microdomains when OLG were cultured on Ln2 
(D-I). PLP and GalCer (O1) primarily colocalized in intracellular vesicular structures in the cell body (M-O). 
 
Accordingly, further insight into the glycosphingolipid microenvironment of PLP 
could provide insight into the role of either lipid in the dynamics of PLP transport. Since the 
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transient localization of PLP in distinct domains was particularly apparent over the first hour 
after biosynthesis, sulfatide, being largely localized to the cell body and resistant to TX-100 
extraction, was considered the major sphingolipid player in early PLP processing. To 
determine whether PLP and sulfatide were present in the same micodomains, double 
immunfluorescence staining with the anti-sulfatide antibody O4 and anti-PLP were 
performed. Little if any co-staining was observed in the plasma membrane by performing 
live staining with the anti-sulfatide antibody (fig. 4A-C), consistent with the biotinylation 
experiments (fig. 2). However, when newly formed OLGs were grown on laminin-2 (Ln2), an 
ECM substrate that strongly promotes myelin membrane formation (Buttery et al., 1999; 
Šišková et al., 2006) and interacts with sulfatide (Baron et al., manuscript in preparation), 
both PLP and sulfatide evidently colocalized at the plasma membrane of the OLG cell 
body (fig. 4 D-F). Moreover, this fraction was at least in part resistant to TX-100 solubilization, 
as reflected by in situ extraction (Fig.4 G-I), implying detergent resistant microdomain 
localization within the cell body plasma membrane. Surface biotinylation experiments 
confirmed the plasma membrane localization of PLP on Ln2 in newly-formed OLGs (data 
not shown, cf. fig. 6). In contrast, both in newly formed and mature OLGs at steady state, 
very little if any intracellular colabeling of PLP and sulfatide was visible (fig. 4 J-L). 
Interestingly, GalCer did colocalize intracellularly with PLP (fig. 4 M-O), but in this case (at 
steady state in newly formed OLGs) the protein is detergent soluble, as revealed by in situ 
extraction. Together, these results would suggest that PLP is present in the plasma 
membrane of the cell body in sulfatide containing microdomains which conveys TX-100 
detergent resistance to PLP. Evidently, PLP does not remain localized in this membrane 
domain, likely reflected by the time-dependent enhancement in TX-100 detergent 
solubilization (fig. 3), and the protein apparently becomes internalized as part of a sheet-
directed vesicular transport process (fig. 1) in which sulfatide and PLP no longer colocalize. 
Rather, the evidence may suggest that at these conditions the protein may have acquired 
access to GalCer-enriched domains. 
To obtain further support for PLP/sulfatide cotransport to the plasma membrane 
during initial post-biosynthetic transport of PLP, the following experiment was carried out. 
The oligodendroglia derived cell line, OLN-93 (Richter-Landsberg and Heinrich, 1996), was 
transfected with a PLP-GFP construct and constructs that either expressed ceramide 
galactosyl transferase (CGT), the enzyme catalyzing the final step in GalCer biosynthesis 
and/or ceramide sulfatide transferase (CST), which catalyzes the biosynthesis of sulfatide. 
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As shown in figure 5, in both mock infected cells (A) and CGT+ cells (B), the GFP-tagged 
PLP was randomly distributed throughout the cell, and no apparent plasma membrane 
localization was seen. In contrast, in cells that also expressed sulfatide (CGT+/CST+), PLP 
translocated to regions near and at plasma membrane (fig. 5C). Hence, these data 
suggested the need for sulfatide as a determining (co-)factor in plasma membrane-
directed transport for PLP. This mechanistic feature, as an essential step in PLP transport to 
the sheet, was further illustrated and emphasized by adjustment of the nature of the ECM 
on which the cells grow. Thus, we exploited the fact that Ln2 promotes myelin biosynthesis, 
and indeed, as suggested by the observation in figure 4, in cells grown on Ln2 plasma 
membrane delivery of PLP in mature OLGs is strongly facilitated. The persistent association 
of PLP with sulfatide, promoted by Ln2 (fig. 4 d-f), potentially governing a plasma 
membrane directed transport step of PLP prior to its delivery to the sheet, was supported 
by determination of the PLP surface pool by biotinylation. In conjunction with PLP 
biotinylation, we also established the protein’s lateral domain distribution by means of TX-
100 extraction, followed by OptiPrep gradient analysis and Western Blotting. As shown in 
figure 6, in the MBP+ stage next to a substantial PLP fraction at the cell surface (60-70%) 
localized to TX-100-resistant microdomains, such a fraction (approx. 20-30 %) could also be 
retrieved from the intracellular pool. The latter is in marked contrast to the virtual absence 
of such a fraction in case cells were grown on PLL (fig. 2). Possibly, this ECM dependent 
distinction in detergent resistant pools reflected the relatively enhanced demand for de 
novo sheet biogenesis, as promoted by Ln2. In this context, Ln2 has been shown to be 
associated with developing axons (Colognato et al., 2002), implying that axons could 
direct intracellular traffic in oligodendrocytes via Ln2-sulftatide interactions. As a final piece 
of evidence in support of PLP’s transport in sulfatide-enriched membrane domains to the 
plasma membrane of the OLG cell body prior to its delivery to the sheet, we took into 
account previous work in which we demonstrated that the t-SNARE syntaxin 3 localizes in 
OLGs to the plasma membrane and primary processes, rather than to the sheet. In this 
study (Klunder et al., submitted; chapter 3) we demonstrated that syntaxin 3 is required for 
the eventual PLP delivery into the sheet, but, given the absence of this t-SNARE from the 
sheet, deposition of the protein in the sheet itself is clearly independent of syntaxin 3. 
Interestingly, syntaxin 3 distributes roughly equally in TX100-soluble and insoluble domains, 
which appears to match the distribution of PLP detergent solubility and insolubility at the 








Figure 5: Localization of PLP-GFP in transfected OLN-93 cells. Mock infected (pLXIN) and OLN-93 cells expressing 
GalCer (CGT), or GalCer and sulfatide (CGT/CST) were transfected with PLP-GFP as described in Materials and 
Methods. The localization of PLP-GFP was determined with immunofluorescence, using anti-GFP antibodies. A. 
OLN-mock, B. OLN-G and C. OLN-GS. Scale bar = 20 µm. The image is representative of at least three 
independent experiments. Note that in OLN-GS cells PLP-GFP is plasma membrane localized, whereas in OLN-
mock and OLN-G cells, PLP-GFP is mainly localised intracellularly. 
 
To examine whether a causal relationship existed between syntaxin 3 and sulfatide 
membrane localization, and hence, that the plasma membrane was the initial target site 




Figure 6: Association of PLP with TritonX-100-resistant membrane microdomains during oligodendrocyte 
differentiation on laminin 2. Newly formed OLGs (GC-stage) and mature OLGs (MBP+-stage) were cultured on 
Ln2 and differentiated for 3 and 10 days, respectively. Cell surface proteins were biotinylated at 4 °C, lysed, 
and subjected to OptiPrep density gradient centrifugation (40 %, 30 % and 10 %). Of each fraction (equal 
volumes), biotinylated proteins, i.e. surface localized, were separated from non-biotinylated proteins, i.e. 
intracellular localized, as described in Materials and Methods. PLP distribution was analyzed by SDS-PAGE, 
followed by Western blotting with anti-PLP antibodies. As a control for microdomain distribution along the 
gradient, GM1 dotblots were performed (Materials and Methods). 
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Newly formed OLGs were grown in the presence of the anti-sulfatide antibody for 4 days. 
Control cultures were grown under the same conditions but without adding anti-sulfatide 
antibody O4. After harvesting, the cells were lysed and the homogenates were 
fractionated on an OptiPrep density gradient and analyzed by Western blotting. In figure 7 





Figure 7: Effect of anti-sulfatide antibody O4 on the association of syntaxin 3 with TritonX-100 resistant 
microdomains. Newly formed OLGs cultured on PLL or Ln2 were treated without (ctrl)) or with O4 (+ O4)) for 4 
days. Cells were lysed, and subjected to OptiPrep density gradient centrifugation (40 %, 30 % and 10 %) as 
described in Materials and Methods. Equal volumes of each gradient fraction were analyzed for syntaxin 3 by 
SDS-PAGE and Western blotting. Representative blots of three independent experiments are shown. Note the 
reduced association of syntaxin 3 with TX-100 resistant membrane microdomains upon treatment with O4 on 
PLL and Ln2. 
 
Thus, it was apparent that the detergent-resistant fraction of syntaxin 3 was relatively 
enhanced (approx. 80 % vs 45 %) when cells had been grown on Ln2, i.e., at conditions 
that promote myelin sheet biogenesis. Hence, these data imply a correlation between 
enhanced biogenesis and the lateral membrane localization of syntaxin 3. Moreover, 
sulfatide appeared to affect this lateral organization as the presence of the antibody 
shifted the localization of syntaxin 3 from a detergent resistant to a detergent soluble 
localization in both PLL (from approx. 50 % to 15 %) and Ln2 (from 80 % to 40 %) cultured 
cells. In this context, we (Baron et al., manuscript in preparation) and others (Bansal et al., 
1998) have shown that anti-sulfatide antibody O4, but not anti-galactocerebroside 
antibody O1, blocks terminal differentiation of OLGs. Our data thus suggest that addition 
of anti-sulfatide antibody O4 interferes with the localization of syntaxin 3, which, as noted, 
is enriched in the cell body plasma membrane. The most straightforward explanation 
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would thus be that a mislocalization of syntaxin 3 interferes with the proper delivery of PLP 
to the plasma membrane. This impediment, in turn, interferes with the subsequent delivery 
of PLP to the myelin sheet, implying that sheet development might be hampered. In line 
with this is the observation that overexpression of syntaxin 3 persevers PLP’s localization in 
TX-100 resistant microdomains and indeed impedes delivery of PLP towards the sheet 
(Klunder et al., submitted). 
 
Concluding remarks 
In summary, in the present work, we have shown, by exploiting the effect that of Ln2 
exert on sheet development in OLGs, and by carrying out pulse chase experiments next to 
steady state analysis in cells at different stages of development, that myelin biogenesis in 
OLGs involves a transcytotic transport mechanism, as exemplified by sheet-directed 
transport of PLP. Thus our data support a model (fig. 8) in which PLP, early after biosynthesis, 
integrates into TX-100 resistant microdomains for transport to the plasma membrane in 
likely a sulfatide dependent manner of the OLG cell body (red structures), involving 
syntaxin 3 mediated docking (squiggle). Here, PLP is apparently redistributed into domains 
that are characterized by TX-100 solubility but CHAPS insoluble, as we propose based upon 
earlier work by Simons et al. (2000). These domains subsequently pinch off as transport 
vesicles (blue), which thus mediate the eventual trafficking of PLP into the sheet. Obviously, 
the molecular mechanisms underlying PLP’s lateral redistribution and internalization remain 
to be determined. However, an interesting possibility could be that as part of this myelin 
sheet-directed transport process, PLP has become integrated in GalCer-enriched 
microdomains, thereby explaining the time-dependent shift from a TX-100 to an CHAPS 
insolubility. Nevertheless, as such, this mechanism would be entirely in line with our previous 
contentions that OLGs can be envisioned as polarized cells, displaying properties 
analogously to those reported for typical polarized cells like epithelial cells. In fact, in such 
cells, like hepatocytes, the major epithelial cell in the liver, similar transcytotic events occur 
in the transport of apical resident proteins, which proceeds via the basolateral surface, 
involving molecular mechanisms that remain to be clarified (Hoekstra et al., 2004). Clearly, 
defining the processes of cellular sorting and transport, in which lipid-protein interactions 
with environmental signals regulate OLG development, is essential for an understanding of 
both normal OLG development and the process of remyelination in demyelinating 
diseases such as multiple sclerosis (MS), which relies on a disturbance of myelin membrane 
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organization. Particularly sulfatide is a key compound in regulating terminal OLG 
differentiation (Bansal et al., 1999; Hirahara et al., 2004). Here, we demonstrated its intimate 
role in PLP transport, as a crucial intermediate step in subsequent transport to and from the 
plasma membrane to the sheet. Sulfatide interacts with several key adhesion and ECM 
proteins, including laminin, secreted by astrocytes and neurons (Mcloon et al., 1988; 




Figure 8: Schematic overview of the trafficking of de novo synthesized PLP to the myelin sheet. (a) Transport of 
PLP from trans-Golgi network to the plasma membrane of the cell body occurs as part of TX-100 insoluble, 
CHAPS soluble membrane microdomains (red); (b) Transport from the plasma membrane to the myelin sheet 
occurs by means of TX-100 soluble, CHAPS insoluble microdomains (blue). N. nucleus; TGN, trans-Golgi-network, 
squiggle, PLP.  See text for further details. 
 
However, in this interaction with the ECM, additional cell surface adhesion receptors very 
likely play a role as well, such as the α6β1 intergrin (Blaschuk et al, 2000; Baron et al, 2003), 
which interacts with Ln2 and promotes myelin biogenesis (Relvas et al., 2000). The principle 











enhanced recruitment of PLP at the plasma membrane, presumably mediated by 
sulfatide. These issues are currently investigated in our laboratory. 
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In the central nervous system (CNS), oligodendrocytes can be considered as 
polarized cells, because the myelin sheath is continuous with the plasma membrane, 
whereas the composition of both membranes differs significantly. Specific transport 
machineries are responsible for the assembly and maintenance of these specialized 
membrane domains. The MAL proteolipid, thought to be involved in polarized trafficking in 
epithelial cells, is in oligodendrocytes predominantly localized in compact myelin together 
with the major myelin proteins MBP and PLP. To address the question whether MAL is 
involved in the sorting of myelin-sheath-associated membrane proteins, oligodendrocyte 
progenitor cells were infected with GFP-MAL encoding retroviral particles. (Over)expression 
of the GFP-MAL protein did not interfere with proliferation, differentiation or cell survival, 
and the intracellular behavior of GFP-MAL was indistinguishable from endogenous MAL. 
Interestingly however, (over)expression of GFP-MAL caused a decrease in PLP expression 
level and an accumulation of PLP in the cell body, whereas no effect on the expression 
and localization of other myelin proteins such as CNP, MAG and MBP was observed. Our 
data suggest that MAL negatively regulates PLP transport to the myelin sheets in cultured 
oligodendrocytes by exerting control on the exiting of PLP from an intracellular 
compartment that appears to be instrumental in the transcytotic transport of PLP from cell 
body plasma membrane to myelin sheet. The in vivo significance of these data may relate 
to the ability of MAL to control the lateral segregation of PLP during myelin compaction. 
 




Oligodendrocytes (OLGs), which belong to the glial cell population of the central 
nervous system (CNS), are responsible for the production of myelin. Myelin constitutes a 
multilamellar membrane organization that ensheathes and insulates the axon, thereby 
facilitating saltatory conduction. Neurological disorders such as multiple sclerosis (MS) rely 
on disruption and degradation of myelin, including a failure of OLG differentiation and 
proper de novo biogenesis of myelin sheaths for repair. Clearly, a detailed understanding 
of extra- and intracellular molecular mechanisms that promote myelination, including the 
biosynthesis and transport of specific myelin membrane components to the myelin sheath, 
will be instrumental in efforts to develop an effective therapy for such a disease.  
The myelin membrane is continuous with the plasma membrane of the OLG, but the 
composition of both membranes differs significantly (de Vries and Hoekstra, 2000; Gielen et 
al., 2006). Therefore, these myelin-producing cells can be considered as polarized cells, 
similar to epithelial cells and neurons. Indeed, previously we have shown (Klunder et al., 
submitted; chapter 3), that the t-SNAREs syntaxins 3 and 4, which are asymmetrically 
distributed in (polarized) epithelial cells (Low et al., 1996; Fujita et al., 1998) are similarly 
asymmetrically distributed in OLGs, syntaxin 3 being enriched at the plasma membrane of 
the cell body, whereas syntaxin 4 localizes at the myelin sheet. Moreover, transcytotic 
transport mechanisms appear to operate between plasma membrane and myelin sheet in 
cultured OLGs (Klunder et al., submitted; chapters 3 and 4). 
The functional involvement of proteins in polarized transport is still poorly defined. 
However, in both epithelial Madin-Darby canine kidney (MDCK) cells and T-lymphocytes 
(Zacchetti et al., 1995; Millan et al., 1997; Martin-Belmonte et al., 1998), the myelin and 
lymphocyte (MAL) proteolipid protein is thought to be involved in regulating vesiculair 
sorting and trafficking. Specifically, depletion of this nonglycosylated integral membrane 
protein, which localizes to glycolipid-enriched membrane microdomains (Kim et al., 1995), 
results in an impairment of overall apical sorting and transport in MDCK cells (Puertollano et 
al., 1999). Consistently, overexpression of MAL increases apical delivery but also disturbs the 
morphology of the MDCK cell layers due to an elaboration of the apical membrane 
(Cheong et al., 1999).  
In CNS, expression of the mal gene is restricted to OLGs and is upregulated during 





myelin formation, myelin-specific proteins and lipids have to be transported to and sorted 
into several different myelin subdomains with different molecular composition, including 
compact myelin, paranodal loop, and peri- and ab-axonal membranes (Krämer et al., 
2001; Larocca and Rodriguez-Gabin, 2002). At steady state, the MAL proteolipid is 
predominantly localized in the compact myelin and is tightly associated with the typical 
myelin glycosphingolipids, galactosylceramide and sulfatide. These lipids are important for 
the organization, and maintenance of glycosphingolipid-enriched membrane 
microdomains (Kim et al., 1995; Frank et al., 1998; Frank et al., 2000), so-called rafts, thought 
to be instrumental in events such as molecular sorting, transport, and signaling. Notably, 
MAL appears to play an important role in the maintenance of axon-glia interactions (Frank 
et al., 2000; Schaeren-Wiemers et al. (2004). Furthermore, in mal-deficient mice the 
expression level of MAG, MBP, and NF155 in myelin and myelin-derived membrane 
domains  was reduced, pointing to a role for MAL in trafficking and/or sorting of myelin-
specific proteins. 
Here, we have (over)expressed a GFP-MAL construct in proliferating OLG progenitor 
cells, and the expression and localization of MAL as well as its effect on transport of myelin-
specific proteins was studied during different stages of OLG development. Our data 
indicate that MAL proteolipid regulates transport of PLP to the myelin sheet from an 
intracellular compartment, localized in the transcytotic pathway, responsible for transport 
of de novo synthesized PLP from cell body plasma membrane to the myelin sheet. 
 
Materials and Methods 
Materials 
Dulbecco’s Modified Eagle’s Medium (DMEM, with 4500 mg/l Glucose and L-
glutamine), L-glutamine, penicillin/streptomycin and Geneticin (G418) were purchased 
from Gibco Invitrogen Corporation (Paisley, UK). Fetal calf serum (FCS) was obtained from 
Bodinco (Alkmaar, The Netherlands). The transfectant FuGene 6 and protease inhibitor 
cocktail tablets (Complete Mini) were obtained from Roche Diagnostic Corp (Mannheim, 
Germany). Biotin was purchased from Pierce (Rockford, IL). Streptavidin was obtained from 
Upstate Lake Placid (New York, NY). Growth factors FGF-2 and PDGF-AA were supplied by 
PeproTech Inc. (London, UK). Paraformaldehyde was supplied by Merck (Darmstadt, 
Germany). All other chemicals were purchased from Sigma Chemical Co. (St. Louis. MO). 
 




The monoclonal antibody against MAL 6D9 (Martin-Belmonte et al., 1998) was a kind 
gift of Dr. Miguel Alonso (Universidad Autómona de Madrid, Spain). The monoclonal 
antibodies against PLP (Greenfield et al., 2006) and TGN-38 (IgG1, Luzeo et al., 1990) were 
generously provided by Dr. V. Kuchroo (Center of Neurological Diseases, Harvard Medical 
School, Boston, MA) and Dr. George Banting (Bristol, UK), respectively. Anti-CNPase (IgG1) 
antibody was obtained from Sigma, anti-GFP was obtained from Roche Diagnostics Corp 
(Mannheim, Germany). Anti-BrdU and anti-MAG antibodies were purchased from 
Chemicon International, Inc. (Temecula, CA). The polyclonal anti-caveolin-1 was obtained 
from BD Transductions Laboratories (Lexington, KY). The monoclonal antibody anti-MBP 
was purchased from Serotec (Oxford, UK). Fluorescein isothiocyanate (FITC), 
tetramethylrhodamine isothiocyanate (TRITC) and Cy-3 conjugated antibodies were 
supplied by Jackson ImmunoResearch Laboratories Inc. (West Grove, PA). Secondary 
horseradish peroxidase (HRP)-conjugated antibodies were obtained from Amersham 
Biosciences (Buckinghamshire, UK). 
 
Constructs 
 General procedures for cloning and DNA manipulations were performed as 
described by Sambrook et al. (1989). The cDNA encoding pEGFPMAL was a kind gift of Dr. 
Miguel Alonso (Universidad Autómona de Madrid, Spain). For cloning the mal gene in the 
retroviral vector pLEGFP-C1 (Clontech Biosciences, Mountain View, CA), the vector was 
digested with the restriction enzymes SalI (Gibco LifeTechnologies) and BglI (Gibco Life 
Technologies), and ligated with the MAL fragment obtained by digestion of the pEGFPMAL 
construct with SalI and BglI. The orientation and the integrity of the obtained pLEGFPMAL 
construct were confirmed by DNA sequencing. 
 
Production of retroviral particles 
The production of retroviral particles and the subsequent infection of OLG 
progenitor cells were performed according to Relvas et al. (2001). Briefly, for production of 
recombination-deficient retroviruses, the constructs were transfected into the GP+E86-
packaging cell line (Genetix Pharmaceuticals Inc., Cambridge, MA), using the FuGene6 
transfection reagent. Two days after transfection, cells were collected, diluted 5-fold and 





(corrected for inactivity) until resistant clones appeared (70 % confluent). The cells were 
subsequently washed with PBS, and packaging cells medium without G418 was added. 
The conditioned medium was collected after 24 hrs, filtered (Schleicher and Schuell, 




 Primary cultures of OLGs were prepared from brains of 1-2 day old Wistar rats as 
described previously (Baron et al., 1998) with slight modifications. Briefly, after decapitating 
the rats, the forebrains were removed and the cells were dissociated, first mechanically 
and then with papain (30 U/ml) in the presence of L-cysteine (0.24 mg/ml) and DNase (10 
μg/ml) for 1 hr at 37 °C. A single cell suspension was prepared by repeated pipetting in 
trypsin inhibitor (1 mg/ml) solution. After centrifugation, the cells were resuspended in 
DMEM medium containing 10 % FCS and seeded into 75 cm2 flasks (Nalge Nunc 
International, Roskilde, Denmark), which were precoated with poly-L-Lysine (PLL, 5 µg/ml) 
at approximately 1.5 brain per flask. The OLG progenitor cells appear as round-shaped, 
phase dark cells on top of monolayers of flat type-1 astrocytes. After 11-12 days in culture, 
the OLG progenitor cells were isolated by mechanical shaking at 240 rpm for 18-20 hrs as 
described by McCarthy and de Vellis (1980). Contaminating astrocytes and microglia 
were subsequently removed by differential adhesion for 20 min at 37 ºC. 
For biochemical analysis, the OLG progenitor cells were plated in proliferation 
medium (SATO medium (Buttery et al., 1999; Maier et al., 2005), supplemented with the 
growth factors FGF-2 (10 ng/ml) and PDGF-AA (10 ng/ml)) on PLL coated dishes (Nunc) at 
a density of 1 X 106 cells per 100 mm dishes. Differentiation was initiated by switching to 
SATO medium supplemented with 0.5 % FCS. For immunocytochemical studies, OLG 
progenitor cells were seeded at a density of 2 Χ 104 cells per well on PLL-coated 8 well 
permanox chambers (Nunc) and cultured as described above. 
 
Infection of oligodendrocyte progenitor cells  
For (over)expression of GFP-MAL, OLG progenitor cells were plated in proliferation 
medium on PLL-coated 100 mm dishes or 8 well chambers slides as described above and 
cultured for 48 hrs in proliferation medium. Infections were carried out by exposing the cells 
to retroviral particles, 8 µg/ml polybrene, 10 ng/ml FGF-2 and 10 ng/ml PDGF-AA for 16-18 
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hrs. The cells were cultured for 24 hrs in proliferation medium and then cultured under 
selection in proliferation medium, supplemented with 400 μg/ml G418 (corrected for 
inactivity) during 5 days. After selection, the cells were cultured on differentiation medium 
(SATO supplemented with 0.5 % FCS) during 3 to 9 days. 
 
Infection of OLN-93 cells 
 The oligodendroglia derived cell line OLN-93, a kind gift of Dr. Christiane Richter-
Landsberg (Department of Biology, Molecular Neurobiology, University of Oldenburg, 
Germany; Richter-Landsberg and Heinrich, 1996), were cultured in DMEM supplemented 
with 10 % heat-inactivated FCS, L-glutamine, and the antibiotics penicillin and 
streptomycin. Cells were trypsinized when they reached near-confluency. GFP-MAL 
expressing and mock-OLN-93 cells were obtained via retroviral infections with the plasmids 
pLEGFP-MAL and pLXIN, respectively. Retroviral infections of OLN-93 cells were carried out 
as described previously (Maier et al., 2006).  
 
Immunocytochemistry 
 Paraformaldehyde-fixed cells (4 % paraformaldehyde in phosphate-buffered saline 
(PBS) for 20 min at room temperature (RT)) were subsequently rinsed with PBS, blocked and 
permeabilized with 10 % FCS and 0.1 % Triton X-100 (TX-100) in PBS, respectively, for 30 min 
at RT. The cells were incubated for 1-2 hrs with appropriately diluted primary antibodies in 
PBS, supplemented with 2.5 % FCS and 0.1 % TX-100 (incubation buffer). The cells were 
washed with PBS and incubated for 30 min at RT with the appropriate secondary antibody 
conjugated with FITC, TRITC or Cy3 diluted in incubation buffer. After washing with PBS, the 
cells were covered with 2.5 % 1, 4-diazobicyclo [2.2.2] octane (DABCO) in 90 % glycerol/ 10 
% PBS, to prevent image fading. Dapi was used for nucleï staining. The samples were 
analyzed with an immunofluorescence microscope (Olympus AX70), equipped with 




 To identify cells that were in the S phase of the cell cycle, a BrdU assay was carried 
out in which the cells were exposed to BrdU at a final concentration of 10 μM for 16 hrs at 





followed by treatment with 2 N HCl for 10 min to denature DNA. BrdU incorporation was 
detected by cell counting via indirect immunocytochemistry by incubation with anti-BrdU 
monoclonal antibody (30 min) followed by goat anti-mouse IgG conjugated to TRITC 
(30 min). Dapi was used for nucleï staining. The samples were analyzed with an 
immunofluorescence microscope (Olympus AX70), equipped with analySIS software. Data 
were processed using Paint Shop Pro and/or Adobe Photoshop Software. At least 500 cells 
per condition were counted. 
 
Preparation of detergent extracts 
The cells were washed with PBS, and harvested by scraping the cells with a rubber 
policeman in 350 μl TNE lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA 
supplemented with 1 % TX-100 and a cocktail of protease inhibitors). Lysis occurred on ice 
for 30 min and the protein content was determined by a Bio-Rad DC Protein Assay (Bio-Rad 
Laboratories, Hercules, CA), using BSA as a standard. Soluble and insoluble material were 
separated by centrifugation for 15 min at 10000 rpm at 4 °C. Pellet and supernatant were 
mixed with SDS reducing sample buffer, heated for 2 min at 95 ºC or 30 min at 37 °C and 
subjected to SDS-PAGE and Western Blotting. 
 
Surface protein biotinylation 
After washing twice with ice-cold PBS, the cells were incubated for 2 hrs with Sulfo-
NHS-L-C-Biotin (0.1 mg/ml in PBS) at 4 °C. Excess biotin was removed by washing the cells 
three times with cell wash buffer (65 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1 mM 
MgCL2) and once with PBS. The cells were harvested by scraping with a rubber policeman 
and pelleted (10000 rpm, 5 min, 4 °C). Lysis was carried out in a medium consisting of 
TNE/TX-100/protease cocktail inhibitors (see above) on ice for 30 min and the protein 
content was measured according to the protocol of the protein determination kit (Biorad). 
The surface biotinylated protein extracts were incubated overnight at 4 °C in a tumbler 
with activated streptavidin-Agarose beads. Beads and supernatant were separated by 
centrifugation, washed and mixed with SDS sample buffer, heated for 2 min at 95 ºC or 30 
min at 37 °C and subjected to SDS-PAGE. Determination of the amount of biotinylated and 
non-biotinylated protein was carried out by Western blotting. 
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OptiPrep density centrifugation 
For density gradient centrifugation a discontinuous OptiPrep gradient (2.25 ml 10 %, 
2.25 ml 30 % and 750 µl 40 %) was prepared. For preparing 40 % OptiPrep 250 µl of total cell 
lysates (equal protein) were added to 500 µl of 60 % OptiPrep. This mixture was then 
overlaid with 30 % and 10 % OptiPrep. Gradients were centrifuged overnight at 40000 rpm 
(SW55 Beckman, 4 °C) and 7 750 μl fractions of the gradient were collected from the top 
(fraction 1) to the bottom (fraction 7). For Western blot analysis, equal volumes were TCA 




To concentrate proteins, the fractions were adjusted to a final volume of 1 ml with 
TNE and treated with DOC (25 mg/ml) for 5 min at 4 °C followed by precipitation with 6.5% 
trichloric acid (TCA) for 15 min at 4 °C. Precipitates were centrifuged for 20 min at 10000 
rpm and 4°C. The pellets were dried and resuspended in 2Χ SDS reducing sample buffer. 
After the pH was adjusted to 6.8 by exposure to ammonia, the samples were heated for 2 
min at 95 ºC or 30 min at 37 °C and subjected to SDS PAGE and Western Blotting. 
 
SDS-PAGE and Western Blotting 
Samples were loaded onto 10 or 12.5 % SDS-polyacrylamide gels and transferred to 
nitrocellulose membranes (Bio-Rad) by semi-dry blotting. The membranes were blocked 
with 5 % nonfat dry milk in Tris buffered saline (TBS) to inhibit nonspecific binding. The 
membranes were washed with TBS-T (TBS supplemented with 0.1 % Tween-20) and 
incubated with appropriate primary antibodies in TBS-T with 0.5 % nonfat dry milk for at 
least 2 hrs at RT. After 3 times washing with TBS-T, the membranes were incubated for 1 hr 
at RT with the appropriate HRP-conjugated antibody (1:2000 in TBS-T). The signals were 
visualized by ECL (Amersham, Pharmacia Biotech), processed with Paint Shop Pro and 
quantified by using Scion Image Software. 
 
Results  
Localization of GFP-MAL is similar to that of endogenous MAL 
MAL proteolipid is expressed during late myelinogenesis and is in vivo predominantly 





(Frank et al., 2000). This relatively delayed developmental expression has hampered 
progress in understanding the function of MAL in OLGs, grown in culture. To overcome this 
problem we (over)expressed MAL in OLG progenitor cells, i.e., O2A stage, which would 
enable us to monitor the protein’s localization during OLG development and its function in 
relation to other myelin (specific) proteins. For this purpose we made use of a GFP-MAL 
construct, which was (over)expressed in OLG progenitors by means of a retroviral 
expression system, yielding an efficiency of more than 90 % GFP-MAL (over)expressing cells 
(data not shown). In MDCK cells, endogenous MAL has been described as an itinerant 
protein that cycles between the trans-Golgi network (TGN) and the plasma membrane 
(Puertollano and Alonso, 1999). To verify whether such properties similarly apply to GFP-
MAL, we first examined its localization in an oligodendroglia derived cell line, OLN-93. As 
shown in figure 1, consistent with the observations in MDCK cells, GFP-MAL was prominently 
present in the plasma membrane and colocalized with the trans-Golgi marker TGN-38 in 




Figure 1: GFP-MAL predominantly localizes to the trans-Golgi network and plasma membrane in the 
oligodendroglia derived cell line OLN-93. OLN-93 cells, retrovirally (over)expressing GFP-MAL, were prepared as 
described in Materials and Methods. The localization of GFP-MAL at steady state was determined. To this end, 
the cells were fixed, permeabilized and co-stained for GFP (A) and TGN-38 (B). Merged image is shown in C 
(GFP/TGN-38). Bar = 20 µm. Representative pictures of 3 independent experiments are shown. 
 
After infection of OLG progenitors with GFP-MAL, the localization of the protein was 
monitored during development. In the O2A stage, GFP-MAL localized to the perinuclear 
region and the plasma membrane of the cell body (fig. 2A1). Upon differentiation, its 
plasma membrane localization gradually diminished and in the GalC stage (fig. 2A2) GFP-
MAL increasingly appeared in vesicular structures throughout the cytoplasm of the cell 
body, whereas in sheet-forming OLGs, at the MBP stage, GFP-MAL was largely present in 
the perinuclear region and the primary processes (fig. 2A3). Endogenous MAL becomes 
A B C 
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largely expressed in mature OLGs (MBP+ stage), and as shown in figure 2A4, its localization 
was comparable to that of GFP-MAL. Finally, the morphology of the GFP-MAL 
(over)expressing OLGs was indistinguishable from that of mock infected immature, mature 




Figure 2: Localization of GFP-MAL in GFP-MAL (over)expressing oligodendrocytes as a function of cell 
development. OLG progenitor cells, retrovirally (over)expressing GFP-MAL were prepared as described in 
Materials and Methods. The localization of GFP-MAL was subsequently determined in OLGs, grown to various 
developmental stages O2A (A1), GalC (A2) and MBP (A3). Additionally, localization of endogenous MAL was 
determined in mature OLGs (MBP+ stage) in A4. To this end, the cells were fixed, permeabilized and stained 
with anti-mouse GFP antibody (A1, A2 and A3) and anti-mouse MAL antibofy (A4). Bar = 20 µm. Representative 
pictures of 3 independent experiments are shown. B: Microdomain localization of endogenous MAL and GFP-
MAL in the MBP+ stage. Mature OLGs (MBP+ stage), expressing endogenous MAL, GFP-MAL, GFP and caveolin 
were extracted with 1 % TX-100 at 4 °C, and analyzed by OptiPrep density gradient centrifugation (40 %, 30 % 
and 10 %). Proteins were visualized by Western Blotting using antibodies directed against MAL (a), GFP (b and 
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In both MDCK cells and myelinating OLGs (Frank et al., 1998; Frank et al., 2000; Kim 
and Pfeiffer, 2002), endogenous MAL has been detected in detergent resistant 
microdomains. To determine whether GFP-MAL similarly integrates into such microdomains, 
lysates of primary cultures of OLGs at the MBP+ stage were extracted with 1 % TX-100 at 4 
°C. The detergent insoluble material was fractionated on an OptiPrep density gradient and 
analyzed by SDS-PAGE and Western Blotting. As a control, GFP-expressing cells were 
treated and analyzed similarly. As shown in figure 2B, GFP-MAL localized essentially in 
fractions that also contained caveolin-1, a well-established marker for detergent resistant 
microdomains, whereas the cytosolic protein GFP was largely excluded from these 
fractions. Similarly, although expressed to a limited extent in cultured OLGs at the MBP+ 
stage, detergent extraction and fractionation revealed that endogenous MAL also 
primarily localized to the so-called raft fractions (fig. 2B). Taken together, these data 
suggest that in mature OLGs, GFP-MAL, like endogenous MAL, largely resides in detergent-
resistant microdomains and that in nonmyelinating OLGs (and in the oligodendroglia 
derived cell line OLN-93), the protein appears to cycle between plasma membrane and 
TGN, as observed in polarized epithelial cells. Upon OLG maturation, the protein shifts to a 
myelin sheet localization as reflected by an appearance in intracellular vesicles and 
primary processes, consistent with the in vivo localization of endogenous MAL in myelin 
sheath. From these data we therefore inferred that GFP-MAL properly reflected the 
properties of endogenous MAL. 
 
GFP-MAL (over)expression does not affect the proliferation and differentiation of 
oligodendrocytes 
The growth factors FGF-2 and PDGF-AA are necessary to keep the OLG progenitor 
cells in a proliferative stage. To determine whether the expression of GFP-MAL changes 
proliferation of the cells, the cells were analysed with a BrdU assay. The cells were 
incubated overnight with BrdU and grown in SATO medium in the presence of PDGF-AA 
and FGF-2. Only in dividing cells BrdU will incorporate. Compared to mock infected cells, 
expression of GFP-MAL in O2A cells did not affect the proliferation of the cells (fig. 3A). 
Thus, in mock infected and GFP-MAL (over)expressing cells, approx. 20 % of the OLGs 
incorporated BrdU. 
In Schwann cells, MAL is involved in the differentiation of these myelinating cells of 
the peripheral nervous system (PNS) (Frank et al., 1999). Upon maturation of OLGs, distinct 
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morphological stages in development can be distinguished. Overall, cell morphology 
changes from a bipolar O2A cell to one that reveals numerous primary processes (GalC), 
while in mature cells in culture (MBP stage) laminar sheets can be distinguished. 
Biochemically, the onset of terminal differentiation is defined by the synthesis of CNP, 
whereas expression of MBP prominently occurs in the sheets of matured cells. Therefore, to 
establish in a more quantitative sense whether GFP-MAL is involved in the regulation of 
OLG differentiation, the number of CNP and MBP expressing cells were determined by 
immunofluorescence microscopy at the distinct developmental phases (from progenitor 




Figure 3: (Over)expression of GFP-MAL affects neither proliferation (A) nor differentiation (B) of cultured 
oligodendrocytes. A: To determine proliferation, the incorporation of BrdU in OLG progenitor cells was 
monitored in GFP-MAL or mock infected (pLXIN) cells. B: For determination of differentiation, the number of 
CNP (onset of differentiation; filled symbols) or MBP (mature; open symbols) positive cells were determined by 
immunostaining as a function of cell development (O2A, O4, GalC and MBP stage, respectively) for mock 
infected cells (left panel) and GFP-MAL (over)expressing cells (right panel). For each developmental stage 
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As shown in figure 3B, it is apparent that the levels of CNP (filled symbols) and MBP 
expression (open symbols) in mock infected and GFP-MAL (over)expressing cells were 
virtually identical, irrespective of cell developmental stage. In summary, the data thus 
demonstrated that neither proliferation nor differentiation of the cells were affected by 
GFP-MAL (over)expression.  
Since the MAL protein is known to be involved in regulating protein transport in 
MDCK cells and thyroid cell lines (Cheong et al., 1999; Puertollano et. al., 1999, 2001; 
Martin-Belmonte et al., 2000, 2001), we next investigated whether MAL could play a similar 
role in protein transport in OLGs. 
 
Interference of MAL with sheet-directed transport of PLP  
To analyze whether the MAL protein might be involved in regulating (protein) 
transport in OLGs, its effect on the localization of some myelin specific proteins was 
determined by immunofluorescence. To this end, we focused on CNP, MAG, PLP and MBP, 
which are expressed during different stages of myelination, and transported to and 
localized at different regions in the myelin sheet, both in vivo and in vitro (Krämer et al., 
2001; Gielen et al., 2006). As shown in figure 4, irrespective of GFP-MAL (over)expression, 
the localization of CNP (fig. 4A, B) and MBP (fig. 4C, D) remained unaltered in mature OLGs 
(MBP stage). Similarly, the expression and distribution of MAG was indistinguishable in mock 
infected and GFP-MAL (over)expressing cells (data not shown). These data thus suggested 
that MAL is not involved in (regulating) transport of these proteins to their final destination. 
However, when investigating the localization of the major myelin protein PLP in mock 
infected and GFP-MAL (over)expressing cells, a diminished staining of PLP in the processes 
was seen in the (over)expressing cells (fig. 4G, F). Specifically, in GFP-MAL (over)expressing 
cells, the proteolipid PLP accumulated as punctuate spots in the cell body, indicating that 
transport of PLP to the processes and the sheets was inhibited (fig. 4F). 
To analyze whether this perturbation of PLP transport was accompanied by an 
altered lateral membrane distribution of the protein, the detergent solubility of PLP was 
determined upon extraction in the cold with TX-100 and CHAPS, respectively. As shown in 
figure 5A, (over)expression of GFP-MAL did not alter the relative partitioning of PLP in a 
soluble versus insoluble detergent fraction. Thus, following extraction with TX-100, 95 % of 
the PLP was recovered from the detergent soluble fraction, irrespective of GFP-MAL over-
expression. A similar observation was made in case of analysis of the soluble and insoluble 
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fractions obtained upon CHAPS extraction, except that the major fraction (approx. 65%) 
was insoluble in this detergent, which remained unaltered, i.e., whether or not the cells had 
been infected with GFP-MAL.  
 
 
Figure 4: Sheet localization of PLP, but not CNP and MBP, was modulated in GFP-MAL (over)expressing cells. 
Localization of the myelin specific proteins CNP (A, B), MBP (C, D) and PLP (E, F) in mock infected (A, C and E) 
and GFP-MAL (over)expressing (B, D and F) OLGs in the MBP stage as determined by immunofluorescence. Bar 
= 20 μm. The figure represents a typical result of at least 3 independent experiments. 
 
In conjunction with an accumulation of PLP in the cell body, we also noted a remarkable 
decrease in the level of expression of PLP in GFP-MAL (over)expressing cells at the MBP 
stage. Thus compared to mock infected cells, the level of PLP expression in GFP-MAL 


































Figure 5: A: Immunoblots of PLP in mock infected and GFP-MAL (over)expressing cells. After TX-100 (upper 
panel) or CHAPS (lower panel) extraction at 4°C and centrifugation, insoluble (pellet) and soluble 
(supernatant) were analyzed by Western blotting. Soluble (S) and insoluble (I) fractions are indicated by gray 
and black bars, respectively. B: Total expression of PLP/ DM20 in mock infected and GFP-MAL overexpressing 
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This feature appeared to be specifically related to PLP expression, since the expression 
levels of CNP, MAG and MBP in GFP-MAL (over)expressing cells were very similar as the 
expression levels of these proteins in mock infected cells (data not shown). 
 
GFP-MAL modulates transport of PLP from plasma membrane to sheet 
The foregoing data revealed that upon GFP-MAL (over)expression, PLP 
accumulated in the cell body of mature sheet-forming cells. Previously (Klunder et al., 
submitted; chapters 3 and 4), we have shown that the itinerary of PLP trafficking following 
de novo biosynthesis involves its transport to the cell body plasma prior to delivery to its 
final destination, the myelin sheet. Accordingly, the present observations raised the 
question whether in GFP-MAL (over)expressing cells transport of PLP to the cell surface was 
impeded immediately following de novo biosynthesis, or that the subsequent transport 
step from plasma membrane toward the myelin sheet was blocked.  
 
 
Figure 6: In GFP-MAL (over)expressing OLGs transport of PLP from the plasma membrane toward the myelin 
sheet is blocked. In the upper panel the Western blot of the biotinylated fraction (outside, o) and the non-
biotinylated fraction (inside, i) are shown. The PLP-bands were quantified and a graphical representation of 
these data is shown underneath the blot, gray bars representing the surface fraction and the black bars the 
fraction within the cells, i.e., not accessible to biotinylation. 
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To discriminate between these possibilities we examined the extent to which PLP could be 
biotinylated in mock and GFP-MAL infected cells, allowing determination of the cell 
surface accessible pool of the protein. At steady state conditions, approx. 35 % of the total 
PLP pool was biotinylated in both mock infected and GFP-MAL (over)expressing cells (fig. 
6). Accordingly, these data would suggest that at steady state similar pools in mock 
infected and GFP-MAL (over)expressing cells had reached the cell surface, suggesting 
that (over)expressed GFP-MAL interferes in particular with PLP transport from the plasma 
membrane towards the myelin sheet. 
 
Discussion 
The aim of the present work was to obtain further insight into molecular mechanisms 
underlying the biogenesis of the myelin sheet in cultured OLGs. Our data suggest that MAL 
negatively regulates PLP transport to the myelin sheets in OLGs by exerting control on the 
exiting of PLP from an intracellular compartment that appears to be instrumental in the 
transcytotic transport of PLP from cell body plasma membrane to myelin sheet. 
In previous studies (de Vries et al., 1998; Klunder et al., in press) we have 
demonstrated that OLGs can be considered as polarized cells, trafficking to the cell body 
plasma membrane and the myelin sheet mimicking the apical- and basolateral-like 
mechanisms, respectively, in epithelial cells. In this context, we therefore investigated the 
MAL proteolipid protein in myelin formation since its regulatory role in polarized membrane 
transport in epithelial cells has been well defined, MAL (over)expression strongly promoting 
apical membrane biogenesis (Cheong et al., 1999; Puertollano et al., 1999; Martin-
Belmonte et al., 2001). Moreover, MAL is also expressed in OLGs, but its role is poorly 
defined. Our data demonstrate that MAL does not affect the proliferation and 
differentiation of OLGs, as was reported for the myelin producing Schwann cells of the PNS 
(Frank et al., 1999). Rather, the evidence suggests that MAL is a negative regulator of 
myelin sheet–directed vesicular transport of PLP. Indeed, transport of CNP, as a marker for 
non-vesicular transport to the sheet, or transport of MBP mRNA, nor the expression and 
distribution of either protein, were affected in mock infected or GFP-MAL (over)expressing 
cells. Neither the expression nor localization of the MAG protein was changed, indicating 
that transport of MAG from Golgi to the sheet was also not modulated in GFP-MAL 
(over)expressing OLGs. To explain the effect of MAL on PLP trafficking, it is relevant to 
consider the transport itinerary of this protein. Elsewhere, we have shown that after its 
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biosynthesis at the ER, PLP is transported from the Golgi to the OLG cell body plasma 
membrane (chapters 3 and 4). Subsequently, the protein is internalized and directed 
towards the myelin sheet along a transcytotic transport pathway from plasma membrane 
to myelin sheet. Importantly, initial transport from Golgi to plasma membrane relies on PLP’s 
integrations into membrane microdomains, characterized by resistance towards 
solubilization by TX-100. Intriguingly, TX-100 insolubility is transient, since after PLP’s departure 
from the plasma membrane (to the sheet), the protein resides in TX-100-soluble but CHAPS-
insoluble domains (chapters 3 and 4; Simons et al., 2000). Here we show that in GFP-MAL 
(over)expressing cells, PLP no longer reaches the myelin sheet but rather, accumulated in 
intracellular compartments (fig. 4). The question then arises whether accumulation was 
due to a block in trafficking of PLP from Golgi to plasma membrane or in the transcytotic 
pathway from plasma membrane to myelin sheet. Several pieces of evidence would 
support the latter scenario. Biotinylation experiments revealed that at steady state there 
was essentially no distinction in the pool of surface localized PLP in mock infected and 
GFP-MAL (over)expressing cells, suggesting that PLP transport to the plasma membrane 
following biosynthesis occurred relatively unhindered. Moreover, at these conditions (fig. 
5), the major fraction of PLP primarily resided in CHAPS insoluble but TX-100 soluble 
microdomains. Kinetically, PLP acquires this property in OLGs post-biosynthetically after 
approx. 60 min (Simons et al., 2000), a typical characteristic of the PLP transport entity 
between plasma membrane and myelin sheet, as shown elsewhere (chapter 4). At the 
molecular level, sulfatide is an important regulator in transcytotic PLP transport (chapter 4), 
and as MAL associates with sulfatide and their levels tightly balanced (Saravan et al., 2004; 
Schearen-Wiemers et al., 2004), MAL might sequester sulfatide from specific (plasma) 
membrane microdomains, thereby impairing PLP trafficking. 
Intriguingly, in GFP-MAL (over)expressing cells, PLP accumulation was accompanied 
by a substantial decrease in expression level of the protein by approx. 35 %. Whether this 
diminishment was related to a down regulation of de novo biosynthesis of PLP, triggered by 
the accumulation process as such, or that accumulated PLP was susceptible to 
degradation, remains to be determined. However, the present observations may bear 
relevance to very recent work by Trajkovic et al. (2006). These authors demonstrated that 
the trafficking of PLP in immortalized oligodendroglia cell lines is under neuronal control. 
Evidence was provided indicating that late endosomal/lysosmal compartments 





of PLP, initially localized at the plasma membrane of the cells. Co-incubation of these cell 
lines with neurons downregulated endocytosis and simultaneously triggered PKA-mediated 
exocytosis of PLP from the storage compartments to the plasma membrane, thereby 
simulating myelination. It is possible that the accumulation sites we observed in GFP-MAL 
(over)expressing OLGs are the same as those noted by Trajkovic et al. (2006), although 
further work is required to characterize these compartments. Interestingly, however, only in 
GFP-MAL (over)expressing OLGs these compartments became more apparent, suggesting 
that exiting from this compartment was (negatively) regulated by MAL. If so, it is also 
tempting to suggest that in OLGs, where PLP is presumably vectorially transported to the 
sheet, degradation may occur in these endosomal/lysosmal compartments, possibly 
explaining its downregulated expression, since ‘recycling’ to the plasma membrane, as 
occurs in immortalized oligodendroglial cell lines (Trajkovic et al. 2006), is less likely. 
The present work thus revealed a potentially novel role for MAL in regulating 
polarized membrane transport, which needs not necessarily be at odds with its well-
defined role in apical trafficking in polarized epithelial cells, where it promotes membrane 
transport from Golgi to apical plasma membrane ((Puertollano et al., 1999; Cheong et al., 
1999). Its overexpression may have stimulate apically-controlled transport of PLP (Kroepfl 
and Gardinier, 2001) to the ‘apical-like’ membrane in OLGs, i.e., the cell body plasma 
membrane, given that the biotinylated pools of PLP were very similar in mock infected and 
GFP-MAL (over)expressing cells. However, the actual pool of PLP accessible in GFP-MAL 
(over)expressing cells may well be larger than that in control cells, since biotinylation 
detects the total pool of surface accessible PLP, i.e., in plasma membrane and sheet. In 
GFP-MAL (over)expressing cells, the latter pool is strongly reduced, implying that MAL could 
have promoted apical, i.e. cell body plasma membrane-directed trafficking, similarly as in 
epithelial cells. Obviously, additional work, including pulse chase experiments, will be 
necessary to clarify this possibility. Nevertheless, it would also appear that MAL 
downregulates subsequent transport to the ‘basolateral’ like sheet, as reflected by sheets 
being relatively devoid of PLP, presumably due to the intracellular entrapment of the 
protein in GFP-MAL (over)expressing cells. Thus, the present work clearly hints to a novel 
role of MAL in regulating PLP-mediated myelin compaction, which warrants further 
investigations. 
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During myelin formation oligodendrocytes (OLGs) utilize basic mechanisms of 
membrane trafficking, commonly seen in eukaryotic cells, as outlined in the introductory 
chapter (Chapter 1). However, whether specific transport pathways, unique to myelin 
biogenesis are involved and if so, how such pathways might be regulated in the 
biogenesis and maintenance of the myelin sheath, has been largely unexplored thus far. 
Such insight is of major relevance in order to device strategies for exogenous manipulation 
to stimulate and/or promote de novo biogenesis of myelin sheath assembly at 
pathological conditions that lead to demyelination, as in the case of multiple sclerosis 
(MS). In addition, the special morphological features of OLGs, consisting of a cell body, 
bounded by a plasma membrane, and myelin ‘protruding’ from that cell body, yet 
maintaining a highly specific and quite distinct membrane composition when compared 
to the plasma membrane, raises many fundamental questions of great interest to current 
cell biology. Accordingly, a major purpose of the work described in this thesis was to 
acquire insight into the sorting and trafficking of structural myelin components such as PLP 
and MBP, and to reveal regulatory mechanisms, instrumental in promoting myelin sheath 
biogenesis. As noted, we believe that this kind of insight is a prerequisite for a prosperous 
advancement in developing therapeutic approaches for a disease as complex as MS.  
The trafficking and sorting of myelin constituents was primarily studied in vitro, using 
isolated OLG precursor cells from newborn rats. This approach also allowed us to study 
myelin biogenesis as a function of cellular development. In chapter 2, molecular 
parameters that govern the targeting and incorporation of myelin proteins and model 
molecules into myelin membranes are investigated. Since we specifically took into 
account the polarized nature of OLGs, based on previous work, we investigated whether 
the presence of a tyrosine residue in the C-terminal part of membrane proteins, acting as 
a basolateral sorting signal in polarized epithelial cells, sufficed to target model proteins to 
the myelin sheet. The data support the concept that the myelin membrane displays 
typical basolateral-like features, and in terms of targeting depends on typical basolateral 
signals, while myelin-directed trafficking is regulated by protein kinase C activity in a 
manner that bears similarity to basolateral membrane–directed trafficking in epithelial 
cells. Chapter 3 describes the role of syntaxins 3 and 4 in OLG polarity and their potential 
ability to regulate trafficking of myelin specific proteins. For the first time we demonstrate a 
functional role of these SNAREs in OLGs and moreover, their distinct activity at either the 
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plasma membrane (syntaxin 3) or sheet (syntaxin 4), which is entirely in line with the 
polarized properties of these membrane domains in OLGs. In chapter 4, we investigated 
the role of exogenous factors on the regulation of myelin biogensis. To this end, OLGs were 
grown on different substrates of extracellullar matrix (ECM) to analyze whether 
extracellular signals are affecting the transport of PLP, which is used as a molecular marker 
for myelin assembly. Our data indicate that sheet-directed transport of PLP in OLGs relies 
on a transcytotic transport mechanism, in which PLP, early after biosynthesis, integrates 
into Triton X-100 resistant microdomains for transport to the plasma membrane of the OLG 
cell body, sulfatide seeming to play an important role in this process. Following transport to 
the OLG plasma membrane, the protein is internalized and subsequently transported to 
the myelin sheet. In chapter 5 the role of MAL in the regulation of sorting and transport of 
PLP is examined. A GFP-MAL construct was overexpressed in proliferating OLG progenitor 
cells and the expression and localization of MAL as well as its effect on transport of myelin 
specific proteins was studied during different stages of OLG development. In this chapter it 
is shown that in GFP-MAL (over)expressing cells neither proliferation nor differentiation was 
affected. Whereas the expression and distribution of CNP, a myelin marker for non-
vesicular transport, or transport of MBP mRNA, were not modified in GFP-MAL 
overexpressing cells, the expression level and transport of PLP was blocked. These data 




In this thesis molecular parameters were identified that regulate transport to the 
myelin sheet, representing part of the complex mechanism of myelination. Importantly, 
further evidence was provided supporting the polarized properties of myelin and plasma 
membrane in oligodendrocytes, bearing similarity to the typical polarized features seen in 
epithelial cells. However, several important issues obviously need further investigation. In 
chapter 2 we demonstrated that basolateral trafficking in OLGs appeared to be 
dependent on a tyrosine signal in the C-terminal membrane domains of transmembrane 
proteins. Thus, the question should now be addressed whether this tyrosine signal and/or 
other basolateral signals, are also operating in the sorting and transport of myelin specific 
proteins, particularly in proteins like MAG and PLP, containg tyrosine and dileucine 





basolateral and apical sorting signals in myelin protein transport and myelin assembly may 
well depend on signals more complex than a single amino acid residue. Indeed, although 
the regulation of the sorting and transport pathway of myelin specific PLP during myelin 
development is still largely obscure, our data in chapter 3 suggest that PLP is sorted and 
transported to the plasma membrane prior to sorting and transport to the myelin sheet, 
indicating at least dual signalling entities. Moreover, the transcytotic mechanism as 
observed partly relies on the t-SNARE syntaxin 3. It will be of interest to determine the 
precise mechanism as to how and where syntaxin 3 regulates the route and docking of 
PLP to and at the myelin sheet. Of particular relevance are the effects of extracellular 
matrix signals on the development of a proper myelin sheet. It is anticipated that a better 
characterization of the  involvement of these signals will shed light on the mechanism by 
which syntaxin 3 is involved in determining and defining the route of PLP transport to the 
myelin sheet. Further work is also needed to determine how syntaxin 3 and syntaxin 4 
differentially regulate the synthesis and/or processing of myelin proteins, including PLP and 
MBP, respectively. Particularly the observation that syntaxins might be able to regulate 
transport of mRNA (of MBP) as well will have an impact of general cellbiological 
significance. Specifically, it will be of interest to determine whether syntaxin 4 actually 
associates with MBP mRNA in some sort of complex. RNAi knock down approaches will 
enable to study this in more detail. In respect to this, overexpression and RNAi knock down 
experiments can be used to study the v- and t-SNARE combinations, required for the 
different pathways involved in the assembly of the myelin membrane. In this process it will 
also be important to elucidate the role of the myelin lipids, GalCer and sulfatide. In this 
regard our initial results, described in chapter 4, indicate that sulfatide is involved in early 
(i.e., plasma membrane-directed) transport of PLP. Additional work will be needed to 
firmly support these preliminary yet highly interesting observations.  
Finally, elucidation of the segregation of myelin proteins during development will be 
of help to provide further insight into the process of myelination during neural tissue 
development. This knowledge will be imperative in the search of therapies in 
demyelinationg diseases, either by preventing a worsening in their development or by 






















Veel mensen kennen in hun omgeving wel iemand die lijdt aan multiple sclerose 
(MS). Het is een ernstige ziekte met een grillig verloop, waarbij perioden met relatief 
goede gezondheid worden afgewisseld met terugvallen. MS kan zowel tot stoornissen in 
de zintuigwaarneming als tot bewegingsproblemen leiden. Omdat bij de laatst 
genoemde problemen spierfuncties uitvallen wordt wel gedacht dat MS een spierziekte is. 
MS is echter een aandoening aan de zenuwen. Spieren worden aangestuurd door 
signalen (impulsen) vanuit de hersenen. Deze impulsen lopen via zogenaamde axonen, 
dat wil zeggen relatief lange uitlopers, die ontspruiten aan het cellichaam van 
zenuwcellen. Om het doorgeven van impulsen efficient te laten verlopen zijn axonen 
omgeven door een isolerende laag van specifieke eiwitten en lipiden. Deze isolerende 
laag wordt de ‘myelineschede’ genoemd. Bij MS treden ontstekingen en beschadigingen 
in hersenen en ruggenmerg op, gekenmerkt door het voortdurend ontstaan en 
verdwijnen van ontstekingshaarden waarbinnen myeline afgebroken wordt 
(demyelinisatie). Zonder de isolerende laag om de axonen neemt de efficiëntie van het 
doorgeven van impulsen drastisch af en lopen de signalen van ieder axon in een 
zenuwbundel ongelijk. 
Tot op heden is de precieze oorzaak voor het ontstaan van MS nog niet bekend. 
Mogelijkerwijs spelen (virus)infecties, geografische en omgevings-, genetische en 
immunologische factoren een belangrijke rol. In de hersenvloeistof van een groot aantal 
MS patiënten zijn antistoffen tegen virussen aangetroffen. Dit is een aanwijzing dat een 
virusinfectie betrokken zou kunnen zijn bij het ontstaan van MS. Er is echter nog geen MS-
veroorzakend virus ontdekt. Een andere mogelijke oorzaak van MS is een auto-
immuunreactie. Hierbij is het immuunsysteem op een dusdanige manier verstoord dat het 
onderscheid tussen "lichaamseigen" en "lichaamsvreemd" niet goed gemaakt kan 
worden. Het lichaam vormt dan antistoffen tegen eigen lichaamsweefsel (in het geval 
van MS antistoffen tegen myeline). Deze "auto-immuuntheorie" is vooral gebaseerd op de 
resultaten van het proefdiermodel van MS: experimentele auto-immuun 
encephalomyelitis (EAE). Dit is een auto-immuunziekte die op MS lijkt en die is 
teweeggebracht in genetisch ontvankelijke onderzoeksdieren.  
Om de effecten van MS te kunnen verminderen, wordt gewerkt aan de 
ontwikkeling van therapieën die de aanmaak van nieuwe myeline stimuleren en daarmee 





is een gedetailleerde kennis nodig over hoe myeline wordt gevormd en over de manier 
waarop de myelinevorming kan worden bevorderd. 
In hersenen en ruggemerg wordt de myelineschede geproduceerd door 
oligodendrocyten. Oligodendrocyten zijn een bepaald type zenuwcellen, die vanuit een 
groot aantal uitlopers een uniek type membraan maken (de myeline sheet). Zodra de 
uitlopers van de oligodendrocyten een axon vinden, worden er membranen gevormd die 
zich dan een aantal malen strak om de axonen wikkelen waardoor er een myelineschede 
ontstaat. De myelineschede heeft een unieke samenstelling en bevat een aantal 
specifieke myeline-eiwitten en -lipiden. De belangrijkste myeline-eiwitten zijn het 
proteolipid protein (PLP), myelin basic protein (MBP) en myelin associated glycoprotein 
(MAG). Belangrijke lipiden zijn de glycosfingolipiden (GSL) galactosylceramide en 
sulfatide. Zonder deze componenten kan er geen functionele myelineschede bestaan. 
Goed beschouwd bestaat de wand of celmembraan van een oligodendrocyt uit 
twee delen met elk hun eigen functie, namelijk het plasmamembraan en de myeline 
sheet. Cellen met twee functioneel verschillende membraandelen worden ook wel 
gepolariseerde cellen genoemd. De twee verschillende membraandelen van 
gepolariseerde epitheelcellen worden aangeduid met de termen apicaal en 
basolateraal. Het transport van eiwitten en lipiden naar deze verschillende typen 
membranen vindt plaats via aparte transportroutes binnen de cel. 
De apicale membranen van epitheelcellen zijn rijk aan GSL, de basolaterale 
membranen niet. Dat de myelineschede ook een hoge concentratie aan GSL bevat doet 
dit membraan heel sterk lijken op een zogenaamd apicaal-type membraan. In eerder 
uitgevoerd onderzoek is het gepolariseerde karakter van oligodendrocyten onderzocht. In 
dit onderzoek is o.a. bestudeerd of in oligodendrocyten ook apicale en basolaterale 
membranen en de daarbij behorende transportroutes voorkomen. Dit blijkt inderdaad het 
geval te zijn, maar op een andere manier dan verwacht. Ondanks de grote hoeveelheid 
GSL in de myeline sheet blijkt dit membraan niet apicaal van karakter te zijn. Ook het 
vervoer van myeline-eiwitten er naar toe gaat eerder via een basolateraal dan via een 
apicaal mechanisme. 
Dit proefschrift is erop gericht om meer inzicht te krijgen in de wijze waarop 
oligodendrocyten de myeline-eiwitten en -lipiden naar de myelineschede dirigeren. Er is 
gekeken naar de rol van specifieke moleculen die betrokken zijn bij de sortering en het 





uitgevoerd met in kweek gebrachte oligodendrocyten, waarbij in de kweek geen 
neuronen en dus geen axonen aanwezig zijn. Dit heeft tot gevolg dat er geen echte 
myelineschede wordt gevormd. Er ontstaan echter wel uitlopers, waardoor er  na enkele 
dagen een meer uitgespreid myeline vel of sheet ontstaat. In deze sheet bevinden zich 
alle componenten (eiwiten en lipiden) die in aanwezigheid van zenuwcellen naar de 
myelineschede zouden worden getransporteerd. De myeline-eiwitten en -lipiden komen 
volgens hetzelfde ontwikkelingspatroon tot expressie als in oligodendrocyten die zich in 
het centrale zenuwstelsel bevinden. 
In hoofdstuk 2 is het basolaterale karakter van myeline nader onderzocht. Hierbij is 
gebruik gemaakt van de apicale en basolaterale markereiwitten, HA en VSV G. Deze 
eiwitten komen van nature niet voor in oligodendrocyten, maar zijn met behulp van een 
retroviraal expressie-systeem in jonge delende oligodendrocyten tot expressie gebracht. 
In gepolariseerde epitheelcellen is de aanwezigheid van het aminozuur tyrosine in het C-
terminale gedeelte van glycoproteinen een belangrijk intramoleculair signaal voor 
basolateraal transport. Om te bepalen of de verandering van slechts één aminozuur in 
een eiwit voldoende kan zijn om het transport te beïnvloeden, zijn tyrosine-mutaties 
aangebracht in HA en VSV G. Uit het expressiepatroon van de mutanteiwitten bleek dat 
de aanwezigheid van een tyrosine in het C-terminale deel van HA, voldoende was om 
eiwitten naar de myeline sheet te dirigeren. Verwijdering van de tyrosine uit het C-
terminale gedeelte van VSV G zorgde ervoor dat VSV G niet meer naar de myeline sheet 
getransporteerd kon worden. Deze waarnemingen ondersteunen het concept dat de 
myeline sheet typische basolaterale eigenschappen vertoont en dat het transport naar 
de sheet dus mogelijk gestuurd wordt door typische basolateral signalen in de myeline-
eiwitten. Deze laatste veronderstelling wordt inderdaad ondersteund door experminenten 
waarbij proteïnkinase C activiteit werd geactiveerd en als gevolg daarvan het transport 
van VSV G en het myeline-eiwit PLP naar de myeline sheet werd geremd. Een dergelijk 
proteïnkinase C gereguleerd basolateraal tansport is eerder in gepolariseerde 
epithelieelcellen aangetoond.  
In hoofdstuk 3 is de functie van endogene membraanfusie-eiwitten, syntaxin 3 en 4, 
in de polariteit van oligodendrocyten beschreven. Syntaxin 3 is voornamelijk intracellulair 
en in het plasmamembraan van oligodendrocyten gelokaliseerd, terwijl syntaxin 4 
voornamelijk in de myeline sheet voorkomt. Tevens is gebleken dat steeds meer syntaxin 4 





myeliniserende cellen, terwijl gedurende dit ontwikkelingsproces de hoeveelheid syntaxin 
3 constant blijft. Om de rol van syntaxin 3 en 4 bij transport van myeline-eiwitten naar de 
myeline sheet te kunnen bestuderen, zijn deze eiwitten zijn tot (over) expressie gebracht in 
oligodendrocyten. Overexpressie van syntaxin 3 heeft geen effect op localisatie van de 
myeline-eiwitten CNP, MAG en MBP, maar blokkeert het transport van PLP naar de 
myeline sheet. Overexpressie van syntaxin 4 heeft geen effect op de myeline-eiwitten 
CNP, MAG en PLP, maar resulteert wel in een sterke afname van de expressie van MBP. In 
tegenstelling tot de andere myeline-eiwitten, wordt MBP niet als eiwit naar de myeline 
sheet getransporteerd, maar in de vorm van mRNA waarbij het pas tot expressie komt als 
het op de plaats van bestemming is gearriveerd. Voor het eerst tonen wij aan in hoofdstuk 
3 dat syntaxin 4 wellicht een rol kan spelen bij het transport van MBP mRNA. 
In hoofdstuk 4 is het transport van het myeline specifieke eiwit PLP nader 
bestudeerd. Door middel van pulse-chase, biotinylering en “detergens-oplosbaarheid” 
experimenten wordt het volgende transport model voor dit eiwit voorgesteld: direct na de 
synthese wordt PLP opgenomen in een Triton X-100-resistente lipide-omgeving (vesikel voor 
transport) en naar de plasmamembraan getransporteerd. Sulfatide speelt een belangrijke 
rol in dit proces. Vervolgens wordt daar de samenstelling van de lipiden rondom PLP 
aangepast en wordt het eiwit in een Triton X-100 oplosbaar vesikel weer intracellulair 
opgenomen waarna het naar de myeline sheet wordt getransporteerd. Aanvullende 
experimenten tonen aan dat voor de eerste stap van het transport naar de plasma 
membraan waarschijnlijk sulfatide nodig is. In deze stap is gebleken dat syntaxin 3, eerder 
beschreven in hoofdstuk 3, betrokken is bij de "docking" van de Triton X-100 resistente 
transport vesikels aan de plasmamembraan. 
In hoofstuk 5 is de rol van het eiwit MAL bij de regulering van het transport van PLP 
bestudeerd. In epitheelcellen is MAL betrokken bij apicaal transport. By analyse van de 
eiwitsamenstelling van de myeline sheet is tevens gebleken dat MAL, samen met MBP en 
PLP, aanwezig is in het compacte deel van myeline. Om te bepalen of MAL ook 
betrokken is bij het transport van myeline-eiwitten, is MAL met een fluorescent label (GFP-
MAL) tot expressie gebracht in oligodendrocyten. Expressie van GFP-MAL heeft geen 
effect op de proliferatie en differentiatie van oligodendrocyten. Ook heeft overexpressie 
van MAL geen effect op het transport van de myeline-eiwitten CNP, MAG en MBP. 
Daarentegen zien we onder deze omstandigheden een sterke daling van de expressie 





PLP naar de sheet is geblokkeerd. Deze resultaten wijzen er dus op dat MAL mogelijk een 
rol speelt bij het tweede deel van het PLP-transport: transport van de plasmamembraan 
naar de myeline sheet. 
 
Toekomst 
In dit proefschrift zijn regulerende factoren beschreven die betrokken zijn bij het 
transport van specifieke eiwitten naar en daarmee de vorming van de myeline sheet. 
Alhoewel een aantal van deze factoren konden worden gekarakteriseerd en hun 
betrokkenheid gedefineerd, is er desalniettemin nog (veel) aanvullend onderzoek nodig 
om een duidelijk beeld te krijgen hoe de verschillende eiwitten gesorteerd en naar het 
myeline getransporteerd worden. In hoofdstuk 2 hebben we laten zien dat basolateraal 
transport in oligodendrocyten afhankelijk is van een tyrosine-signaal in het C-terminale 
membraan gedeelte van modeleiwitten. Verder onderzoek zal moeten aantonen of 
dergelijke intramoleculaire signalen ook een rol spelen bij het transport van myeline 
specifieke eiwitten, met name MAG and PLP, die respectivelijk tyrosines en dileucines 
bevatten. Verder is de regulering van het transport van het myeline-eiwit PLP tijdens de 
myelinevorming een onderwerp dat nader onderzoek vraagt. Het is interessant om de rol 
van syntaxin 3 en mogelijke ‘omgevingsfactoren’ betrokken bij het PLP transport in meer 
detail te onderzoeken. Ook is vervolgonderzoek  nodig om de specifieke rol van syntaxin 3 
and syntaxin 4 in de regulatie van sortering en transport van myeline-eiwitten, met name 
PLP en MBP, op te helderen. Hierbij dient ook nadrukkelijk de rol van de myeline-lipiden, 
galactosylceramide en sulfatide, op de sortering en transport van de myeline eiwitten te  
worden betrokken.  
Verondersteld mag worden dat deze kennis meer inzicht zal geven over de manier 
waarop het myeline wordt gevormd en hoe dit proces kan worden bevorderd. Deze 
inzichten zullen bijdragen aan het ontwikkelen van therapieën die mogelijkerwijs een 
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